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Summary 
Cellular metabolic adaptations play a central role in the body's response to 
environmental changes and external stimuli and allow the maintenance of a proper energy 
balance. Transcriptional activators enable the integration of incoming signals and sensing of 
altered energy levels. Dysregulation of such metabolic pathways is a common mechanism of 
various tissue dysfunctions contributing to different diseases. A key player in cellular 
metabolism is the transcriptional coregulator Peroxisome proliferator-activated receptor 
coactivator 1 alpha (PGC-1α). PGC-1α is expressed in tissues with high basal oxidative capacity 
such as brain and muscle and regulates the expression of a plethora of genes in response to 
various external cues, including exercise and fasting. This makes PGC-1α an extremely powerful 
metabolic sensor and a potential therapeutic target in metabolic diseases. Similarly, its 
downregulation during muscle aging and its central function in the control of mitochondrial 
gene expression suggests its crucial role in the development of age-related muscle disorders. 
However, to establish the true therapeutic potential of PGC-1α, it is important to evaluate its 
impact on metabolic sensing in those tissues and the consequences of its modulation in such 
pathological conditions. 
To determine the role of PGC-1α in central metabolic sensing and brain regulation of 
energy balance, we deleted the coactivator specifically in murine AgRP and POMC neurons 
located in the arcuate nucleus. The ablation of PGC-1α in POMC neurons did not reveal any 
major phenotype. Conversely, absence of PGC-1α in AgRP cells drove an increase in fat mass 
coupled with a reduction in locomotor activity and body temperature. Mice lacking the 
transcriptional coactivator in AgRP neurons exhibited a blunted leptin response and reduced 
food intake in fed and fasted conditions. Mechanistically, we demonstrated that fasting-induced 
AgRP expression is blunted in those mice and in an immortalized AgRP cell line, thereby leading 
to reduced feeding response upon fasting. Collectively, our results highlight a novel role for 
PGC-1α in neuronal regulation of energy homeostasis, which could be of therapeutic interest for 
the treatment of obesity and diabetes.  
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To determine the role of PGC-1α in muscle aging, we used muscle-specific PGC-1α 
deletion and overexpression mouse models. We confirmed that PGC-1α preserves 
mitochondrial function and protein expression, as well as muscle endurance during aging. More 
importantly, we identified a novel function for PGC-1α in muscle, involving the regulation of 
calcium homeostasis through the control of genes responsible for mitochondrial calcium uptake 
and mitochondrial association with the sarcoplasmic reticulum. We suspect that PGC-1α-
mediated amelioration of calcium metabolism protected the old muscle against ER stress and 
prevented tubular aggregate formation, which all contributed to reducing muscle apoptosis. 
Finally, we used muscle cells treated with ceramide or thapsigargin to demonstrate that PGC-1α 
inhibited apoptosis initiated by mitochondrial or calcium homeostasis impairments. This 
strongly confirms the potential therapeutic usage of PGC-1α to reduce age-related muscle 
disorders but also other diseases involving calcium dysregulation.  
 
In a final study, we used the same animal models that either received late-life endurance 
training or stayed untrained to determine the role of PGC-1α in exercise-mediated muscle 
improvements during aging. We demonstrated that PGC-1α could not only ameliorate muscle 
endurance but also age-associated motor dysfunctions. We also showed that PGC-1α muscle 
deletion led to pre-mature sarcopenia. Finally, we revealed that PGC-1α modulates many 
beneficial outcomes of exercise in the old muscle. PGC-1α muscle overexpression was sufficient 
to mimic or even override exercise beneficial effect on muscle aging. This further illustrates the 
importance of the coactivator in muscle aging and to maximize exercise positive outcomes in 
the old muscle 
 
In conclusion, the work undertaken in this thesis delineates new facets of PGC-1α-
controlled metabolism. We described a role for PGC-1α as metabolic sensor in the brain and 
presented novel aspects of muscle metabolism regulated by the coactivator. We showed that it 
is protective in several ways against age-related muscle disorders and that it promotes exercise 
effects in this context. This work therefore improves our understanding of the biological 
processes regulated by PGC-1α and established the transcriptional regulator as a promising 
target for therapeutic approaches in metabolic and age-associated muscle diseases.
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Abbreviations 
AgRP Agouti-related protein  
AMPK AMP-activated protein kinase 
ANS Autonomic nervous system  
ATF2 Activating transcription factor 2  
BAIBA β-aminoisobutyric acid  
BAP1 BRCA1 associated protein-1  
BAT Brown adipose tissue  
Bax BCL2 Associated X  
BCL2 B-Cell CLL/Lymphoma 2  
BDNF Brain derived neurotrophic factor  
BNIP3 BCL2/Adenovirus E1B 19kDa interacting protein 3 
BSA Bovine serum albumin 
CaMKIIα Calmodulin-dependent protein kinase IIα  
CaMKIV Ca2+/calmodulin-dependent protein kinase IV  
CART Cocaine- and amphetamine-regulated transcript  
CD36 Fatty acid translocase/CD36  
CPT1 Carnitine O-palmitoyltransferase 1  
CREB cAMP response element-binding protein  
CSQ1 Caslequestrin 1  
CSQ2 Caslequestrin 2  
CYPD Cyclophilin D  
DHRP Dihydropyridine receptor  
DMEM Dulbecco's modified Eagle's medium 
Drp1 Dynamin-related protein 1 
ERRs Estrogen-related receptors  
ERRα  Estrogen related receptor α 
ER stress Endoplasmic reticulum stress  
ERα Estrogen receptor-α  
FABP4 Fatty acid binding protein aP2  
FAO Fatty acid oxidation  
Fis1 Fission 1  
FNDC5 Fibronectin type III domain-containing protein 5  
FOXO1 Forkhead box O1  
FOXO3 Forkhead-Box-Protein O3  
FXR Farnesyl X receptor  
GCN5 General Control Of Amino Acid Synthesis Protein 5-Like 2  
GFP Green fluorescent protein 
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GLUT4 Glucose transporter 4  
Gpr17 G Protein-Coupled Receptor 17  
GPx Glutathione peroxidase  
GR Glucocorticoid receptor  
HAT Histone acetyltransferase  
HFD High fat diet  
HFN4 Hepatic nuclear factor-4  
ICV Intracerebroventricular  
IGFBP5  Insulin like growth factor binding protein 5 
IL-6 Interleukin 6  
IP3R Inositol 1,4,5-trisphosphate receptor type 
KO Knock out 
LDH Lactate dehydrogenase  
Letm1 lLucine zipper and EF-hand containing transmembrane protein 1 
LH Lateral hypothalamus  
LXR Liver X receptor  
MAM Mitochondria-associated-membranes  
MC3R Melanocortin-3  
MC4R Melanocortin -4 receptors  
MCAD Medium-chain acyl-coenzyme A dehydrogenase  
MEF-2 Myocyte enhancer factor-2  
Metrnl Meteorin-like  
Mfn1 Mitofusin 1  
Mfn2 Mitofusin 2  
mPTP Mitochondrial permeability transition pore opening  
mtDNA Mitochondrial DNA  
myoD Myogenic differentiation  
NAD Nicotinamide adenine dinucleotide  
NF-kB Nuclear factor kappa B  
NMJ Neuromuscular junction  
NPY Neuropeptide Y  
OGT O-GlcNAc transferase  
Opa1 Optic atrophies 1  
ORA1 ORAI Calcium Release-Activated Calcium Modulator 1  
OXPHOS Oxidative phosphorylation 
p38 MAPK P38 mitogen-activated protein kinase  
PDK4 Pyruvate dehydrogenase kinase 4  
PGC-1α/β Peroxisome proliferator-activated receptor γ coactivator 1α/β 
pH2AX Phospho-H2A Histone Family Member X 
PKA Protein kinase A  
POMC Proopiomelanocortin  
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PPARα Peroxisome proliferator-activated receptor  
PPARγ Peroxisome proliferator-activated receptor gamma  
ppRB  Phosphor-prepro-retinoblastoma-associated protein 
PVN Paraventricular nucleus  
PXR Pregnane X receptor  
RER Respiratory exchange ratio  
RNF34 Ring-finger-containing protein  
ROS Reactive oxygen species 
RYR Ryanodine receptor  
S6K1 S6 kinase 1  
SAR Serine/arginine-rich motifs  
SERCA Sarco/endoplasmic reticulum Ca2+-ATPase  
SHP Small heterodimer partner  
shRNA Specific short hairpin RNA 
SIRT1 Sirtuin 1  
SIRT3 Sirtuin 3 
SOD2 Superoxide dismutase 2  
SR Sarcoplasmic reticulum  
SREBP-1 Sterol regulatory element-binding protein 1  
STAT3 Signal transducer and activator of transcription 3  
STIM1 Stromal Interaction Molecule 1  
SWI/SNF Switch/sucrose nonfermentable  
TA Tibialis anterior 
TBP TATA binding protein 
Tfam Transcription factor A  
TNF Tumor necrosis factor  
TWEAK–Fn14 TNF-related weak inducer of apoptosis  
UCP1 Uncoupling protein 1  
UCP2 Uncoupling protein 2  
UCP3 Uncoupling protein 3 
UPR Unfolded protein response  
VDAC Voltage-dependent anion channel 
VEGF Vascular endothelial growth factor  
VLH Ventrolateral hypothalamus  
VMH Ventromedial hypothalamus  
WAT White adipose tissue  
WT Wild type 
XIAP  X-linked inhibitor of apoptosis protein 
ZNF746 Zinc Finger Protein 746 
α-MSH α-melanocyte-stimulating hormone  
β3-AR β3-adrenergic receptor  
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I. Introduction 
A. PGC-1α: a versatile coactivator of transcription 
Gene expression regulation plays a central role in cellular metabolism. For this reason, 
coregulators of transcription factors controlling the expression of various metabolic pathways 
are critical for cellular energetic adaptation to environmental changes and external stimuli. 
Accumulated lines of evidence firmly established the PGC-1 superfamily as particularly relevant 
coactivators of transcription for the control of energy metabolism. Peroxisome proliferator-
activated receptor gamma (PPARγ) coactivator 1 alpha (PGC-1α), the founding member of the 
superfamily, was originally discovered in a yeast two hybrid assay that aimed at identifying 
PPARγ binding proteins which determines the brown adipose tissue (BAT) and white adipose 
tissue (WAT) transcriptional specificity of PPARγ (Puigserver, Wu et al. 1998). PGC-1β is the 
closest homologue of PGC-1α with 40% of identity in the N-terminal domain, 35% in the central 
domain and 48% at the C-terminal site (Lin, Handschin et al. 2005). The PGC-1 superfamily is 
well conserved among various species indicating the key role in metabolic regulation (Lin, 
Handschin et al. 2005, LeMoine, Lougheed et al. 2010). PGC-1α does not bind to DNA and 
regulate transcription through chromatin remodeling (Puigserver, Adelmant et al. 1999), co-
activation of specific transcription factors (Puigserver, Wu et al. 1998) and control of mRNA 
splicing (Monsalve, Wu et al. 2000). PGC-1α is highly responsive to different environmental 
stimuli and acts as a molecular switch for many metabolic pathways leading to energetic 
adaptation such as adaptive thermogenesis or mitochondrial biogenesis (Puigserver, Wu et al. 
1998, Lin, Wu et al. 2002). Its versatile role is conferred by its interaction with numerous 
transcription factors in a tissue-specific manner (Villena 2015). Conversely to most ubiquitously 
expressed transcriptional coregulators, PGC-1α is only expressed in highly basal oxidative tissues 
including brain, skeletal muscle, heart, BAT and kidney (Esterbauer, Oberkofler et al. 1999, Wu, 
Puigserver et al. 1999, Knutti, Kaul et al. 2000). In addition, in organs where PGC-1α is 
expressed at low levels such as liver and WAT (Puigserver, Wu et al. 1998, Liang and Ward 
2006), its expression can be induced by fasting and cold exposure respectively (Handschin and 
Spiegelman 2006, Barbatelli, Murano et al. 2010). PGC-1α expression is also induced in 
I. Introduction 
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hypothalamus upon fasting (Ma, Li et al. 2010) and in skeletal muscle after exercise (Baar, 
Wende et al. 2002, Pilegaard, Saltin et al. 2003). The role of the coactivator in the latter two 
organs is discussed in more detail in this work. 
 
1. PGC-1α structure and molecular mechanism of action 
The PGC-1α gene is located on chromosome 5 in mice and 4 in humans, and encodes a 
nuclear protein of 91kDa that regulates transcription by binding transcription factors that will 
recognize specific promoter sequences on target genes. In addition, recruitment of the 
coactivator is also dependent on the promoter targeted by the transcription factor. Thus, in 
BAT, PGC-1α co-activates PPARγ to induce the expression of the uncoupling protein 1 (UCP1) 
but does not promote the PPARγ target fatty acid binding protein aP2 (FABP4) expression 
(Puigserver, Wu et al. 1998). Besides PPARγ, PGC-1α can interact with various other nuclear 
receptors (Fig. 1) including thyroid hormone receptor (Puigserver, Wu et al. 1998), retinoid 
receptors (Puigserver, Wu et al. 1998), glucocorticoid receptor (GR) (Knutti, Kaul et al. 2000), 
estrogen receptor-α (ERα) (Tcherepanova, Puigserver et al. 2000), PPARα (Vega, Huss et al. 
2000), PPARβ (Wang, Lee et al. 2003), RXRα (Delerive, Wu et al. 2002), farnesyl X receptor 
(FXR) (Zhang, Castellani et al. 2004), pregnane X receptor (PXR) (Bhalla, Ozalp et al. 2004), 
hepatic nuclear factor-4 (HFN4) (Rhee, Inoue et al. 2003), liver X receptor (LXR) (Lin, Yang et al. 
2005) and the estrogen-related receptors (ERRs) (Huss, Kopp et al. 2002, Schreiber, Emter et al. 
2004). Non-nuclear transcription factors have been identified as PGC-1α partners such as 
myocyte enhancer factor-2 (MEF-2) (Michael, Wu et al. 2001), forkhead box O1 (FOXO1) 
(Puigserver, Rhee et al. 2003), or sterol regulatory element-binding protein 1 (SREBP-1) (Lin, 
Yang et al. 2005) (Fig. 1). This extensive but non-exhaustive list of PGC-1α partners indicates the 
ability of the coactivator to regulate many different metabolic pathways. PGC-1α interacts with 
its different transcription factors through multiple protein domains. Most of the nuclear 
receptors bind to a LXXLL motif at the N-terminal site of PGC-1α (Fig. 1), which is the case for 
PPARα (Vega, Huss et al. 2000) and ERα (Tcherepanova, Puigserver et al. 2000). 3 LXXLL motifs 
are identified (Knutti, Kressler et al. 2001). In most cases the link through the second LXXLL 
motif relies on the fixation of a ligand by the receptor, but not for hepatic nuclear factor-4 for 
I. Introduction 
 
8 
example (Yoon, Puigserver et al. 2001). When the binding depends on the second LXXLL motif, 
PGC-1α generally interacts with the activation function 2 region of the receptor within the 
domain bound to the ligand, located in the C-terminus of the receptor. If this motif is not 
involved, the interaction with the receptor is mainly done at the central or N-terminal part of 
the receptor. Some transcription factors interact with other regions of PGC-1α. As follows, MEF-
2 binds to PGC-1α in the region located between the amino acid 400 and 550 (Fig. 1) (Michael, 
Wu et al. 2001), whereas PPARγ can bind to both the second LXXLL motif and in another region 
between amino acid 200 and 400 (Wallberg, Yamamura et al. 2003). 
 
 
 
Figure 1: Structure, interaction sites and post-translational modifications sites of the PGC-1α 
transcriptional coactivator. adapted from (Kupr and Handschin 2015) 
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Conversely to other coactivators such as cAMP response element-binding protein (CREB) 
binding protein (CBP/p300) and members of the steroid receptor coactivator (p160/SRC) family, 
PGC-1α does not have an intrinsic histone acetyltransferase (HAT). Therefore, the strong 
transcriptional activation domain at the N-terminal site of PGC-1α is in charge to bind 
coactivators with a HAT domain to remodel chromatin structure into a state that allows the 
transcriptional machinery to access the targeted genes (Puigserver, Adelmant et al. 1999). At 
the C-terminal extremity, PGC-1α associates with the RNA polymerase II and the TRAP 220 sub-
unit of the complex TRAP/mediator (Fig. 1) (thyroid hormone receptor-associated proteins), 
which facilitates interactions with the transcription initiation machinery (Wallberg, Yamamura 
et al. 2003). This extremity also recruits the switch/sucrose nonfermentable (SWI/SNF) 
chromatin-remodeling complex through its interaction with BAF60a (Li, Liu et al. 2008). On top 
of that, PGC-1α carboxyterminal region contains a RNA recognizing motif involved in RNA and 
single-strand DNA binding and short serine/arginine-rich motifs (SAR) (Fig. 1), which have been 
demonstrated to couple pre-mRNA splicing and transcription (Monsalve, Wu et al. 2000). In this 
fashion, after docking to transcription factors, the first mechanism by which PGC-1α activates 
gene expression is the recruitments of coactivators remodeling chromatin and the 
transcriptional machinery. However, PGC-1α transcriptional activator complexes are also able to 
remove repressors of transcription such as histone deacetylases or other inhibitors of 
transcription. For example, interaction of PGC-1α and the glucocorticoid receptor prevents the 
inhibiting binding of the corepressor small heterodimer partner (SHP) to the transcription 
factor, which further enhances gluconeogenic gene expression (Borgius, Steffensen et al. 2002). 
Similarly, the corepressor NCor1 and PGC-1α regulate oxidative metabolism in an antagonistic 
manner through the modulation of ERRα transcriptional activity in skeletal muscle (Perez-
Schindler, Summermatter et al. 2012). This demonstrates that gene expression regulation is 
dictated by a balance of co-repression and co-activation.  
I. Introduction 
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2. PGC-1α: a nodal regulator of cellular energy metabolism 
PGC-1α regulation as a metabolic sensor 
PGC-1α expression regulation under different stimulus is the first mechanism by which 
PGC-1α is responding to energetic changes. PGC-1α level increase can be triggered by a plethora 
of stimulus in a tissue-specific manner (Fig. 2). In muscle, PGC-1α expression is induced after 
exercise through different mechanisms (Fig. 2). First, exercise has been shown to induce an 
increase of PGC-1α through the activation of the p38 mitogen-activated protein kinase (p38 
MAPK) pathway in an activating transcription factor 2 (ATF2) dependent manner (Akimoto, 
Pohnert et al. 2005) (Fig. 2). Secondly, activation of Ca2+/calmodulin-dependent protein kinase 
IV (CaMKIV) and calcineurin A upon nerve stimulation interact and activate the transcription 
factor MEF2, which in turn induces PGC-1α transcription (Handschin, Rhee et al. 2003) (Fig. 2). 
Interestingly, MEF2 is also activated by p38 MAPK and might also mediate PGC-1α level 
increases though this pathway. Alternatively, CaMKIV also phosphorylates and activates the 
transcription factor CREB, which ultimately binds to the PGC-1α gene and activates its 
transcription (Wu, Kanatous et al. 2002, Handschin, Rhee et al. 2003) (Fig. 2). In a third 
pathway, Sirtuin 1 (SIRT1) expression and activity are stimulated upon nicotinamide adenine 
dinucleotide (NAD)(+)/NADH concentration ratio changes upon exercise (White and Schenk 
2012) and stimulate PGC-1α promoter activity (Amat, Planavila et al. 2009) (Fig. 2). Remarkably, 
in the presence of myogenic differentiation (myoD) and SIRT1, PGC-1α transcription induction 
further promotes its own promoter activity in a positive auto regulatory feedback loop 
(Handschin, Rhee et al. 2003, Amat, Planavila et al. 2009). Finally, AMP-activated protein kinase 
(AMPK) is stimulated by a high AMP/ATP ratio reflecting defects in energy production or 
increased energy consumption and therefore is activated by exercise (Jorgensen, Wojtaszewski 
et al. 2005). Activation of AMKP leads to increase of PGC-1α gene expression (Suwa, Nakano et 
al. 2003, Jorgensen, Wojtaszewski et al. 2005) (Fig. 2). Contrary to exercise, insulin down-
regulates PGC-1α mRNA expression by Akt phosphorylation and nuclear exclusion of FoxO1, a 
protein known to activate PGC-1α promoter (Fig. 2). In BAT, cold exposure is sensed by the 
sympathetic nervous system via the β3-adrenergic receptor (β3-AR) (Puigserver, Wu et al. 1998, 
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Boss, Bachman et al. 1999) that will activate cAMP signaling and Protein kinase A (PKA). 
cAMP/PKA signaling stimulation will increase PGC-1α transcription through both CREB 
(Handschin, Rhee et al. 2003) and the p38 MAPK-ATF2 axis (Cao, Daniel et al. 2004) (Fig. 2). 
Alternatively, cold exposure induced PGC-1α mRNA expression in BAT is mediated by nitric 
oxide-cGMP pathway (Nisoli, Clementi et al. 2003). In the liver, similar to cold exposure in BAT, 
glucagon stimulates the cAMP/PKA pathway that will induce CREB and the p38 MAPK-ATF2 axis, 
ultimately resulting in PGC-1α gene expression elevation (Herzig, Long et al. 2001, Cao, Collins 
et al. 2005) (Fig. 2). Heart, BAT, and liver thyroid hormones also increase PGC-1α mRNA levels 
indicating that PGC-1α expression additionally responds to hormonal changes (Puigserver, Wu 
et al. 1998, Weitzel, Radtke et al. 2001, Goldenthal, Weiss et al. 2004) (Fig. 2). Fascinatingly, 
PGC-1α is able to potentiate its own transcription by interacting with transcription factors that 
promote its expression such as myoD/SIRT1 as depicted above and MEF2 in muscle (Handschin, 
Rhee et al. 2003), FOXO1 in the liver (Daitoku, Yamagata et al. 2003), PPARγ in WAT (Hondares, 
Mora et al. 2006) and ERRγ in BAT (Wang, Liu et al. 2005) (Fig. 2). Those specific positive auto-
regulatory feedback loops dependent on the presence of particular transcription factors further 
increase the specificity and the fine-tuning of the PGC-1α responses to different stimulus in 
different tissues. 
 
 
Figure 2: Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) 
transcription. adapted from (Fernandez-Marcos and Auwerx 2011) 
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Several post-translational modifications of PGC-1α are equally important to regulate 
PGC-1α function according to different environmental changes. In addition to increasing its 
expression upon exercise (Akimoto, Pohnert et al. 2005), p38 MAPK phosphorylates PGC-1α at 
threonine-262, serine-265, and threonine-298 in response to cytokines (Puigserver, Rhee et al. 
2001) (Fig. 1). PGC-1α phosphorylation by p38 MAPK releases the co-repressor p160MBP from 
PGC-1α, which increases its co-transcriptional activity (Fan, Rhee et al. 2004) and enhances its 
stability (Puigserver, Rhee et al. 2001). The latest stabilization mechanism is important for PGC-
1α activity as its normal half-life lasts between 2 and 3 hours (Puigserver, Rhee et al. 2001, 
Sano, Tokudome et al. 2007). AMPK, induced by exercise in skeletal muscle (Jorgensen, 
Wojtaszewski et al. 2005), also phosphorylates PGC-1α at two other threonine-177 and serine-
538 sites to enhance PGC-1α co-transcriptional activity (Jager, Handschin et al. 2007) (Fig. 1). In 
an opposite manner, in addition to repress its gene expression (Southgate, Bruce et al. 2005), 
insulin stimulates hepatic Akt inhibition of PGC-1α activity through phosphorylation of its 
serine-570 (Li, Monks et al. 2007) (Fig. 1). A second post-translational modification that dictates 
PGC-1α activity is its acetylation status. PGC-1α is deacetylated by SIRT1 thereby promoting its 
co-transcriptional action, whereas it is heavily acetylated relocated within the nucleus by 
General Control Of Amino Acid Synthesis Protein 5-Like 2 (GCN5) which inhibits its activity 
(Lerin, Rodgers et al. 2006, Gerhart-Hines, Rodgers et al. 2007) (Fig. 1). As mentioned above, 
Sirt1 activity generally increases during  energetic states such as fasting, exercise, or oxidative 
stress in order to promote cellular energy loads to overcome these situations (Houtkooper, 
Canto et al. 2010). Likewise GCN5 is sensitive to different energetic status (Dominy, Lee et al. 
2010). As follows, in a coordinated manner, GCN5 and SIRT1 amounts are respectively increased 
and reduced upon caloric excess, lowering PGC-1α co-transcriptional function (Dominy, Lee et 
al. 2010). Consistently, GCN5 and SIRT1 levels are respectively reduced and elevated after 
caloric restriction, promoting PGC-1α action (Dominy, Lee et al. 2010). These data indicate that 
the SIRT1/GCN5-PGC-1α pathway acts as a powerful and flexible metabolic sensor of the cellular 
energetic level. Similarly, methylations of arginine-665, -667, and -669 by the protein arginine 
methyltransferase 1 have been shown to improve PGC-1α mediated transcriptional activation 
(Teyssier, Ma et al. 2005) (Fig. 1). On the contrary, PGC-1α SUMOylation in conserved lysine-
183 reduces its activity (Fig. 1). Lastly, while ubiquitination does not affect PGC-1α function, it 
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regulates its stability and therefore its cellular concentration. For example, the Ring-finger-
containing protein (RNF34) interacts with the C-terminal site of PGC-1α in BAT and drives its 
degradation via its specific E3 ubiquitin ligase activity (Wei, Pan et al. 2012). Interestingly, 
RNF34 is suppressed upon cold exposure and β3-adrenergic receptor signaling in BAT, 
suggesting that ubiquitination at least contributes to the PGC-1α expression pattern and 
thermogenesis action in this tissue (Wei, Pan et al. 2012). Plus, while both the E3 ubiquitin 
ligase SCF ubiquitin ligase complex subunit CDC4 and F-box, WD repeat domain containing 7 
trigger ubiquitin-proteasome degradation of PGC-1α, Necdin stabilizes PGC-1α through 
inhibition of its ubiquitin-mediated proteolysis. 
 
Counter to post-translational modification, transcription of different isoforms upon 
environmental changes alters the structure and therefore the different domains of PGC-1α 
(Martinez-Redondo, Pettersson et al. 2015), which ultimately also changes PGC-1α activity and 
regulation. For example, a shift of promoter activity towards an upstream transcription start site 
drives the expression of alternative PGC-1α transcripts, named PGC-1alpha-b and PGC-1alpha-c, 
upon exercise and β-adrenergic stimulation in skeletal muscle (Miura, Kai et al. 2008, 
Chinsomboon, Ruas et al. 2009). Captivatingly, fasting promotes the expression of the regular 
PGC-1alpha-a transcript from the proximal promoter in liver, but not the PGC-1alpha-b and 
PGC-1alpha-c variants (Miura, Kai et al. 2008). This further suggests that specific isoform 
expression could be induced to drive the expression of precise targets and prevent the loss of 
energy in the activation of non-required metabolic pathways. Accordingly, different PGC-1α 
variants can also be regulated and activated in a specific manner. Thus, even if NT-PGC-1α 
proteins that lack the C-terminal domain can still co-activate PPARα and PPARγ, this interaction 
is strictly ligand dependent (Zhang, Huypens et al. 2009). Moreover the lack of the C-terminal 
site makes NT-PGC-1α resistant to Twist-1-mediated inhibition in BAT and for this reason NT-
PGC-1α cannot be repressed by the negative feedback loop engaging Twist-1 (Jun, Gettys et al. 
2012). To date, more than ten PGC-1α isoforms have been identified with variations in their 
tissue expression, regulation and function (Martinez-Redondo, Pettersson et al. 2015) which 
gives another dimension to the complexity and the versatility in the response that PGC-1α can 
bring to different stimuli. 
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PGC-1α: a central metabolism molecular switch  
Through its regulation and activation, PGC-1α will integrate environmental stimuli as 
well as the current cellular energetic status and regulate the transcription of its target genes to 
adapt cellular and tissue metabolism accordingly (Fig. 3). As mentioned before, PGC-1α can be 
induced in tissues where its expression is basally low and is highly expressed in organs requiring 
elevated oxidative metabolism. Its expression in multiple tissues implies that it regulates various 
metabolic functions. Skeletal muscle is one of the tissues where PGC-1α has been the most 
extensively studied. The different processes that PGC-1α control in the skeletal muscle includes 
mitochondrial biogenesis and function (Wu, Puigserver et al. 1999, Lin, Wu et al. 2002), 
conversion of muscle type II glycolytic fibers to type IIa  and I oxidative fibers (Lin, Wu et al. 
2002) and fatty acid oxidation (FAO) (Olesen, Kiilerich et al. 2010) (Fig. 3). The role of PGC-1α in 
skeletal muscle is discussed more extensively in section I.C.2. 
 
Comparable to skeletal muscle, cellular and animal models depicted PGC-1α as a strong 
inducer of mitochondrial biogenesis in hearts (Lehman, Barger et al. 2000, Russell, Mansfield et 
al. 2004) (Fig. 3). Global loss of PGC-1α leads to 30–50% reduction in oxidative gene expression 
and slight reductions in mitochondrial activity in the heart that results in mild contractile 
alterations on basal conditions (Arany, He et al. 2005, Lehman, Boudina et al. 2008). However, 
those moderate deficiencies become detrimental under stress conditions. As a result, PGC-1α 
knockout mice display major heart malfunctions leading to heart failure when exposed to 
transverse aortic constriction (Arany, Novikov et al. 2006) (Fig. 3). In addition, these mice 
display lower heart contraction force and beat rate, as well as ventricular dysfunctions following 
extreme exercise or dobutamine treatments (Arany, He et al. 2005, Leone, Lehman et al. 2005). 
These dysfunctions could be imputed to insufficient ATP and fatty acid generation by cardiac cell 
of knock out animals (Fig. 3) that would not be able to sustain an increased contraction required 
in these situations (Leone, Lehman et al. 2005). Therefore, if basal heart functions are not 
deteriorated by the absence of PGC-1α, its role as a molecular switch is particularly important 
when the heart is intensely stimulated. Prenatal development is another condition that requires 
high energy production through elevated mitochondrial biogenesis and during which the heart 
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undergoes a switch in energy substrate preference from glucose in the fetal period to fatty acids 
(Lehman and Kelly 2002). Intriguingly, while double deletion of PGC-1α and PGC-1β does not 
severely affect the myocardial function if induced in the adult stage, the same gene ablations 
triggered perinatal death with reduced mitochondrial biogenesis and absence of arrest of fetal 
gene expression when induced before birth (Lai, Leone et al. 2008, Martin, Lai et al. 2014) (Fig. 
3). These data further show that albeit dispensable for basal metabolism, the PGC-1 
coactivators are critical in the process of metabolic adaptation to changes in energetic 
requirements. 
 
Furthermore, in BAT, while PGC-1α global knockout mice are cold intolerant due to 
failure in the upregulation of the thermogenic program through UCP1 and deiodinase-2 (Dio2) 
transcription, its ablation does not alter their expression upon normal temperatures (Lin, Wu et 
al. 2004). Increased transcription of the thermogenic and mitochondrial program upon PGC-1α 
upregulation in human (Tiraby, Tavernier et al. 2003) and mouse (Puigserver, Wu et al. 1998) 
white adipocytes further strengthen the importance of PGC-1α for the control of thermogenesis 
(Fig. 3). In WAT, scattered brown-like adipocytes can differentiate to beige adipocytes after 
stimulation with cold and FGF21 (Fisher, Kleiner et al. 2012). In line with its role in BAT, PGC-1α 
plays a role in this differentiation process (Fig. 3), notably by promoting the expression of 
mitochondrial and thermogenic genes (Fisher, Kleiner et al. 2012).  
 
In liver, PGC-1α is induced and activated by fasting and will accordingly regulate a broad 
metabolic program including gluconeogenesis, fatty-acid β-oxidation, ketogenesis, heme 
biosynthesis, and bile acid homeostasis to adapt liver metabolism to the energetic crisis 
triggered by starvation (Lin, Handschin et al. 2005) (Fig. 3). This is done through the co-
activation of numerous hepatic transcription factors such as HNF4α, PPARα, GR or FOXO1 (Lin, 
Handschin et al. 2005) (Fig. 3). Following these observations, mice lacking PGC-1α expression or 
with specific liver PGC-1α knock-down, fail to regulate hepatic gluconeogenic gene expression 
and hepatic glucose production (Lin, Wu et al. 2004, Handschin, Lin et al. 2005) (Fig. 3) and 
display insulin resistance (Koo, Satoh et al. 2004), hypoglycemia and hepatic steatosis upon 
fasting (Leone, Lehman et al. 2005). Interestingly, SITR1 deacetylation and S6 kinase 1 (S6K1) 
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phosphorylation of hepatic PGC-1α respectively potentiates and represses the regulation of 
gluconeogenic genes by PGC-1α without altering its capacity to induce the transcription of 
genes related to oxidative metabolism (Rodgers, Lerin et al. 2005, Lustig, Ruas et al. 2011). This 
further demonstrates the fantastic ability of PGC-1α to induce specific gene networks to 
propose the appropriate answer to certain energetic and metabolic demands. 
 
 
Figure 3: PGC-1α functions in various tissues, as well as its partners and metabolic regulators. 
adapted from (Besseiche, Riveline et al. 2015) 
 
B. PGC-1α and the brain in the regulation of energy homeostasis 
For survival, a living organism has to conserve a tight energetic balance, which is 
determined by energy intake and expenditure. Body energy homeostasis is achieved through 
fast metabolic adaptation to various situations and environmental changes such as physical 
activity, fasting or temperature alteration. Those metabolic changes are mainly mediated by a 
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transcriptional mechanism controlled by transcription factors and their coactivators (Francis, 
Fayard et al. 2003) that are sensitive to the cellular energetic status and that consequently 
regulate gene expression. 
 
1. Brain control of whole body energy homeostasis  
The ability to maintain energy homeostasis is a fundamental prerequisite for the proper 
of any living being. The body needs to store excess of calories when available to face periods of 
energetic deficit and ensure basal physiologic functions as well as additional critical energy 
demanding activities such as flight from predators or food foraging. This can occur over 
different amounts of time, from the simple sleeping overnight fast to longer periods of 
hibernation for example. Body weight and temperature maintenance are two examples 
perfectly illustrating how well healthy organisms are able to preserve stable energetic states. 
Accumulated lines of evidence implicates the central nervous system as a primary regulatory 
system of energy balance for the body (Morton, Meek et al. 2014). Indeed, as PGC-1α can sense 
signals of the energetic status in the cell and adapt cellular metabolism accordingly, the brain is 
able to monitor and integrate multiple metabolic inputs from peripheral organs to enact 
appropriate and consequential metabolic and behavioral responses (Fig. 4). Thus, the central 
nervous system balances mechanisms of food intake with processes regulating energy 
expenditure, including thermoregulation, basal metabolism, and physical activity to meet 
changes in the body energy state (Sandoval, Cota et al. 2008). Hypothalamus has been shown 
to control a broad range of function essential for the regulation of energy homeostasis such as 
sleep and arousal, hunger and thirst (Fig. 4) (Waterson and Horvath 2015).  
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Figure 4: Control of energy homeostasis by arcuate nucleus neurons. adapted from (Barsh and 
Schwartz 2002) 
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Hypothalamic control of food intake and body weight 
The role of the hypothalamus as a central regulator of feeding has been established in a 
study done in 1951 where the authors showed that ventromedial hypothalamus (VMH) and 
ventrolateral hypothalamus (VLH) lesions respectively trigger over- and under-feeding in the rat 
(Anand and Brobeck 1951, Anand and Brobeck 1951). It is now established that the arcuate 
nucleus, located in the hypothalamus, is a key element of the regulation of energy balance. It is 
adjacent to the median eminence and surrounds the third cerebroventricle, which facilitates the 
entry of hormones and nutrients from the systemic circulation and cerebrospinal fluid (Xu, 
Kaelin et al. 2005). Two main types of neurons expressing either neuropeptide Y (NPY) and 
agouti-related protein (AgRP) or proopiomelanocortin (POMC) and cocaine- and amphetamine-
regulated transcript (CART) populate the arcuate nucleus (Fig. 4). The ablation of NPY and AgRP 
neurons leads to food intake and body weight reduction (Gropp, Shanabrough et al. 2005, 
Luquet, Perez et al. 2005) whereas the loss of POMC and CART neurons promotes an opposite 
effect (Xu, Kaelin et al. 2005), firmly demonstrating the importance of these two kinds of 
neurons in the control of energy homeostasis (Fig. 4). Furthermore, AgRP and NPY expressions 
are increased during food deprivation while POMC and CART expression levels are decreased 
(Ziotopoulou, Erani et al. 2000, Savontaus, Conwell et al. 2002), illustrating their role for the 
integration of energy deficit signals. Neurons of the arcuate nucleus project and act on a second 
order of neurons (Fig. 4) in different other nuclei of the hypothalamus such as the 
paraventricular nucleus (PVN), VMH and lateral hypothalamus (LH), as well as on autonomic 
preganglionic neurons in the brain stem and spinal cord to regulate energy balance (Bouret, 
Draper et al. 2004). α-melanocyte-stimulating hormone (α-MSH), a product of 
posttranscriptional processing of POMC, is released from the synaptic terminal of POMC 
neurons and binds to melanocortin-3 (MC3R) and melanocortin-4 receptors (MC4R) on second-
order neurons to reduce food intake and increase energy expenditure (Millington 2007). 
Consistently, MC4R deletion leads to hyperphagia and obesity with reduced energy expenditure 
(Huszar, Lynch et al. 1997). AgRP is released from AgRP neurons and competes with α-MSH for 
MC3Rs and MC4Rs to antagonize its effects (Ollmann, Wilson et al. 1997) while NPY induces 
food intake via Y1 or Y5 receptors (Yulyaningsih, Zhang et al. 2011). NPY triggers rapid feeding 
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stimulation whereas AgRP action is promoting food intake for a longer period (Bingham, 
Anderson et al. 2008). 
 
Hypothalamic control of energy expenditure and metabolism 
Opposite to energy intake that creates a positive energy homeostasis, energy 
expenditure promotes a negative energy balance. Besides regulating feeding, the hypothalamus 
and the arcuate nucleus can alter various mechanisms resulting in energy expenditure to 
maintain an appropriate energetic state including locomotor activity, FAO and thermogenesis 
(Fig. 4) (Spiegelman and Flier 2001). For example, leptin administration in the arcuate nucleus 
stimulates sympathetic BAT innervation (Rahmouni and Morgan 2007) whereas suppression of 
the leptinergic pathway prevents sympathetic BAT activation (Fig. 4) (Harlan, Morgan et al. 
2011). Consistently, alteration of the MCR4 prevents central leptin induction of UCP1 in both 
BAT and WAT and decreases oxygen consumption (Ste Marie, Miura et al. 2000, Zhang, Kilroy 
et al. 2005). AgRP and NPY neurons naturally inhibits BAT thermogenesis but their inhibition 
releases this repression and activates sympathetic fibers on BAT (Bewick, Gardiner et al. 2005, 
Shi, Lau et al. 2013), therefore contributing to the leaner phenotypes of these mice compared 
with controls animals. Plus, intracerebroventricular (ICV) administration of NPY reduces core 
body temperature (Currie and Coscina 1995, Hwa, Witten et al. 1999), oxygen consumption 
(Currie and Coscina 1995, Hwa, Witten et al. 1999) and represses thermogenic activity in BAT 
(Egawa, Yoshimatsu et al. 1991). Opposite to the AgRP/NPY-BAT inhibition, POMC neuronal 
activation and α-MSH central treatment promote BAT activation through the sympathetic 
nervous system (Butler and Cone 2002, Yasuda, Masaki et al. 2004, Yasuda, Masaki et al. 
2004). In line with these data, α-MSH analogue MTII central administration elevates core body 
temperature (Murphy, Nunes et al. 2000), oxygen consumption (Hamilton and Doods 2002) 
and uncoupling proteins expression in both BAT and skeletal muscle (Cettour-Rose and Rohner-
Jeanrenaud 2002). In addition to BAT regulation, co-administration of leptin and insulin 
stimulates WAT browning and energy expenditure that protects against diet induced obesity 
(Dodd, Decherf et al. 2015). This suggests that thermogenesis represent a substantial source of 
energy expenditure that can compensate an excess of calorie intake. 
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Several lines of evidence indicate that the arcuate nucleus also regulates locomotor 
activity (Fig. 4). Both intracerebroventricular administration of NPY and deletion of the MC4R 
reduce spontaneous locomotion (Heilig, Vecsei et al. 1989, Ste Marie, Miura et al. 2000) 
whereas intracerebroventricular infusion of CART leads to the opposite effects (Kimmel, Gong 
et al. 2000). These results fit with the lower activity observed during energetic deficit where 
AgRP and NPY levels are increased and CART and POMC expression decreases (Ziotopoulou, 
Erani et al. 2000, Savontaus, Conwell et al. 2002). Voluntary activity is therefore used as an 
energy-conserving mechanism during energetic crisis. Further genetic modifications point 
towards a role for the arcuate nucleus in the regulation of locomotor activity. For example, 
voluntary activity is increased in obese mice that express leptin receptor only in POMC neurons 
compared to mice completely lacking leptin receptors. (Huo, Gamber et al. 2009). Similarly, 
constitutive activation of Signal transducer and activator of transcription 3 (STAT3) in AgRP cells, 
which mediates leptin inhibiting signaling in AgRP neurons increases spontaneous activity and 
partially protects from high fat diet feedings (Mesaros, Koralov et al. 2008). These results 
demonstrate that leptin induced spontaneous locomotor activity is driven by both POMC and 
AgRP neurons. Finally, deletion of other elements such as PPARγ in POMC neurons and ROCK1 
in AgRP neurons also alters locomotor activity (Huang, Lee et al. 2013, Long, Toda et al. 2014). 
 
The metabolic adaptation of different tissue to environmental changes also includes 
alterations in the control of nutrient storage, transformation and substrate utilization. 
Therefore, autonomic nervous system (ANS) modulation of peripheral organ activity via efferent 
nerves is an essential adaptive response initiated by the brain, according to the different 
energetic states recorded. Interestingly, both AgRP and POMC neurons project to the pre-
autonomic structures such as the PVN and show direct action on peripheral tissues (Fig. 4). 
Thus, central MCRs inhibition triggers elevation of lipid synthesis and storage and insulin 
stimulated glucose uptake in the WAT, glucose metabolism decrease in BAT and muscle and 
triglyceride synthesis and export from the liver, all independent from food intake (Nogueiras, 
Wiedmer et al. 2007). Conversely, central activation of MCR promotes lipid mobilization in 
WAT. This perfectly illustrates initiation of changes in substrate utilization and storage by the 
melanocortin system. Furthermore, AgRP release has been shown to be mandatory for fasting-
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induced hepatic stimulation by the sympathetic nervous system resulting in liver triglycerides 
synthesis while central AgRP knock-down preserves animals from liver steatosis upon high fat 
diet feeding (Warne, Varonin et al. 2013). Lastly, restauration of leptin receptors in POMC 
neurons of mice with global leptin receptor knock-out restored blood glucose levels (Huo, 
Gamber et al. 2009) while mice with AgRP neurons specific ablation of insulin receptors display 
hepatic insulin resistance (Konner, Janoschek et al. 2007). Changes in arcuate leptin signaling 
alter hepatic glucose production via reduction of hepatic gluconeogenic gene expression and 
BAT glucose uptake (German, Kim et al. 2009). However, leptin microinjection in the VMH 
increases glucose uptake in skeletal muscle, heart and BAT (Minokoshi, Haque et al. 1999). 
Together, those data show that the arcuate nucleus is important for nutrient partitioning and 
for whole body glucose metabolism.  
Peripheral regulators of appetite 
Various circulating elements reflect fat storage and inform our brain about the energetic 
reserve of our body (Fig. 4 and 5). Leptin is mainly expressed in the adipose tissue (Zhang, 
Proenca et al. 1994) and its circulating levels are highly correlated to fat mass (Maffei, Halaas et 
al. 1995), although it is suppressed by food restriction and restored by insulin administration or 
refeeding (Frederich, Lollmann et al. 1995, Maffei, Halaas et al. 1995). Central leptin 
administration reduces spontaneous and fasting-mediated hyperphagia (Davis, Mullins et al. 
1998) through repression of AgRP and NPY expression and elevation of CART/POMC levels 
resulting in AGRP and POMC neurons inactivation and activation respectively (Stephens, 
Basinski et al. 1995, Schwartz, Baskin et al. 1996, Hahn, Breininger et al. 1998, Elias, 
Aschkenasi et al. 1999). Similar to leptin, pancreas secreted insulin reflects long-term energy 
homeostasis (Woods, Decke et al. 1974) and correlates with total adiposity but also fat 
distribution (Porte, Baskin et al. 2002). Insulin is rapidly secreted after feeding (Polonsky, Given 
et al. 1988) and decreases food intake and body weight when injected centrally (Air, Strowski et 
al. 2002). Intracerebroventricular insulin administration abolishes fasting-induced increase in 
arcuate nucleus NPY transcript levels (Schwartz, Sipols et al. 1992) and elevates POMC 
expression (Benoit, Air et al. 2002).  
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Hormones produced by the gut provide information about energy intake. Ghrelin is 
secreted by the stomach in periods of fasting (Cummings, Clement et al. 2002) and its plasma 
levels inversely correlates with adiposity (Otto, Cuntz et al. 2001). Central injection of ghrelin 
elevates food intake, body weight and represses fat utilization (Tschop, Smiley et al. 2000, 
Wren, Small et al. 2001) while central administration of anti-ghrelin antibodies diminishes 
fasting induced refeeding (Nakazato, Murakami et al. 2001). Failure of ghrelin to induced 
feeding after arcuate nucleus ablation (Tamura, Kamegai et al. 2002) and in mice lacking 
AgRP/NPY signaling, (Chen, Trumbauer et al. 2004) demonstrates that ghrelin regulation of 
food intake is mediate through the arcuate nucleus. Glucagon-like peptide-1, secreted from the 
L cells of the small intestine (Herrmann, Goke et al. 1995) inversely correlates to body mass 
(Holst, Schwartz et al. 1983), inhibits food intake (Ranganath, Beety et al. 1996, Naslund, 
Barkeling et al. 1999) and is released post-feeding (Herrmann, Goke et al. 1995). 
 
Some circulating nutrients such as glucose, fatty acids or amino acids, signal nutrients 
availability and the energy status to the brain that can then regulate their production and 
utilization (Fig. 5). Thus, glucose reflects available energy resources and hypoglycemia indicates 
energetic deficits (Myers and Olson 2012). Consequently, central injection of glucose or fatty 
acids decreases food intake (Obici, Feng et al. 2002) while glucose anti-metabolite 2-deoxy-D-
glucose promotes it (Miselis and Epstein 1975). Similarly, inhibition of carnitine 
palmitoyltransferase-1 elevates Long-chain fatty acyl-CoA content in the hypothalamus leading 
to reduced feeding (Obici, Feng et al. 2003). Finally, Interleukin-6, which is released by the 
muscle according to exercise intensity and duration, induces energy expenditure and reduces 
body fat upon intracerebroventricular injection (Wallenius, Wallenius et al. 2002). 
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2. The role of PGC-1α in the brain 
PGC-1α in the healthy and sick brain 
Like in every other highly energy demanding tissue, PGC-1α is highly expressed in the 
brain (Esterbauer, Oberkofler et al. 1999, Wu, Puigserver et al. 1999, Knutti, Kaul et al. 2000) 
where it is required for GABAergic neuronal development (Cowell, Blake et al. 2007) (Fig. 3). 
The brain largely relies on mitochondria to produce ATP that will serve for ion homeostasis and 
neuronal firing activity. Mitochondrial dysfunction therefore represents a common mechanism 
for many neurological disorders (Chaturvedi and Flint Beal 2013). Given the master role of PGC-
1α in the regulation of the mitochondrial function (Houten and Auwerx 2004), it is natural to 
speculate about its contribution to the neuronal function. On that account, while the role of 
PGC-1α in the brain has not been investigated as extensively as in peripheral tissues (e.g. 
skeletal muscle or BAT), several studies already provided evidence for its fundamental role in 
the central nervous system. For example, global deletion of PGC-1α leads to motor dysfunctions 
(Lucas, Dougherty et al. 2012), neurological abnormalities such as myoclonus and dystonia, and 
signs of neurodegeneration in the cortex, thalamus, basal ganglia, substantia nigra and 
hippocampus (Lin, Wu et al. 2004, Jiang, Kang et al. 2016) (Fig. 3). Interestingly, striatal 
degeneration, hyperkinetic movement disorders and mitochondrial dysfunction, also displayed 
in PGC-1α global knockout mice (Lin, Wu et al. 2004, Leone, Lehman et al. 2005), are all 
reminiscent symptoms of the Huntington disease (Fig. 3) (Dayalu and Albin 2015). Moreover, 
PGC-1α expression and activity are decreased in brains of both Huntington disease patients 
(McGill and Beal 2006) and mouse models (Cui, Jeong et al. 2006, Weydt, Pineda et al. 2006) 
and PGC-1α deletion aggravates the neurodegeneration of striatal neurons and motor 
abnormalities of the mouse model (Cui, Jeong et al. 2006). In this animal model, mutant 
huntingtin interacts and binds with the CREB/TAF4 complex, which impairs PGC-1α promoter 
activation and represses the transcription of its target genes (Cui, Jeong et al. 2006, McGill and 
Beal 2006). Importantly, overexpression of PGC-1α in both cultured striatal neurons and in the 
striatum of the huntingtin disease mouse model leads to neuroprotection and enhances 
mitochondrial function (Fig. 3) (Cui, Jeong et al. 2006). Finally, polymorphism in PGC-1α and its 
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target genes like nrf1 or tfam modify the age onset of the Huntington disease (Weydt, Soyal et 
al. 2009, Taherzadeh-Fard, Saft et al. 2011), confirming its important place in the pathogenesis 
of this neurodegenerative disorder. 
 
Similar to Huntington disease, a decrease of PGC-1α levels and expression of its target 
genes is observed in patients with Parkinson disease (Zheng, Liao et al. 2010) and PGC-1α global 
knockout results in neurodegeneration of the dopaminergic neurons in the substantia nigra 
which characterizes the disease (Lin, Wu et al. 2004) (Fig. 3). Consistently, PGC-1α global 
deletion leads to increased vulnerability to MPTP induced degeneration of nigral dopaminergic 
neurons (St-Pierre, Drori et al. 2006) while its overexpression or activation by resveratrol 
protects dopaminergic neurons of the MPTP mouse model of Parkinson disease (Mudo, Makela 
et al. 2012). PGC-1α promoter has recently been shown to be more methylated in Parkinson 
disease patients, which participates to its transcription repression (Su, Chu et al. 2015). In 
addition, a study showed that PGC-1α knock-down increases α-synuclein accumulation in 
human neuronal cells, which also occurs in Parkinson (Tsunemi and La Spada 2011) disease 
patients. Consistently, another work shows that PGC-1α protects from a mutant α-synuclein-
mediated cell death in vitro by improving expression of oxidative phosphorylation (OXPHOS) 
genes (Zheng, Liao et al. 2010). Correlating with lower expression of PGC-1α in Parkinson 
disease patients, several studies report that alterations of Parkinson disease genes expression 
affect PGC-1α levels. For instance, upon inactivation of parkin, the parkin interacting substrate 
PARIS (ZNF746) is not degraded and represses the expression of PGC-1α by binding insulin-
response sequences in the PGC-1α promoter (Shin, Ko et al. 2011), simultaneously leading to 
the selective loss of dopamine neurons in the substantia nigra. The substantia nigra 
neurodegeneration induced by PARIS overexpression is reversed by either PARKIN or PGC-1α 
co-expression (Shin, Ko et al. 2011). 
 
Other investigations indicate beneficial effects of PGC-1α in Alzheimer and amyotrophic 
lateral sclerosis diseases and other neuronal conditions (Fig. 3). In Alzheimer disease patients, 
PGC-1α levels are decreased (Qin, Haroutunian et al. 2009). In a mouse model of Alzheimer 
disease, PGC-1α decreases the accumulation of aggregated Aβ peptide (Katsouri, Parr et al. 
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2011), promotes neuronal survival and prevents learning impairments (Kim, Nguyen et al. 
2007). In an amyotrophic lateral sclerosis mouse model, PGC-1α improves survival, motor 
function, blood glucose and motor neuron survival (Zhao, Varghese et al. 2011) (Fig. 3). Besides 
these conditions, recent investigations illustrated beneficial effect of PGC-1α after intracerebral 
hemorrhage (You, Hou et al. 2016), traumatic spinal cord injury (Hu, Lang et al. 2016) and in 
multiple sclerosis (Nijland, Witte et al. 2014). Mechanistically, PGC-1α improves neuronal 
mitochondrial dysfunctions and reduces oxidative stress (Fig. 3) (Lin, Wu et al. 2004, St-Pierre, 
Drori et al. 2006), which greatly participates to neuronal protection and many disorders 
ameliorations mediated by PGC-1α. In addition, deletion of PGC-1α alters inhibitory synaptic 
transmission in the motor cortex, which could contribute to cortical hyper-excitability and 
motor abnormalities of various neurological conditions (Dougherty, Bartley et al. 2014). 
Together those elements confirm the importance of PGC-1α for healthy neuronal function and 
suggest that modulation of PGC-1α could be an attractive target in the fight against multiple 
neurological diseases. However, upregulation of PGC-1α expression would need to be carefully 
controlled as sustained overexpression of PGC-1α in the substantia nigra impairs the function of 
dopaminergic neurons (Ciron, Lengacher et al. 2012). 
 
PGC-1α as a potential regulator of energy homeostasis in the arcuate nucleus 
Since PGC-1α is a master inducer of mitochondrial function (Houten and Auwerx 2004) 
and drives utilization of fat as fuel (Liang and Ward 2006), one would expect its global deletion 
to result in weight gain and elevate the susceptibility to induced obesity. Paradoxically, mice 
with whole body PGC-1α ablation display resistance to obesity upon high fat diet feeding (Lin, 
Wu et al. 2004). This unexpected result is likely driven by the increased metabolic rate, insulin 
sensitivity and spontaneous activity of these mice. However, it is difficult to discriminate which 
tissue could be responsible for the altered systemic energy balance. In addition, PGC-1α 
controls various metabolic pathways in different tissues further modulating systemic 
metabolism through crosstalks and secondary effects, which makes the interpretation even 
more difficult. To test whether the changes in whole body energy homeostasis were due to the 
action of PGC-1α in the brain or in peripheral tissues, Lin and collaborators developed a PGC-1α 
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brain knockout mouse by crossing PGC-1α flox/flox mice with calcium/calmodulin-dependent 
protein kinase IIα (CaMKIIα)-Cre transgenic mice (Ma, Li et al. 2010). Similar to whole body 
deletion of PGC-1α, its neuronal ablation results in resistance to obesity and liver steatosis, 
despite high fat diet feeding and hyperphagia, and leads to increased metabolic rate and insulin 
sensitivity suggesting a role for PGC-1α in the central control of energy balance (Fig. 3). 
However, the resistance to body weight gain upon a high fat diet remains less pronounced than 
for the PGC-1α whole body knockout mice and brain deletion of PGC-1α does not lead to 
hyperactivity. This suggests that CaMKIIα negative neurons or peripheral tissues might also 
contribute to energy balance alteration observed in PGC-1α whole body knockout mice. 
Alternatively, it cannot be ruled out that some CaMKIIα positive cells still lack cre expression or 
that PGC-1α expression is not fully abolished in a subset of CaMKIIα neurons and could still 
mediate its role in the regulation of energy homeostasis. Further evidence suggests that PGC-1α 
not only influences energy homeostasis in the brain but also directly regulates energy balance 
from the central hypothalamic feeding center. For example, hypothalamic PGC-1α levels are 
increased upon fasting (Coppari, Ramadori et al. 2009) (Fig. 3) and PGC-1α is present in NPY 
neurons (Draper, Kirigiti et al. 2010). Interestingly, both its whole body (Lin, Wu et al. 2004) 
and neuronal (Ma, Li et al. 2010) ablation blunt the fasting-induced expression of the feeding 
peptides AgRP and NPY (Fig. 3). These results indicate that PGC-1α responds to fasting signals in 
the hypothalamus and that it is required to coordinate transcriptional changes necessary to 
cope with fluctuations in body energy content. Converse to fasting, high fat diet and fatty acids 
treatment depletes PGC-1α in the hypothalamus, which affects ERα expression (Fig. 5) and 
induces hypothalamic inflammation (Morselli, Fuente-Martin et al. 2014) (Fig. 3) supporting the 
role of PGC-1α in the hypothalamus for transcriptional adaptation to changes in energetic 
signaling. Besides inflammation, ERα downregulation in different hypothalamic neurons that 
alters food intake, energy expenditure, and body weight could also be regulated by PGC-1α (Xu, 
Nedungadi et al. 2011). In addition, the disruption of the circadian rhythm by the global 
deletion of PGC-1α (Liu, Li et al. 2007) and the circadian oscillation of PGC-1α in POMC neurons 
(Agapito, Zhang et al. 2014) (Fig. 3) reinforces the idea of a major role for PGC-1α at the central 
level.  
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Figure 5: Signaling pathways in AgRP and POMC neurons regulating energy homeostasis. 
 
As described above, PGC-1α is an excellent energy metabolic sensor and can integrate 
various signals in peripheral tissues that are also used in the arcuate nucleus to regulate whole 
body energy homeostasis (Fig. 3 and 5). As a result, in liver, PGC-1α responds to subcutaneous 
ghrelin injections to increase hepatic gluconeogenic production (Barazzoni, Zanetti et al. 2007) 
(Fig. 3). In a chronic kidney disease mouse model showing muscle mass decline, ghrelin has 
been shown to reduce the methylation of a cysteine residue upstream of the PGC-1α gene 
which improved the PGC-1α expression decrease observed in these mice (Tamaki, Hagiwara et 
al. 2015). The ghrelin mediated increase in PGC-1α levels likely contributed to the improved 
mitochondrial amounts, muscle mass and exercise performance of ghrelin treated mice, 
indicating that PGC-1α responds to ghrelin and can in turn coordinate an appropriate metabolic 
adaptation. Similarly, a study indicates that PGC-1α ameliorates insulin-stimulated glucose 
transport in muscle and that its upregulation mediates insulin sensitivity improvements induced 
by exercise (Bonen 2009). In line with these results, PGC-1α overexpression ameliorates 
disrupted insulin signaling in muscle and its deletion disturbs it (Pagel-Langenickel, Bao et al. 
2008) (Fig. 3). Interestingly, muscle knock-down of the insulin receptor reduces PGC-1α 
expression and mitochondrial bioenergetics (Pagel-Langenickel, Bao et al. 2008). In liver, insulin 
indirectly regulates PGC-1α transcriptional activity through foxo1 interaction to control the 
expression of the gluconeogenic program (Puigserver, Rhee et al. 2003). Leptin, another 
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regulator of appetite, also influences muscle PGC-1α expression to regulate muscle mass (Fig. 
3). Indeed leptin injections restore muscle mass and PGC-1α expression that were decreased in 
leptin-deficient ob/ob mice compared to control mice (Sainz, Rodriguez et al. 2009). The 
restoration of muscle mass is likely promoted by PGC-1α mediated downregulation of atrophic 
genes (Sandri, Lin et al. 2006). Likewise, in BAT, PGC-1α expression is reduced in both leptin-
deficient ob/ob mice and leptin-unresponsive db/db mice and leptin treatments rescued PGC-
1α and UCP1 expression (Kakuma, Wang et al. 2000) (Fig. 3). Moreover, PGC-1α cold-exposure 
induction was largely reduced in leptin unresponsive rats (Kakuma, Wang et al. 2000). Those 
results indicate that PGC-1α integrates leptin signaling to promote cold exposure adaption in 
BAT. Finally, in liver, leptin treatment stimulates PGC-1α expression, thereby activating 
mitofusin 1 (Mfn1) and ultimately ameliorating hyperlipidemia (Hsu, Lee et al. 2015). In liver 
cells, PGC-1α also responds to GLP-1 through miR-23a downregulation and mediates GLP-1 
protection against apoptosis (Wang, Li et al. 2015) (Fig. 3). In the same manner, upon treatment 
with GLP-1 receptor agonists, PGC-1α promotes mitochondrial biogenesis and anti-oxidation to 
provide neuroprotection (An, Chen et al. 2015). Lastly, PGC-1α expression was shown to be 
increased dose-dependently upon free fatty acids exposure and inhibited by glucose treatment 
(Zhang, Liu et al. 2005) (Fig. 3) indicating that PGC-1α is also sensing fatty acids and glucose 
levels. Taken together, those data show that PGC-1α is sensitive to all the elements that act on 
the arcuate nucleus to regulate whole body energy homeostasis (Fig. 5). This therefore strongly 
indicates that PGC-1α could plays a key role in AgRP and POMC neurons by integrating and 
sensing signals of whole body energy balance sent by peripheral tissues. 
 
In addition to responding to all the regulators of appetite, PGC-1α also steps in many 
signaling pathways controlling energy balance in the arcuate nucleus (Fig. 5). Thus, SITR1 that 
activates PGC-1α through de-acetylation is required in AgRP neurons for food intake regulation 
(Dietrich, Antunes et al. 2010). SIRT1 inhibition disrupts POMC inhibitory tones and AgRP 
neuronal activity, which leads to impaired food intake induction during the dark period and 
upon ghrelin treatment, ultimately leading to reductions in both fat and lean mass (Dietrich, 
Antunes et al. 2010). Intriguingly, SIRT1 loss in POMC neurons leads to an opposite phenotype 
that is hypersensitive to diet-induced obesity through reduction of energy expenditure 
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(Ramadori, Fujikawa et al. 2010) which suggest that SIRT1 is regulated by different signals in 
AgRP and POMC neurons or that it is engaged in different signaling pathways in those two kinds 
of cells. A second major regulator of PGC-1α through phosphorylation, the AMPK, plays a key 
role in the control of energy homeostasis (Fig. 5). Indeed, AMPK is activated upon fasting in the 
arcuate nucleus and promotes the activation of NPY neurons and an induction of food intake 
that is dependent of NPY (Kohno, Sone et al. 2011). AMPK is responsible for glucose sensing in 
both AgRP and POMC neurons (Claret, Smith et al. 2007). In addition, similar to SIRT1 deletion, 
loss of AMPK in AgRP and POMC neurons respectively, leads to a lean phenotype and increased 
obesity due to reduced energy expenditure and impaired food intake (Claret, Smith et al. 2007). 
Besides being regulated by elements involved in the arcuate nucleus control of energy balance, 
PGC-1α interacts with various proteins that are also necessary for AgRP and POMC neuronal 
activity. For example, the O-GlcNAcylation of PGC-1α by the O-GlcNAc transferase (OGT) in liver 
prevents PGC-1α from degradation by promoting the binding of the de-ubiquitinase BRCA1 
associated protein-1 (BAP1) (Ruan, Han et al. 2012). Glucose availability modulates 
gluconeogenesis through the stabilization of PGC-1α via the OGT. In turn, PGC-1α binds to the 
OGT and targets it to the FOXO1 protein for its GlcNAcylation, which increases its transcriptional 
activity and eventually contributes to the induction of gluconeogenesis (Housley, Udeshi et al. 
2009). Interestingly, both OGT and FOXO1 are essential for central control of energy 
homeostasis (Fig. 5). Upon fasting, OGT expression in the AgRP neurons suppresses WAT 
browning through the activation of AgRP neuronal activity in order to conserve energy (Ruan, 
Dietrich et al. 2014). Activation of FOXO1 in AgRP neurons induces food intake while its 
inactivation inhibits it and promotes leanness through the regulation of G Protein-Coupled 
Receptor 17 (Gpr17) (Kitamura, Feng et al. 2006, Ren, Orozco et al. 2012). In POMC neurons, 
FOXO1 inhibits leptin-induction of POMC expression by interacting with STAT3 which prevents 
its binding to the specificity protein –POMC promoter complex (Fig. 5) (Yang, Lim et al. 2009, 
Ma, Fuentes et al. 2015). Since PGC-1α is a master regulator of mitochondrial FAO (Vega, Huss 
et al. 2000) and controls the expression of uncoupling protein 2 (UCP2) (Oberkofler, Klein et al. 
2006) and carnitine O-palmitoyltransferase 1 (CPT1) (Baldan, Relat et al. 2004), it is interesting 
to note that SIRT1 and AMPK signaling in the AgRP neurons engages a change in the redox 
status, leading to the generation of ATP and sustained neuronal activity through β-oxidation of 
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fatty acids via UCP2 and CPT1 (Fig. 5) (Andrews, Liu et al. 2008, Lopez, Lage et al. 2008, 
Dietrich, Antunes et al. 2010). Consistently, the expression UCP2 is necessary in AgRP neurons 
to mediate ghrelin-induced food intake (Andrews, Liu et al. 2008) and CPT1 has been shown to 
be a major regulator of feeding (Fig. 5) (Obici, Feng et al. 2003). PPARγ, a well-known binding 
partner of PGC-1α involved in FAO metabolism (Puigserver, Wu et al. 1998), is important for 
energy balance maintenance in the arcuate nucleus. Indeed, its activation within AgRP neurons 
is enough to elevate AgRP/NPY mRNA level and food intake (Garretson, Teubner et al. 2015) 
while during high fat diet, it sensitizes POMC neurons to leptin and mediates their cellular, 
biological, and functional adaptations (Long, Toda et al. 2014). Aside from mitochondrial FAO, 
mitochondrial dynamics also represent a crucial element in the signaling pathways that 
activates AgRP and POMC neurons and that is controlled by PGC-1α (Fig. 5) (Martin, Lai et al. 
2014, Cannavino, Brocca et al. 2015, Greene, Lee et al. 2015). In AgRP neurons, food 
deprivation induces mitochondrial fission whereas over-feeding leads to mitochondrial fusion 
(Dietrich, Liu et al. 2013, Nasrallah and Horvath 2014) mainly through Mfn1 and 2. Indeed, 
single deletion of both mitofusins proteins in AgRP neurons protects against high fat diet 
induced mitochondrial fusion and obesity (Dietrich, Liu et al. 2013). Conversely, POMC neuron-
specific Mfn2 deletion results in hyperphagia, decreased energy expenditure and morbid 
obesity in chow-diet fed mice (Schneeberger, Dietrich et al. 2013, Contreras, Nogueiras et al. 
2016). This phenotype is driven by the disruption of mitochondrial endoplasmic reticulum 
association that triggers an increase of ER stress mediated leptin resistance in the POMC 
neurons (Fig. 5). Moreover, genetic models, inducing ER stress in POMC neurons triggers hepatic 
gluconeogenesis that is abolished when ER stress is relieved (Schneeberger, Gomez-Valades et 
al. 2015). In line with previous results, mice overexpressing the stress reliever X-box-binding 
protein 1 (Xbp1) in POMC neurons display increased energy expenditure and thermogenesis 
markers BAT and WAT (Williams, Liu et al. 2014). Remarkably, PGC-1α has been shown to 
mediate the ER stress response to exercise in muscle (Wu, Ruas et al. 2011) and could 
potentially also impact POMC neuronal signaling in the same manner. 
 
Taken together, the facts that PGC-1α senses and responds to all signaling elements 
altering the arcuate nucleus regulation of energy balance and that it interacts, controls and 
I. Introduction 
 
32 
regulates many players of the AgRP and POMC signaling pathways (Fig. 3 and 5), strongly 
indicate that PGC-1α is a keystone in the function of AgRP and POMC neurons. The effects of 
global and neuronal PGC-1α ablation on energy balance further reinforce this hypothesis. In this 
view, specific deletion of PGC-1α in AgRP and POMC neurons could provide new essential 
information about the regulation of energy homeostasis in the arcuate nucleus. In addition, this 
would also prevent the long array of dysfunctions in multiple tissues and brain area from the 
other knockout mouse models that might overshadow the selective effects of PGC-1-α deletion 
in those neurons. 
 
C. PGC-1α and skeletal muscle aging 
Similar to the brain, skeletal muscle requires fast metabolic adaptations to switch to 
different energy metabolism and substrate utilization according to the environmental 
conditions, the source of energy available and the type of effort it has to produce. For example, 
in high intensity exercise of short duration, the degradation of glycogen to lactate is used as the 
primary source of fuel, whereas during prolonged submaximal exercise almost all ATP molecules 
arises from oxidative metabolism of carbohydrates and lipids (Withers, Sherman et al. 1991). In 
this aim, living organisms need various mechanisms to sense energy availability inside the 
muscle cell and at the whole body level and to integrate and execute central commands of 
contraction. As neurons, skeletal muscle is very demanding in energy, especially for actin–
myosin cross-bridge cycling during contraction and in addition to other energy dependent 
cellular processes such as excitation–contraction coupling. Since the ATP intramuscular 
concentration is low (5–6 mmol/kg wet weight), a substantial production is required to sustain 
the energetic demand during exercise. Muscle is therefore another organ where PGC-1-α 
endorses an important role as a coactivator of mitochondrial biogenesis and as a metabolic 
sensor. Consequently, it is also very likely involved in mitochondrial dysfunction related myo-
pathophysiology including muscle aging.  
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1. Skeletal muscle aging 
By 2050, the world population over 60 years old will have risen from 11% to 22%. 2 
billion people will be over 60 years old and 400 million over 80 years old (World Health 
Organization, http://www.who.int/en/). Increased life expectancy is undoubtedly positive, 
although it implies higher incidence of chronic health conditions and a rise in prevalence of 
impairment and disability. Cognitive decline, musculoskeletal disorders, frailty and sarcopenia 
heavily contribute to elder’s disability and loss of independence. The lack of mobility, as well as 
the daily-required activities, frequently difficult and painful, often leads to further reduced 
activity, which exacerbates those aging related disorders and creates a vicious cycle, ultimately 
resulting in a severe decay in health span. Muscle loss of function is a strong predictor for 
mobility limitation, increased rates of falls and ultimately mortality. For example, an elderly with 
low muscle strength has a 2.6-fold greater chance of mobility limitation and a 2.1-fold higher 
risk of mortality than an older adult with high muscle force (Manini, Visser et al. 2007). 
Understanding the mechanisms of muscle aging and unraveling treatments to improve muscle 
disorders would definitely enhance the independency and the life quality of our exponentially 
growing elderly population. 
 
Skeletal muscle loss and dysfunction during aging  
The term sarcopenia was used for the first time by Rosenberg to refer to the loss of lean 
mass with aging (Rosenberg 1997). In the last few years, the definition of sarcopenia was 
extended and criteria for diagnosis were added, including low muscle mass measured by 
bioelectrical impedance or dual energy X-ray absorptiometry [DEXA] but also muscle weakness 
determined by grip strength and altered muscle functions, such as low walking speed, altered sit 
to stand time or impaired balance (Cruz-Jentoft, Baeyens et al. 2010) (Fig. 6). Muscle cross 
sectional area starts to decline after the fourth decades of age in humans (Lexell, Taylor et al. 
1988, Short, Vittone et al. 2004). Muscle mass decreases at 1-2% per year after the age of 50 
years (Hughes, Frontera et al. 2002) and declines at approximately 25% between 50 and 75 
years of age (Balagopal, Rooyackers et al. 1997). The loss of muscle mass further accelerates in 
advanced elderly, in such a way that the prevalence of sarcopenia is 50% in adults over 80 years 
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old whereas only 15% of adults over 65 years old are sarcopenic (Iannuzzi-Sucich, Prestwood et 
al. 2002) (Fig. 6). Several studies using computed tomography, MRI and ultrasonography 
demonstrated that muscle tissue reduction is accompanied by infiltration of fat and connective 
tissue (Sipila and Suominen 1994, Jubrias, Odderson et al. 1997, Kent-Braun, Ng et al. 2000), a 
condition known as myosteatosis (Taaffe, Henwood et al. 2009). This further reduces the net 
contractile muscle mass estimated though cross sectional area measurement. In parallel of 
muscle mass loss, a decrease of muscle strength is observed in elderly adults (Fig. 6). Isokinetic 
strength presents a drop of 14% and 16% per decade for knee extensors and knee flexors 
respectively in both men and women (Hughes, Frontera et al. 2001). Other studies indicated a 
higher loss of muscle strength and mass in men than women, especially in the lower limbs 
(Frontera, Hughes et al. 2000, Hughes, Frontera et al. 2001). Importantly, the authors found 
that muscle strength normalized to free-fat mass also decreases with age, demonstrating that 
not only muscle mass but also muscle efficiency, or in other words, muscle quality, declines with 
age. This decline of muscle mass and function with age translates in lower aerobic performance 
(Fig. 6), as determined by lower maximal oxygen consumption (Short, Vittone et al. 2004) and 
reduced resting body metabolic rate (Piers, Soares et al. 1998, van Pelt, Dinneno et al. 2001). 
Moreover sarcopenia negatively impacts balance performance (Fig. 6). Elderly adults displaying 
sarcopenia have a chance to fall increased by 3 fold compared to an elderly person without 
sarcopenia (Landi, Liperoti et al. 2012). A fall accident that triggers hospitalization, 
immobilization, reduced muscle and locomotor activity, increases sarcopenia and the risk of 
falling, reproducing the vicious cycle mentioned above. 
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Figure 6: Muscle functional and molecular changes during aging 
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Age-related changes in the muscle fiber 
The decline in muscle mass and whole muscle cross sectional area implies both a 
decrease in myofiber numbers (hypoplasia) (Lexell, Taylor et al. 1988) and size (atrophy) 
(Aniansson, Hedberg et al. 1986), conversely to disuse atrophy that only triggers loss in muscle 
fiber cross sectional area  but not in numbers (Fig. 6). Muscle fiber atrophy is strongly driven by 
size reduction of type II fibers, which have been largely demonstrated to be more sensitive to 
age-related atrophy than type 1. One of the first works in this domain showed that area of type I 
and type II fibers display a 23% and 42% reduction between 20-29 and 55-60 year old 
individuals (Larsson 1978). A second study found a 26% decrease in cross sectional areas of type 
II fibers but no difference in areas of type I fibers between 80 year old and 20 year old subjects 
(Lexell, Taylor et al. 1988). Higher decrease in type IIb than type IIa fibers has been reported 
while another work depicted no difference between the 2 subtypes (Klitgaard, Mantoni et al. 
1990, Coggan, Spina et al. 1992). However, age-related muscle cell atrophy seems to be muscle 
dependent as experiments on biceps brachii did not show changes in fiber size between the 
different fiber types of young and old adults (Klitgaard, Mantoni et al. 1990). In addition, the 
clear assessment of different fiber types is harder at old age as many fibers co-express MHC-I 
and –II (Andersen 2003). Alteration of expression of the different isoforms and thusly fiber type 
shifts are dependent on different processes occurring during aging. Neuropathic denervations 
touching preferentially fast motor units drive a shift toward slow fiber type (Campbell, 
McComas et al. 1973). However, muscle disuse and lack of neuromuscular activity promotes 
expression of fast MHC isoforms driving the opposite shift (Fluck and Hoppeler 2003, Liu, 
Schlumberger et al. 2003) while finally, exercise leads to a shift towards slower fiber type (Fig. 
6). Therefore an “aging fiber type signature” does not really exist, as fiber type difference can be 
the consequence of various events, leading to discrepancy between studies performed in 
different conditions. For example, while early cross sectional studies found a selective decline of 
type II fibers promoting an increase of type I/II ratio with age (Larsson 1978), other work found 
a rather close decline between type I and type II fibers with age (Lexell, Downham et al. 1986, 
Lexell, Taylor et al. 1988). Finally, individual muscle fibers also produce lower maximal force 
with age, independent of fiber type and even after normalization for fiber size. This indicates 
I. Introduction 
 
37 
that reduction of muscle strength cannot be caused only by hypoplasia and atrophy but also 
implies other age-related muscle changes.  
 
Molecular mechanisms driving muscle aging 
Age-related deterioration of the neuromuscular junction (NMJ), the interaction site 
between the nerve and the muscle, has been widely reported (Wokke, Jennekens et al. 1990, 
Balice-Gordon 1997, Deschenes, Roby et al. 2010) (Fig. 6). However, it is not established 
whether it is cause or consequence of sarcopenia, or whether these changes are endorsed by 
pre-synaptic or post-synaptic deteriorations. Muscle atrophy might originate from pre-synaptic 
dysfunction. Likewise the changes of fiber types described above and fiber type grouping 
observed in aged muscle (Lexell and Downham 1991) constitutes evidences for a 
denervation/reinnervation process in the aging muscle (Beermann, Cassens et al. 1977, 
Kostrominova 2010). On the other hand, the rise of central nuclei in old muscle indicates post-
synaptic involvements. In addition, NMJ age-associated changes differ among muscle types 
suggesting that they could be linked to muscle activity levels (Rosenheimer 1990). NMJ 
alterations encompass various pre- and post- synaptic changes during muscle aging (Fig. 6). In 
mice tibialis anterior muscle, between 6 and 24 months of age, the number of fragmented NMJ 
goes from less than 5% to over 80% while faint acetyl-choline receptor from 0% to 8% and fully 
denervated endplates from 0% to 15% (Valdez, Tapia et al. 2010). In the same muscle, pre-
synaptic change includes a rise from 0% to 15% sprouting axons, approximately 1% to over 20% 
swelling axons and 2% to 40% thin axons between 6 and 24 month old mice. Additionally, age-
related increases in area, perimeter, branched synaptic fold and subsarcolemmal vesicles have 
been reported (Fahim and Robbins 1982, Fahim 1993), as well as lower synaptic vesicles, 
correlated to increased amplitude of evoked endplate potentials associated with an enhanced 
neurotransmitter turnover (Kelly and Robbins 1983).  
 
While NMJ deterioration might be a cause or a consequence of muscle loss during aging, 
satellite cells alterations represent a likely contributor of age-associated muscle atrophy, as they 
constitute the regenerative power of the muscle (Fig. 6). Especially, decline of satellite cells 
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associated with fiber type II (Verdijk, Koopman et al. 2007) indicates that their deterioration 
contributes to muscle loss, as it is mainly driven by the atrophy of those fiber types. Both 
decline in satellite cell numbers and function jeopardizing the regenerative capacity of the 
whole muscle (Sousa-Victor, Gutarra et al. 2014) can be attributed to loss of satellite cells 
regenerative capacity, exhaustion to forced differentiation and apoptosis. This leads to 
increased fibrosis due to aberrant repair after injury (Fry, Lee et al. 2015). Besides intrinsic 
satellite cell alterations during aging, rejuvenation of satellite cell upon exposure to young 
environment and circulatory system indicates that extrinsic factors impact satellite cell aging 
(Villeda, Luo et al. 2011). For instance, increasing inflammation in old muscle has been shown 
to negatively impact stem cell function (Franceschi, Bonafe et al. 2000, Smythe, Shavlakadze et 
al. 2008). In line with this observation, inhibition of the pro-inflammatory marker, nuclear 
factor-kappa B and the resulting decrease of IL-6 improve muscle regenerative capacities in 
aged mice (https://dash.harvard.edu/handle/1/17464788). In addition, increased levels of 
interleukins 1 and 6, as well as tumor necrosis factor α during aging, enhances catabolic activity 
in the muscle (Doherty 2003). 
 
Contrary to catabolic factors, extrinsic factors stimulating muscle growth are reduced 
with age, which further reduces muscle mass (Fig. 6). For example, growth hormone, insulin-like 
growth factor and testosterone levels are all reduced in older adults (Corpas, Harman et al. 
1993, Morley, Kaiser et al. 1997). Likewise, inhibition of proteolysis and activation of protein 
synthesis by insulin in response to feeding is reduced in aged subjects (Wilkes, Selby et al. 
2009). Muscle protein synthesis upon amino acid feeding is also reduced in elderly adults 
(Cuthbertson, Smith et al. 2005). In parallel, aging inhibits insulin stimulated muscle glucose 
uptake and disposal, and lipid utilization by the mitochondria (Cleasby, Jamieson et al. 2016), 
therefore impairing muscle growth and function. In turn, as muscle represent 40-50% of the 
body mass, it is the primary source of glucose disposal (Baron, Brechtel et al. 1988) and its age-
associated insulin insensitivity largely contributes to whole body insulin resistance. For the same 
reason, muscle mass age-related reduction, further contributes to alterations of whole body 
glucose homeostasis. In line with those observations, sarcopenia has been recently associated 
with the metabolic syndrome (Dominguez and Barbagallo 2016, Lee, Hong et al. 2016) which 
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includes obesity, hypertension, hyperglycemia and insulin resistance (Srikanthan, Feyh et al. 
2016). 
 
In addition of external factors impacting skeletal muscle aging, intra-cellular pathways 
and processes are impaired in the old myofiber, leading to muscle dysfunction and muscle mass 
loss. The main function of skeletal muscle, with preservation of body homeostasis, is to allow 
posture maintenance and body motor functions, both relying on its contractile ability. A key 
physiological process for muscle contraction affected by aging is the excitation-contraction 
coupling mechanism that transforms sarcolemmal action potential into muscle force generation 
(Delbono 2002) (Fig. 6). The dihydropyridine receptor (DHRP) is an essential protein for this 
process. It activates calcium release from the sarcoplasmic reticulum (SR), which in turn will 
bind troponin C, resulting in actomyosin interaction and muscle contraction. When this 
excitation-contraction coupling mechanism is altered in any way, muscle displays lower fiber 
activation, force generation and ultimately reduced whole muscle strength (Manini and Clark 
2012). In old muscles, DHRP concentration is reduced (Fig. 6), as well as its coupling with the 
ryanodine receptor (RYR) and consequently the induced calcium release (Renganathan, Messi 
et al. 1997, Delbono 2000). Interestingly, authors also demonstrated that muscle 
overexpression of the insulin growth factor-1 prevents age-related reduction of the DHRP level 
and function, resulting in improved muscle strength. This shows that age-associated reduction 
of this factor is not only important for muscle mass as described above but also for muscle 
function. Alternatively, NMJ alterations could also cause excitation-contraction uncoupling as 
denervation reduces DHRP and RYR expression (Delbono 1992, Ray, Kyselovic et al. 1995). 
Besides lower expression of the excitation-contraction proteins, another study reported 
changes in the organization and the structure of the junction between SR and transverse 
tubules during muscle aging of humans (Boncompagni, d'Amelio et al. 2006) (Fig. 6). The 
junctional alterations included morphological and cellular disposition changes, as well as 
reduced occurrence of the junctional units, which in turn reduces the amount of calcium 
released from the SR to the myoplasma (Jimenez-Moreno, Wang et al. 2008) and its availability 
for the contractile apparatus, ultimately associated with a lower muscle strength (Payne, 
Jimenez-Moreno et al. 2009). Additionally, a portion of the SR calcium store is segregated from 
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the calcium releasing machinery with age (Fig. 6) (Weisleder, Brotto et al. 2006) (likely due to 
the disruption of the sarcolemma-SR junction), further reducing the amount of calcium available 
for muscle contraction and reinforcing muscle weakness. On the other hand, oxidation and 
nitrosilation of the RYRs disturbs calbastatin function that limits ryanodine receptor calcium 
release (Andersson, Betzenhauser et al. 2011). As a consequence, calcium leak from the SR is 
increased in old muscle and impairs myoplasmic calcium homeostasis (Boschek, Jones et al. 
2008) (Fig. 6). Impaired calcium re-uptake by the SR, associated to lower sarco/endoplasmic 
reticulum Ca2+-ATPase (SERCA) activity in elderly adults reinforces intracellular calcium level 
increase in old muscle (Hunter, Thompson et al. 1999).  
 
Increased myoplasmic calcium levels during muscle aging represents a harmful stress for 
the muscle, not only because it disrupts excitation-contraction coupling but also because 
dysregulated calcium cytosolic levels are toxic for the cell (Kass and Orrenius 1999) and that 
proper calcium signaling regulating key cellular functions, such as cell survival/death 
(Zhivotovsky and Orrenius 2011) (Miyawaki, Zhou et al. 1996) and ATP production (Jouaville, 
Pinton et al. 1999), rely on highly precise calcium homeostasis. Therefore, a large range of 
mechanisms are used by the cell to buffer possible excess of calcium, including high capacity 
binding protein, pump and exchanger for SR re-uptake, and the mitochondria which sequester 
calcium as soon as it overrides the dangerous concentration of 500nM in the cytosol, thus 
representing a major buffering and detoxifying compartment (Kass and Orrenius 1999). 
However, prolonged or extreme calcium overload due to failure of those mechanisms, such as 
the age-related calcium leak or reduced calcium SR-reuptake described above, will lead to cell 
damages and ultimately cell death (de Leiris and Boucher 1990, Richter 1993). Decreased 
mitochondrial calcium handling is also observed in old muscle and will be discussed in more 
detail in in this section and in section V.B.2 of this thesis.  
 
Cytosolic calcium perturbation can in turn promote endoplasmic reticulum stress (ER 
stress), originally induced to restore homeostasis and overcome stresses and protein misfolding 
(Kania, Pajak et al. 2015) but  that might lead to cellular damage and eventually cell death if 
stresses are too excessive or prolonged (Sano and Reed 2013). Interestingly, although not much 
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work has been done on ER stress in the old muscle, several lines of evidence indicate SR burden 
in old muscle (Fig. 6). First, disruption of SR-sarcolemmal junctions as well as SR protein levels 
alteration discussed above already indicates SR dysregulation in the aged muscle. Second, 
markers of ER stress induced apoptosis and chaperone protein, also up-regulated to respond to 
ER stress, are increased with aging in muscles (Ogata, Machida et al. 2009). In other studies, 
authors showed correlating increase of apoptosis and caspase-12 further indicating ER stress 
cell death induction in the aging muscle (Dirks and Leeuwenburgh 2004, Chung and Ng 2006). 
Lastly, old mice display sarcoplasmic reticulum aggregates, named tubular aggregates, which are 
also a clear sign of the SR burden in the old muscle (Fig. 6). Interestingly, human mutations of 
the ORAI Calcium Release-Activated Calcium Modulator 1 (ORA1) and of Stromal Interaction 
Molecule 1 (STIM1), two elements that modulate influx of cellular calcium after intracellular 
calcium store depletion, both cause tubular aggregate myopathies (Endo, Noguchi et al. 2015, 
Okuma, Saito et al. 2016). This strongly suggests that tubular aggregates form upon SR-calcium 
homeostasis dysregulation. Interestingly caslequestrin 1 (CSQ1) presence and SERCA1 
crystallization are important for tubular aggregate formation (Boncompagni, Protasi et al. 
2012), further suggesting that SR protein alterations might be the trigger of tubular aggregate 
formation. Alternatively, as tubular aggregates display a calcium buffering capacity (Salviati, 
Pierobon-Bormioli et al. 1985), they might represent a compensatory mechanism to lower age-
related increase of cytosolic calcium.  
 
Oxidative stress is another major type of stress induced during aging that could lead to 
cellular damage and dysregulation observed in old muscles (Fig. 6). Basal production of reactive 
oxygen species (ROS) such as O2O- and H2O2, responsible of oxidative stress, are increased with 
age in both rodents and humans (Bejma and Ji 1999, Capel, Rimbert et al. 2005). Different sites 
of ROS production exist in cells. Mitochondria are the primary source of ROS in muscle and its 
role in oxidative stress will be further discussed in the subsection “Mitochondrial dysfunction 
and muscle aging” of the section I.C.1. Xanthine oxidase catabolism generates O2O- during 
purine catabolism (Hellsten, Ahlborg et al. 1988) and its enzymatic activity is increased in old 
muscle possibly resulting in age-associated O2O- overproduction (Lambertucci, Levada-Pires et 
al. 2007, Ryan, Jackson et al. 2011). Nicotinamide adenine dinucleotide phosphate oxidases 
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located in the sarcolemma can also generate ROS (Ji 2001) and thereby very likely trigger 
calcium leak by damaging RYRs. Despite anti-oxidative enzymes adaptation as defense 
mechanism (Gianni, Jan et al. 2004), humans and other mammals display increased oxidative 
damage such as DNA or protein oxidation and lipid peroxidation in old muscles. (Radak, Naito et 
al. 2002, Lambertucci, Levada-Pires et al. 2007, Feng, Xie et al. 2008). In addition, oxidative 
stress has been shown to affect muscle contractile proteins (Reid 2008), thereby reducing 
muscle strength and fatigue resistance (Reid, Khawli et al. 1993), to reduce protein synthesis 
and muscle regeneration, and to increase proteolysis (Derbre, Gratas-Delamarche et al. 2014).  
 
The different cellular stresses accumulate during muscle aging and above a threshold 
cannot be counteracted by defense mechanism anymore. This leads to increased cellular 
apoptosis during muscle aging (Fig. 6) (Leeuwenburgh 2003, Marzetti, Lawler et al. 2008, 
Marzetti, Privitera et al. 2010). Data indicate that oxidative stress resulting in DNA/protein 
damage, imbalanced protein synthesis and degradation, but also mitochondrial dysfunction, 
most likely leads to increased apoptosis in old muscle (Braga, Sinha Hikim et al. 2008, Meng 
and Yu 2010) (Fig. 6). Age-associated increased cytosolic calcium levels might also lead to cell 
death in old muscles through stimulation of the sarcoplasmic reticulum-mediated apoptotic 
pathway (Nitahara, Cheng et al. 1998, Meng and Yu 2010) (Fig. 6). Given both the role and the 
ability of mitochondria to induce programmed cell death and its age-associated dysfunction, 
mitochondria-driven cellular apoptosis is considered as a central mechanism leading to muscle 
cell death during aging (Fig. 6). For example, old animals observe a pro-apoptotic shift in BCL2 
Associated X (Bax) / B-Cell CLL/Lymphoma 2 (BCL2) protein ratio (Pistilli, Jackson et al. 2006, 
Marzetti, Wohlgemuth et al. 2008). In addition, increased susceptibility of mitochondrial 
permeability transition pore opening (mPTP) leading to mitochondria swelling and cell death 
ratios have been noticed in aged muscles (Chabi, Ljubicic et al. 2008), correlating with a higher 
cyclophilin D (CYPD)/ Voltage-dependent anion channel (VDAC) ratio (Marzetti, Wohlgemuth et 
al. 2008) that is known to induced mPTP opening and mitochondrial swelling (Baines, Kaiser et 
al. 2005).  
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Mitochondrial dysfunction and muscle aging 
In addition to being the main energy producer of the muscle, mitochondria are key 
organelles that regulate various cellular functions such as cell cycle, signal transduction or 
apoptosis (McBride, Neuspiel et al. 2006, Wang and Youle 2009). Increasing lines of evidence 
exhibit age-related mitochondria dysfunction and indicate its key role in muscle aging via 
multiple mechanisms (Fig. 6). As mentioned above, mitochondria are the primary source of free 
radicals (Nakamura, Takamura et al. 2009) which makes its closely located mitochondrial DNA 
(mtDNA) and protein, particularly susceptible to age-associated ROS overproduction and 
oxidative damages (Mansouri, Muller et al. 2006, Chabi, Ljubicic et al. 2008). Supporting the 
role of ROS in mitochondrial dysfunction during aging, old transgenic mice expressing the 
human catalase, targeted to the mitochondria, show protection against age-associated 
oxidative damage and reduced mitochondrial mass. MtDNA is dramatically affected by ROS 
since 70% of muscle mtDNA present deletions in subjects older than 80 years of age (Chabi, 
Mousson de Camaret et al. 2005). In addition to mtDNA oxidative damage, mtDNA quantity, 
reflecting mitochondrial mass is also impaired by aging in muscle. This has been demonstrated 
by different methods measuring mitochondrial quantities such as electronic microscopy, DNA 
copy numbers or proteomics (Barazzoni, Short et al. 2000, Conley, Jubrias et al. 2000, Short, 
Bigelow et al. 2005). Correlating with lower mitochondria numbers, muscle mitochondrial 
enzymatic activities are reduced with age (Trounce, Byrne et al. 1989) as well as basal and 
maximal ATP production (Short, Vittone et al. 2004, Short, Bigelow et al. 2005). Another study 
reports a drop of 50% in oxidative capacity per muscle volume and 30% per mitochondrial 
volume in old compared to young individuals (Conley, Jubrias et al. 2000). In addition to their 
lower ATP production, higher number of depolarized mitochondria further indicates 
mitochondrial damages (Terman, Kurz et al. 2010). Morphologically, mitochondria of old 
muscles are abnormally enlarged with a rounder shape and exhibit shortened cristae and matrix 
vacuolization (Beregi, Regius et al. 1988, Shigenaga, Hagen et al. 1994). However, it is not clear 
whether mitochondrial alterations are causing sarcopenia or reflects secondary effects of age-
associated muscle insulin resistance and reduced physical activity (Petersen, Befroy et al. 2003, 
Lanza, Short et al. 2008). 
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Mitochondria are highly dynamic organelles being constantly adjusted by mitochondrial 
biogenesis, fusion and fission events and degradative mechanism. Mitochondrial biogenesis 
greatly influences mitochondrial mass. Alteration in AMPK-induced mitochondrial biogenesis in 
old muscle (Reznick, Zong et al. 2007) suggests that impaired mitochondrial production 
contributes to reduced mitochondrial densities observed in aged muscle (Chabi, Ljubicic et al. 
2008). Mitochondrial fusion is important for energy exchange, equilibration of the 
mitochondrial proteins and allows mixing of dysfunctional mitochondria with healthy ones, 
which can alleviate respiratory alterations due to their mtDNA mutations (Sato, Nakada et al. 
2006). However, this process also enables accumulation of mutated mtDNA during aging. 
Therefore, dysregulation of this process during muscle aging could contribute to accumulations 
of damaged mitochondria. For example, mutation of the key fusion protein optic atrophies 1 
(Opa1) in human muscle triggers a reduction in oxidative phosphorylation and ATP production 
(Lodi, Tonon et al. 2004). Interestingly, another key protein of mitochondrial fusion, mitofusin 2 
(Mfn2) is downregulated in old muscle (Crane, Devries et al. 2010). The counterpart of fusion is 
mitochondrial fission which together with autophagy, regulates mitophagy and the removal of 
impaired mitochondria (Benard and Karbowski 2009). Age-associated increase of fission 1 (Fis1) 
protein (O'Connell and Ohlendieck 2009) might be the consequence of higher numbers of 
dysfunctional mitochondria. Reduced mitochondrial fusion and fission in muscle aging, as 
suggested by reduced amount of fusion and fission protein levels (Ibebunjo, Chick et al. 2013), 
might lead to reduced mitochondrial turnover which would be exacerbated by decreased 
mitochondrial protein renewal, as suggested by lower mitochondrial protein synthesis and 
proteolysis in aged muscle (Rooyackers, Adey et al. 1996, Combaret, Dardevet et al. 2009). 
 
Lastly, some data indicate that mitochondria of old muscle have an impaired calcium 
handling. First, in aged muscle, the capacity of mitochondria to uptake calcium is altered 
(Fernandez-Sanz, Ruiz-Meana et al. 2014, Pietrangelo, D'Incecco et al. 2015). This could very 
likely contribute to the increased cytosolic calcium levels depicted previously. Second, 
mitochondrial association to the sarcoplasmic reticulum, allowed by mitochondria-associated-
membranes (MAM), is reduced with age. Old muscles exhibit both lower numbers of 
mitochondria association with the SR and less tethers associating the two organelles thereby 
I. Introduction 
 
45 
weakening each association (Fernandez-Sanz, Ruiz-Meana et al. 2014, Pietrangelo, D'Incecco et 
al. 2015). Moreover, Pietrangelo and colleagues demonstrated in the same publication that the 
distance between SR and mitochondria is enlarged in muscles of old animals. The 
communication between the two organelles is important for calcium signaling and cellular 
homeostasis, cell survival, ER stress and mitochondrial function. Therefore, although it has not 
been extensively studied yet, these data strongly suggest that age-related impaired 
mitochondrial calcium handling could contribute to muscle stresses and dysfunction observed 
during aging.  
 
2. The function of PGC-1α in skeletal muscle health and 
diseases 
PGC-1α: a master regulator of mitochondrial and muscle metabolism 
PGC-1α is expressed in highly oxidative tissue including skeletal muscle and promotes 
oxidative metabolism (Fig. 7) when overexpressed in the latter (Lin, Wu et al. 2002) or in culture 
of muscle cells (Wu, Puigserver et al. 1999). Especially, overexpression of PGC-1α in mice white 
glycolytic muscle turns them into red oxidative muscles, likely through the induction of oxygen-
bound cytochrome-c and myoglobin. Muscle and muscle cells with elevated PGC-1α levels also 
exhibit increased mitochondrial mass and biogenesis (Fig. 7) (Choi, Befroy et al. 2008), as well 
as enhanced mRNA and protein levels of various mitochondrial metabolic genes and respiratory 
subunits (Lin, Wu et al. 2002, St-Pierre, Lin et al. 2003, Wende, Schaeffer et al. 2007). In 
addition, they show ameliorated enzymatic activities for FAO, Krebs cycle and oxidative 
phosphorylation, which result in improved mitochondrial respiration. In parallel, transcriptional 
co-activation of PGC-1α also stimulates the production of heme biosynthesis, ion transport such 
as calcium, mitochondrial translation and protein import, which further improves mitochondrial 
respiratory capacity (Wu, Puigserver et al. 1999, St-Pierre, Lin et al. 2003). Accordingly, mice 
overexpressing PGC-1α display higher endurance and fatigue resistance (Lin, Wu et al. 2002, 
Calvo, Daniels et al. 2008). In line with these data, PGC-1α muscle specific knock-out animals 
have diminished expression of mitochondrial respiratory chain protein and mRNA, 
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mitochondrial respiration capacities and endurance performances (Handschin, Chin et al. 2007, 
Handschin, Choi et al. 2007). Mechanistically, PGC-1α co-activates and even regulates 
expression of multiple transcription factors that controls the expression of gene essential for 
mitochondrial biogenesis and function, including ERRα, PPARs and NRF-1 and 2 (Wu, Puigserver 
et al. 1999, Kelly and Scarpulla 2004). For example, NRF-1 and 2 have been shown to regulate 
transcription factor A (Tfam) expression, essential for the transcription and replication of the 
mitochondrial DNA (Kelly and Scarpulla 2004). Other data also suggest that PGC-1α could 
directly control the transcription of mitochondrially encoded genes. Indeed, PGC-1α and SIRT1 
are present in the mitochondrial apparatus and are immunoprecipitated together with Tfam 
and mitochondrial PGC-1α level increases upon exercise (Aquilano, Vigilanza et al. 2010, 
Safdar, Little et al. 2011). In addition to control mitochondrial biogenesis, studies also showed 
that PGC-1α controls mitochondrial dynamics including fusion, fission and mitophagy (Garnier, 
Fortin et al. 2005, Soriano, Liesa et al. 2006, Vainshtein, Desjardins et al. 2015, Vainshtein, 
Tryon et al. 2015, Kang and Ji 2016). 
 
Muscle PGC-1α not only regulates mitochondrial genes but also different processes of 
muscle metabolism. PGC-1α induces the expression of key fatty acids metabolism enzymes such 
as CPTI, medium-chain acyl-coenzyme A dehydrogenase (MCAD) and fatty acid 
translocase/CD36 (CD36) in both cell culture and muscle (Vega, Huss et al. 2000, Wende, 
Schaeffer et al. 2007, Calvo, Daniels et al. 2008). Overexpression of pyruvate dehydrogenase 
kinase 4 (PDK4) in muscle with elevated PGC-1α levels possibly further contributes to increase 
FAO in transgenic animals. Finally, PGC-1α increases lactate uptake in the muscle and drives a 
switch in lactate dehydrogenase (LDH) Isoenzyme-type, promoting transformation of lactate in 
pyruvate that can be used in the Krebs cycle. Furthermore, muscle PGC-1α enhances the 
expression of glucose transporter 4 (GLUT4) indicating higher glucose refueling and glycogen 
synthesis in muscle (Fig. 7) but lowers glycolysis and glucose oxidation, increasing muscle 
glycogen levels (Wende, Schaeffer et al. 2007, Calvo, Daniels et al. 2008). Similarly, PGC-1α 
promotes de novo lipid synthesis in muscle, which together with increased glycogenesis are 
important to replenish energy levels after exercise when PGC-1α levels are concomitantly 
increased (Summermatter, Baum et al. 2010). Paradoxically, it worsens high fat diet (HFD) 
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induced insulin resistance in sedentary animals but improves glucose homeostasis in exercised 
mice fed with the same diet (Summermatter, Shui et al. 2013). Enhanced fatty acids oxidation 
and mitochondrial metabolism of PGC-1α transgenic mice increases their endurance capacities 
(Fig. 7) and lowers their respiratory exchange ratio (RER) during exercise (Calvo, Daniels et al. 
2008). However, they showed reduced running performance in high intensity exhaustive 
exercise bouts, very likely because of their inability to use muscle glycogen (Wende, Schaeffer 
et al. 2007). Together, these data indicate a switch from glycolytic to oxidative metabolism 
induced by PGC-1α in muscle. Accordingly, mice muscles overexpressing PGC-1α display an 
increase in the proportion of fiber type I and IIa (Lin, Wu et al. 2002). Interestingly, PGC-1α 
muscle specific knock out animals have a reduction in the proportion of these types of fibers 
(Handschin, Chin et al. 2007) but not PGC-1α whole body knockout mice indicating 
compensatory mechanisms (Arany, He et al. 2005). Finally, in line with a switch towards slow 
fiber types, PGC-1α remodels calcium transient and calcium handling and promotes a shift of 
the CSQ1 (fast type) towards caslequestrin 2 (CSQ2) (slow type) expression (Summermatter, 
Thurnheer et al. 2012). 
 
Figure 7: The coordinated actions of peroxisome proliferator-activated receptor gamma 
coactivator-1 (PGC-1) in skeletal muscle. (Correia, Ferreira et al. 2015) 
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PGC-1α and anti-oxidants 
Increased mitochondrial metabolism and respiratory capacities potentially increases 
mitochondrial ROS production and oxidative damages. Consequently, to prevent increased 
oxidative stress in transgenic animals, PGC-1α enhances the expression of detoxifying enzymes 
(Fig. 7) such as superoxide dismutase 2 (SOD2) (Wenz, Rossi et al. 2009). Conversely, PGC-1α 
muscle specific knockout animals exhibit reduced levels of SOD1 and 2 and glutathione 
peroxidase (GPx)1 mRNA and protein levels in muscle (Handschin, Choi et al. 2007, Leick, 
Wojtaszewski et al. 2008, Leick, Lyngby et al. 2010). Similar observations were reported upon 
induction of those enzymes by H2O2 in fibroblast, where PGC-1α suppresses ROS (St-Pierre, 
Drori et al. 2006). Additionally, PGC-1α up-regulates UCP2 and 3 in cells (St-Pierre, Lin et al. 
2003), possibly increasing uncoupling and thereby reducing ROS production, as well as sirtuin 3 
(SIRT3) (Kong, Wang et al. 2010) that is known to deacetylate and activate SOD2 (Shi, Wang et 
al. 2005).  
 
PGC-1α and muscle secreted factors 
While ROS production can induce an inflammatory response through activation of the 
redox sensitive nuclear factor kappa B (NF-kB) (Morgan and Liu 2011), PGC-1α muscle deletion 
promotes expression of various inflammatory genes and increases blood interleukin 6 (IL-6) 
levels (Handschin, Choi et al. 2007) (Fig. 7). Those animals also exhibit an exacerbated 
inflammatory response upon exercise concomitant with increased muscle damage and blood 
tumor necrosis factor (TNF)α concentrations (Handschin, Chin et al. 2007). However, other 
studies using PGC-1α muscle deficient mice generated with a different genetic method did not 
show differences in plasma IL-6 or TNFα concentrations (Olesen, Larsson et al. 2012, Sczelecki, 
Besse-Patin et al. 2014). In line with the data of the first study, mice overexpressing muscle 
PGC-1α present lower muscle and plasma IL-6 and TNFα levels (Wenz, Rossi et al. 2009, Olesen, 
Larsson et al. 2012). In turn, PGC-1α expression is decreased in multiple conditions with 
increased systemic inflammation such as type 2 diabetes or aging (Patti, Butte et al. 2003, 
Sczelecki, Besse-Patin et al. 2014). Mechanistically, PGC-1α prevents pro-inflammatory 
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cytokines expression upon inflammation stimulus and reduces p65 phosphorylation and p65 
activation of NF-kB (Wenz, Rossi et al. 2009, Eisele, Salatino et al. 2013). 
 
In skeletal muscle, PGC-1α promotes oxygen and nutrients consumption by increasing 
mitochondrial respiration and energy metabolism. Importantly, PGC-1α concomitantly enhances 
angiogenesis that supplies muscle with more oxygen and fuel (Fig. 7) (Arany, Foo et al. 2008, 
Tadaishi, Miura et al. 2011). Angiogenesis increase upon PGC-1α overexpression in myocytes is 
mediated by induction and secretion of the vascular endothelial growth factor (VEGF), as well as 
other angiogenic factors and is independent of the hypoxia –inducible system (Arany, Foo et al. 
2008). Increased angiogenesis allows proper recovery after ischemia, which is therefore 
impaired in mice with PGC-1α deletion and enhanced in animals overexpressing muscle PGC-1α. 
In line with those data, a recent study showed that PGC-1α induces the formation of functional 
and non-leaky blood vessels through upregulation of secreted phosphoprotein 1 which recruits 
macrophages and activates the migration of adjacent cells (Rowe, Raghuram et al. 2014). 
Importantly, deleting secreted phosphoprotein 1 prevents the formation of proper vessels by 
PGC-1α. PGC-1α upregulation in skeletal muscle also ameliorates blood flow recovery after 
hindlimb ischemia of diabetic mice (Rowe, Raghuram et al. 2014). Finally, while PGC-1α is 
dispensable for basal capillarization, previous work showed that it is required for exercise 
induced angiogenesis and VEGF upregulation (Chinsomboon, Ruas et al. 2009, Leick, Hellsten et 
al. 2009). 
 
Besides regulating VEGF expression, as well as inflammatory related factors released by 
the muscle, PGC-1α controls muscle secretion of several other myokines (Fig. 7) that can trigger 
different effects in various tissues. First, PGC-1α induces the expression of Fibronectin type III 
domain-containing protein 5 (FNDC5) mRNA, further transformed in irisin and released in blood 
vessels (Bostrom, Wu et al. 2012). Irisin will trigger WAT browning and its systemic delivery 
promotes energy expenditure and improves glucose homeostasis in obese mice (Bostrom, Wu 
et al. 2012). It is released in the blood after exercise and cold exposure, two major triggers of 
PGC-1α muscle induction (Lee, Linderman et al. 2014). Interestingly, peripheral FNDC5 gene 
delivery to mouse liver stimulates expression of brain derived neurotrophic factor (BDNF) in the 
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hippocampus, which improves synaptic plasticity and memory (Kuipers and Bramham 2006, 
Wrann, White et al. 2013). Recently, PGC-1α has been shown to mediate the transformation of 
kynurenine to kynurenic acid (Fig. 7) (Agudelo, Femenia et al. 2014). Since kynurenic acid 
cannot cross the blood–brain barrier, the conversion alleviates stressed induced depression by 
preventing kynurenine to reach the brain and to induce neuro-inflammation and synaptic 
dysfunction. As exercise also induces this PGC-1α-mediated conversion, this process might be 
how exercise improves depression and various cognitive disorders (Abe 2012, Adamson, Ensari 
et al. 2015). β-aminoisobutyric acid (BAIBA), product from valine catabolism, is released by 
muscle and increased in plasma of both exercised and PGC-1α muscle overexpressing mice 
(Roberts, Bostrom et al. 2014). Following its secretion, BAIBA will activate FAO in the liver and 
WAT browning (Roberts, Bostrom et al. 2014). This increases energy expenditure, reduces 
adiposity and improves glucose tolerance. In addition to the secretion of those factors, the 
isoform PGC-1α4 inhibits muscle secretion of myostatin, a condition that is known to reduce 
adiposity and increase adipose lipolysis and FAO, thereby promoting WAT browning and 
increased energy expenditure (Zhang, McFarlane et al. 2012, Shan, Liang et al. 2013). Finally, 
this isoform and exercise both drive the expression and secretion of meteorin-like (Metrnl), 
which again increases WAT browning and energy expenditure as well as glucose utilization (Rao, 
Long et al. 2014). 
 
PGC-1α and NMJ regulation 
Several lines of evidence indicate that muscle PGC-1α is important for NMJs structure 
and function (Fig. 7). PGC-1α muscle deletion reduces the expression of multiple NMJ genes 
such as acetyl choline receptors or utrophin, and impairs acetylcholine receptor clustering 
(Handschin, Kobayashi et al. 2007). In light of these elements, we studied pre- and post- 
synaptic rearrangements of the NMJ in PGC-1α muscle specific knock animals. No substantial 
changes were observed in PGC-1α muscle deficient mice in comparison to wild type (WT) 
animals (Fig. 8). We therefore did not further investigate in this direction. Conversely, muscle 
elevation of PGC-1α levels improves acetylcholine receptor clustering and the transcription of 
NMJ genes (Handschin, Kobayashi et al. 2007, Arnold, Gill et al. 2014). Its overexpression in 
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cultured muscle is sufficient to promote the same effects (Handschin, Kobayashi et al. 2007). In 
muscle, overexpression of PGC-1α improves the NMJ post-synaptic structure, increases NMJ 
synaptic folding but also ameliorates NMJ function and by the same way muscle fatigue 
resistance. In addition, PGC-1α increases pre-synaptic branching and complexity (Chakkalakal, 
Nishimune et al. 2010, Arnold, Gill et al. 2014). PGC-1α delivery in the muscle after P10, post 
synapse elimination, promotes a shift towards slow motor neurons indicating that pre-synaptic 
remodeling are mediated by a retrograde signaling from muscle to motor neurons (Chakkalakal, 
Nishimune et al. 2010). 
 
Figure 8: Muscle PGC-1α deletion does not alter the NMJ. (a-d) NMJ pre- and post- synaptic 
analysis indicating NMJ innervation, fragmentation, neurofilament sprouting and acetyl-choline 
receptor densities (n=2-3). Values are mean ± SEM. 
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PGC-1α in muscle related diseases 
The maintenance of NMJ integrity by PGC-1α is an asset for the protection against 
various neuromuscular disorders. For example, PGC-1α improves exercise capacity, lowers 
creatine kinase levels in blood, and prevents exercise-associated muscle damage and necrosis to 
ameliorate muscle dystrophy in mdx mice, a model of Duchenne muscular dystrophy 
(Handschin, Kobayashi et al. 2007). Similarly, PGC-1α improves the muscle phenotype of 
utrophin-mdx mice, which present higher muscle dysfunction than the previous model (Chan, 
Rowe et al. 2014). Of note, PGC-1α delivery, after the disease has developed, partially rescues 
the phenotype by improving strength and fatigue resistance and reducing inflammation (Selsby, 
Morine et al. 2012, Hollinger, Gardan-Salmon et al. 2013). Likewise during aging, PGC-1α has 
been shown to improve NMJ integrity (Wenz, Rossi et al. 2009). Lastly, PGC-1α improves NMJ 
structures and preserves muscle mass in an amyotrophic lateral sclerosis mouse model in which 
SOD1G37R mutation induces motor neuron degeneration (Da Cruz, Parone et al. 2012). This 
also suggests that PGC-1α could play an important role to sustain muscle mass in other 
conditions triggering muscle atrophy. 
 
Reduction of PGC-1α levels in multiple disorders reducing muscle mass further support 
this hypothesis. For example, muscle PGC-1α mRNA expression decreases in human disuse 
muscle atrophy (Suetta, Frandsen et al. 2012, Wall, Dirks et al. 2015). Likewise PGC-1α 
expression is reduced in human (Safdar, Hamadeh et al. 2010) and murine (Sczelecki, Besse-
Patin et al. 2014) muscle aging. Similar observations have been seen in rodent models of 
muscle-wasting-associated diseases like diabetes or cancer (Sandri, Lin et al. 2006). In addition, 
PGC-1α reduces muscle fiber atrophy induced by denervation and fasting, and blunts the 
associated increase of atrophy-related genes in mice (Sandri, Lin et al. 2006). The suggested 
mechanism is the prevention of Forkhead-Box-Protein O3 (Foxo3) mediated atrophy and 
atrogin1 transcription activation. Similarly, PGC-1α protects against TNF-related weak inducer of 
apoptosis (TWEAK–Fn14)-associated muscle wasting. PGC-1α repression and FoxO3- mediated 
atrophy induced by TWEAK–Fn14 signaling further suggests that it reduces muscle mass by 
diminishing PGC-1α levels in muscle, which in turn will cause atrophy through the FoxO3 
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pathway. Finally, PGC-1α4 isoform, induced by resistance exercise training, promotes insulin-
like growth factor-1, mammalian target of rapamycin and reduces myostatin expression (Ruas, 
White et al. 2012, White, Wrann et al. 2014) resulting in muscle hypertrophy and improved 
muscle strength. Accordingly, PGC-1α4 protects from cancer-associated cachexia (Ruas, White 
et al. 2012). 
 
Similar to muscle wasting conditions, PGC-1α expression is decreased in diabetic 
disorders. Since mitochondrial dysfunctions are also observed in muscles of diabetic patients, it 
has been postulated that PGC-1α could play a role in diabetes and muscle insulin resistance. 
However, mice with PGC-1α deficient muscle present little alteration in glucose handling and 
insulin sensitivity. Interestingly, high PGC-1α elevation in muscle increases diet-induced insulin 
resistance, likely due to increased intramuscular lipid accumulation, while moderate increases 
of PGC-1α, similar to exercise-induced PGC-1α elevation, improves insulin sensitivity in cells and 
muscles (Bonen 2009). In addition, high PGC-1α overexpression potentiated exercise beneficial 
effect on insulin sensitivity, further supporting that muscle PGC-1α mediates exercise-
associated amelioration of insulin resistance (Summermatter, Shui et al. 2013). 
 
3. PGC-1α and exercise as potential treatments against muscle 
aging 
PGC-1α and aging 
Aging is a multifactorial process, but as in muscle, age-related pathologies in other 
organs are considered to be initiated or at least correlated to mitochondrial dysfunction. 
Mitochondrial disorders are often associated with neurological disorders, diabetes, 
endocrinopathies and other systemic diseases (DiMauro and Schon 2008). Interestingly, similar 
conditions occurring during aging are also correlated with mitochondrial dysfunctions (Baker, 
Betik et al. 2006, Civitarese, Carling et al. 2007). In addition to regulating mitochondrial 
function, PGC-1α is linked to different factors involved in the general process of aging, including 
SIRT1, insulin/IGF signaling and mammalian target of rapamycin (Fadini, Ceolotto et al. 2011). 
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The versatile role of PGC-1α likely impacts the aging process in different organs affected by 
mitochondrial dysfunction and by alteration in the mentioned pathways during aging (Fig. 9). 
For example, in the heart, SIRT1 and PPARα, that control PGC-1α expression and activity, 
protect against age-associated hypertrophy, metabolic disorders and inflammation (Planavila, 
Iglesias et al. 2011). Interestingly, similar effects were observed after resveratrol treatment, 
which also indirectly activates PGC-1α. Moreover, while age-related dysfunctional vasculature 
contributes to cardiac disorders, PGC-1α is important for the vasculature wall and also promote 
angiogenesis (Fig. 9) (as described above) (Rowe, Jiang et al. 2010). On top of that, PGC-1α 
reduction might cause the switch from fatty acids to glucose utilization observed in the aging 
failing heart (Huss and Kelly 2005) as it normally induces mitochondrial function and FAO in this 
tissue (Fig. 9) (Huss and Kelly 2004). Recently, PGC-1α deletion has also been shown to 
accelerate vascular aging (Fig. 9) and atherosclerosis, correlating with increased telomere 
alterations and DNA damages (Xiong, Patrushev et al. 2015). 
 
Figure 9: PGC-1α and age-related disorders. Adapted from (Wenz 2011) 
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In the brain, mitochondrial dysfunction is also detrimental during aging (Bender, 
Krishnan et al. 2006). As described in section I.B.3, PGC-1α plays a major role in this organ to 
maintain mitochondrial function and strongly affects neuronal diseases (Fig. 9) that are 
developed with age such as Huntington, Alzheimer or Parkinson diseases. Finally, general 
mitochondrial dysfunction is considered to be a potential underlying effect of the age developed 
insulin resistance, whereas increased mitochondrial function improves it (Petersen, Befroy et al. 
2003, Dumas, Simard et al. 2009, Wenz, Rossi et al. 2009). Of note, PGC-1α promoter 
methylation is reduced in muscle of diabetic subjects (Barres, Osler et al. 2009) and PGC-1α 
expression is negatively correlated to steatosis stages (Fig. 9) (Wang, Kamat et al. 2011). In 
accordance with these results, rosiglitazone, that indirectly activates PGC-1α, improves age-
related liver pathology (Gupte, Liu et al. 2010). 
 
In muscle, age-associate PGC-1α expression reduction at the mRNA and protein levels 
has been largely described in humans and rodents (Chabi, Ljubicic et al. 2008, Wenz, Rossi et al. 
2009, Ghosh, Lertwattanarak et al. 2011, Kang, Chung et al. 2013). Correlating with this, aging 
triggers changes in multiple skeletal muscle processes and structures that are actually affected 
by PGC-1α levels (as described in I.C.1 and I.C.2), including NMJ, ROS, inflammation and 
mitochondrial function and numbers (Fig. 9). Those data support an important role for PGC-1α 
in muscle aging. Accordingly, Wenz and collaborators demonstrated that muscle PGC-1α 
overexpression positively impacts several aspects of muscle aging in mice (Wenz, Rossi et al. 
2009). Muscle PGC-1α upregulation ameliorated age-associated diminished oxidative and anti-
oxidant capacities, ATP production, and endurance performance (Fig. 9). Accompanying those 
ameliorations, PGC-1α reduced inflammatory marker amounts and apoptosis. In addition, PGC-
1α improved NMJ integrity and at the systemic level, lean body mass and insulin sensitivity (Fig. 
9). Furthermore, PGC-1α muscle overexpression has been shown to delay the myopathy onset 
of a mouse model of mitochondrial myopathy and to increase both health and lifespan of these 
animals by improving OXPHOS defect and ATP production (Fig. 9). Interestingly, bezafibrate, a 
PPAR agonist that activates PGC-1α, recapitulates these positive effects in cells of patients with 
OXPHOS dysfunctions, demonstrating the potential of PGC-1α to improve myopathies with 
mitochondrial defects. Finally, other works with PGC-1α overexpression used the coactivator to 
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reverse the aging phenotype of the mtDNA mutator mouse model that develops a pre-mature 
aging and mitochondrial dysfunctions (Dillon, Williams et al. 2012), and to improve the 
phenotype of another mouse model encompassing telomere linked mitochondrial defects, 
(Sahin, Colla et al. 2011) which are also present during aging (Mikhelson and Gamaley 2012). 
Another study oppositely investigated the consequences of muscle PGC-1α deletion on aging 
(Sczelecki, Besse-Patin et al. 2014). Authors found as expected that both aging and PGC-1α 
deletion in young mice decreases electron transport chain gene expression and function but 
also that PGC-1α deletion exacerbated those changes in old muscles. Interestingly, they also 
revealed that PGC-1α muscle deletion worsen age-related glucose tolerance decline and further 
increased fat mass, insulin resistance and WAT and liver expression of inflammatory markers 
during aging (Fig. 9). However, descriptions of the effect of muscle PGC-1α deletion on muscle 
function or other muscle metabolic processes have not been reported in this work and are still 
missing. In addition, when many processes altered by aging are influenced by PGC-1α 
upregulation, only a part of them have been studied and shown to be altered by the coactivator 
in an aging context. 
 
Exercise improves muscle aging 
Currently, exercise is one of the best interventions against skeletal muscle aging. 
Resistance training has been shown to be particularly efficient to improve muscle mass and 
strength in elderly subjects (Fig. 10) (Fiatarone, Marks et al. 1990, Liu and Latham 2009) and in 
very old frail patients (Fiatarone, Marks et al. 1990, Serra-Rexach, Bustamante-Ara et al. 2011). 
It also ameliorates aerobic capacities, mobility, motor functions and balance in the elderly 
population (Fig. 10) (Kortebein, Ferrando et al. 2007, de Vries, van Ravensberg et al. 2012, 
Gault and Willems 2013). In line with improved muscle force, exercise training ameliorates 
myofiber atrophy, strength and power (Cartee, Hepple et al. 2016). However, the hypertrophic 
response seems to be blunted in older adults compared to young (Bickel, Cross et al. 2011). 
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Mitochondrial amelioration and cellular anti-oxidant defense induced by exercise are 
thought to be main players of the beneficial exercise effects on muscle in the elderly population 
(Ji 2001, Tarnopolsky 2009), but those adaptations are rapidly abolished after exercise 
cessation. Also, exercise quantity seems to be more important than exercise intensity for 
mitochondrial biogenesis induction (Bishop, Granata et al. 2014). Mitochondrial mass, OXPHOS 
protein expression and mitochondrial enzymatic activities and oxidative capacities are 
remarkably improved by exercise in aged muscle (Fig. 10) (Skorjanc, Traub et al. 1998, Pette 
and Skorjanc 2001, Short, Vittone et al. 2003, Menshikova, Ritov et al. 2006). Importantly, 
several studies demonstrated that mitochondrial adaptation to exercise occurs similarly in 
young and old humans and rodents (Farrar, Martin et al. 1981, Short, Vittone et al. 2003, 
Ghosh, Lertwattanarak et al. 2011). Of note, exercise can transform damaged mitochondria 
back to healthy and functional ones (Jubrias, Esselman et al. 2001, Conley, Jubrias et al. 2013). 
Exercise also improves expression of mitochondrial dynamic genes in old humans likely 
contributing to improve mitochondrial wellness (Konopka, Suer et al. 2014). Lastly, similar to 
PGC-1α, exercise rescues the pre-mature aging phenotype and mitochondrial dysfunctions 
displayed by the mtDNA mutator mice (Safdar, Bourgeois et al. 2011) 
 
 
Figure 10: Exercise ameliorations of muscle aging. Adapted from (Garatachea, Pareja-Galeano 
et al. 2015) 
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In addition to ameliorate mitochondrial function, exercise also improves other processes 
impaired in old muscles (Fig. 10). Some of those ameliorations are briefly discussed here. For 
example, amounts of physical activity are negatively correlated to levels of inflammatory 
markers in both young and elderly adults (Fig. 10) (Pedersen and Fischer 2007) and this 
phenomenon is associated with altered muscle mass in old rats (Marzetti, Groban et al. 2008). 
Increase in mass of aged muscle after exercise could also be pushed by the restoration of 
growth factor levels such as IGF-1 (Fig. 10) (Urso, Fiatarone Singh et al. 2005). In addition, 
satellite cell content and myogenic regulating factors of satellite cells are increased with 
exercise in older adults (Kim, Kosek et al. 2005, Dreyer, Blanco et al. 2006), which could also 
contribute to restore muscle mass (Fig. 10). Moreover, exercise reduces apoptosis in old rats, 
thereby attenuating fiber atrophy (Fig. 10) (Song, Kwak et al. 2006). In this study, exercise 
showed a particularly strong rescuing effect on apoptotic markers as it decreased by 95-96% 
caspase-3 cleavage and Bax/Bcl-2 ratio and brought back DNA fragmentation to the level of 
young animals. Finally, exercise improves age-related NMJ deteriorations, such as NMJ 
fragmentation, denervation and neurofilament sprouting (Fig. 10) (Valdez, Tapia et al. 2010). 
At the systemic level, exercise also rescues impaired whole body energy homeostasis. Especially, 
insulin sensitivity is restored by exercise in old humans (Pauli, Ropelle et al. 2010, Wang, 
Patterson et al. 2013) and rats the day following exercise. In accordance with these data, 
muscle insulin-stimulated glucose uptake and Glut4 expression are increased 3 hours post-
exercise in old rats (Sharma, Wang et al. 2015). Different types of chronic exercises such as 
cycling, running or walking can lead to increased insulin sensitivity and GLUT4 levels in older 
adults and rodents (Gulve, Rodnick et al. 1993, Evans, Racette et al. 2005, Consitt, Van Meter 
et al. 2013, Bienso, Olesen et al. 2015).  
 
Taken together, those data demonstrate that exercise can slow down the majority of 
muscle aging disorders. However, its effect is still limited and exercise is not always easy for 
elderly to practice. Therefore it would be extremely beneficial in the fight against muscle aging 
to reveal a molecule able to increase exercise effects and to mimic it. 
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PGC-1α mediates, potentiates and mimics exercise-induced amelioration in young 
skeletal muscle 
When going through the previous sections, what is striking is the number of processes 
and parameters that are positively impacted by both exercise and PGC-1α expression, many of 
which are actually impaired with aging. This includes mitochondrial content, function, dynamics, 
enzymatic activities but also neuromuscular adaptations, oxidative metabolism and fiber type 
switch towards slow muscle, muscle mass and endurance, myokines and other muscle secreted 
factors, GLUT4 expression and glycogen storage, insulin signaling, inflammation, angiogenesis 
and anti-oxidative enzymes induction. Another muscle adaptation to exercise is the unfolded 
protein response (UPR) that is the consequence of ER stress induced by exercise. On the 
contrary to UPR increase in old muscle, likely due to chronic ER stress, UPR after exercise 
constitutes a defense mechanism to restore and conserve cellular homeostasis. Interestingly, a 
previous study demonstrated that muscle PGC-1α overexpression also mimics exercise in the 
induction of the UPR (Wu, Ruas et al. 2011). In light of those elements, PGC-1α seems to be a 
molecule that can strongly mimic exercise in improving muscle function and possibly muscle 
aging. 
 
The strong exercise-mimetic effect of PGC-1α also suggests that the coactivator is 
important for muscle adaptation to training. This is supported by the fact that many signaling 
pathways activated by exercise converge to PGC-1α induction and activation as described in 
section I.A.1. To further investigate this hypothesis, some studies evaluated the requirement of 
PGC-1α expression to mediate exercise effect on muscle. Thus, PGC-1α expression has been 
shown to be required for the UPR induction upon both exercise and ER stress stimulation in 
muscle (Wu, Ruas et al. 2011). Interestingly, muscles deleted for PGC-1α present higher damage 
post-exercise than muscles of control animals, supporting the idea that they cannot promote an 
appropriate defense against exercise-induced muscle stress (Handschin, Chin et al. 2007). In 
addition, our laboratory recently highlighted that exercise enhances muscle ketolytic capacity 
only in the presence of PGC-1α in the muscle (Svensson, Albert et al. 2016). Finally, other works 
showed that muscle PGC-1α is mandatory for exercise induction of angiogenesis and VEGF 
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(Chinsomboon, Ruas et al. 2009), as well as for exercise stimulation of mitochondrial biogenesis 
and mitochondrial enzyme expression (Geng, Li et al. 2010). However, a previous study showed 
that muscle PGC-1α was dispensable for training induced mitochondrial gene expression (Leick, 
Wojtaszewski et al. 2008). Interestingly, the same authors showed that PGC-1α expression is 
required by exercise to prevent age-related decline in citrate synthase activity and SOD2 protein 
content in 13-month-old mice (Leick, Lyngby et al. 2010) while another work found that 
exercise could increase SOD2 expression in young muscle lacking PGC-1α expression (Geng, Li et 
al. 2010). The discrepancy of those results still leaves the question of the necessity of PGC-1α 
expression for exercise-stimulated mitochondrial protein expression opened. However the 
variation of the results could be due to whole-body versus muscle specific deletion of PGC-1α, 
different exercise protocols and sacrifice timing post-training. In addition, other proteins and 
mitochondrial measure should be used to characterize in a more comprehensive way the 
requirement of PGC-1α expression for exercise muscle adaptations. 
  
In addition to mediating some exercise effects, PGC-1α levels affect exercise 
performance (Handschin, Chin et al. 2007, Calvo, Daniels et al. 2008, Perez-Schindler, Svensson 
et al. 2014) and therefore training capacity. Lower training efficiency might ultimately reduce 
the beneficial effects expected from exercise. On the other hand, reduced daily activity might be 
the cause of PGC-1α expression decrease in older adults, resulting in lower mitochondrial 
content and function (Chabi, Ljubicic et al. 2008, Wenz, Rossi et al. 2009, Ghosh, 
Lertwattanarak et al. 2011, Kang, Chung et al. 2013). Importantly, a study showed that people 
over 80 years of age that went through a life-long endurance training, have higher muscle PGC-
1α mRNA content than an age matched healthy subject that had normal activity levels (Lanza, 
Short et al. 2008). Furthermore, exercise training can stimulate PGC-1α expression, and 
accordingly mitochondrial biogenesis gene expression, enzymatic activity and ATP production in 
young and old individuals (Short, Vittone et al. 2003, Lanza, Short et al. 2008, Cobley, Bartlett 
et al. 2012). However, while most of these parameters are induced at similar levels in young 
and old subjects by exercise, PGC-1α and Tfam protein expression are less exercise-stimulated 
in old compared to young subject (Lanza, Short et al. 2008).  
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Finally, studies revealed that PGC-1α overexpression combined with exercise could have 
synergistic effects. For example, muscle glucose uptake as well as whole-body glucose 
homeostasis of mice fed with HFD is further improved by exercise in mice with elevated PGC-1α 
expression than in WT exercised mice (Summermatter, Shui et al. 2013). However, the 
combination of PGC-1α upregulation and exercise to maximize muscle function improvements is 
still much understudied and therefore deserves high attention.  
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D. Aim of the Thesis 
Since the identification of the coactivator of transcription factors PGC-1α, many 
publications have demonstrated its extensive role in regulating energy metabolism processes 
such as thermogenesis, gluconeogenesis or mitochondrial biogenesis in different organs in 
response to various stimuli such as cold exposure or exercise. In addition, recent studies in 
muscle have shown that it regulates crosstalks between different organs through myokines, as 
well as whole body glucose homeostasis. PGC-1α therefore now represents a muscle metabolic 
sensor that can impact whole body homeostasis. However the role of PGC-1α in the brain, 
another major organ regulating whole body homeostasis, is still restricted to local neuronal 
survival and function. This prompted us to generate mouse models with deletion of PGC-1α 
specifically in AgRP and POMC neurons, which are in charge of regulating whole body energy 
balance, in order to investigate whether it could play a similar role those cells. Our findings 
regarding the role of PGC-1α in AgRP- and POMC- neuronal regulation of energy balance are 
presented in section II of this thesis and the aims in the first part of this thesis were: 
1. Define the role of PGC-1α in AgRP and POMC neurons for the regulation of food 
intake and whole body energy balance 
2. Determine if PGC-1α regulates AgRP and POMC expression upon different 
energetic stimulus in order to achieve this function 
The second part of the thesis focuses on the role of PGC-1α in muscle aging. Muscle 
aging involves mitochondrial dysfunctions as a primary cause of muscle disorders but also 
displays many other alterations such as disruption of calcium homeostasis, ER stress and 
apoptosis. In the literature, one study examined the consequences of PGC-1α overexpression on 
mitochondrial dysfunction, inflammation, insulin resistance, oxidative stress and apoptosis 
during aging while another work focused on the outcomes of PGC-1α muscle deletion on 
systemic changes during aging. In our study, we used muscle specific PGC-1α overexpression 
and deletion mouse models to characterize in a broader way the influence of PGC-1α on 
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mitochondrial and muscle function disorders in the old muscle. We also wanted to determine 
the repercussions of muscle PGC-1α modulation on other muscle metabolic processes that are 
potentially regulated by PGC-1α and influenced by aging but not studied in the previous 
investigations. The results concerning this study are presented in III of this thesis. The general 
aims of our second project were: 
3. Characterize the impact of PGC-1α modulation on mitochondrial aging and age-
associated muscle damage and dysfunction 
4. Identify new pathways influenced by PGC-1α that leads to age-related muscle 
alterations 
Finally, we were interested in unraveling the role PGC-1α in the context of exercise 
treatment against muscle aging. Exercise is one of the most effective treatments to slow down 
sarcopenia and positively impacts the majority of age-related muscle alterations. As PGC-1α is 
strongly induced by exercise and share many beneficial repercussions that exercise has on 
muscle, we hypothesized that it could be the factor that mediates exercise-associated muscle 
adaptations during aging. In addition, we though that PGC-1α could be a therapeutic target to 
potentiate exercise effects or to replace exercise training in the fight against muscle aging. The 
results of those investigations are presented in section IV of this work and the aims can be 
resumed as follow: 
5. Determine if PGC-1α mediates exercise effects during muscle aging. 
6. Investigate if PGC-1α modulates exercise-induced muscle adaptation during 
aging. 
Some results during this thesis led to new ideas and projects that are still ongoing and 
that will be discussed in section V. 
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A. Abstract 
Objective.  
Food intake and whole-body energy homeostasis are controlled by agouti-related protein 
(AgRP) and pro-opiomelanocortin (POMC) neurons located in the arcuate nucleus of the 
hypothalamus. Key energy sensors, such as the AMP-activated protein kinase (AMPK) or sirtuin 
1 (SIRT1), are essential in AgRP and POMC cells to ensure proper energy balance. In peripheral 
tissues, the transcriptional coactivator PGC-1α closely associates with these sensors to regulate 
cellular metabolism. The role of PGC-1α in the ARC nucleus however remains unknown. 
 
Methods.  
Using AgRP and POMC neurons specific knockout (KO) mouse models we studied the 
consequences of PGC-1α deletion on metabolic parameters during fed and fasted states and on 
ghrelin and leptin responses. We also took advantage of an immortalized AgRP cell line to assess 
the impact of PGC-1α modulation on fasting induced AgRP expression. 
 
Results.  
PGC-1α is dispensable for POMC functions in both fed and fasted states. In stark contrast, mice 
carrying a specific deletion of PGC-1α in AgRP neurons display increased adiposity concomitant 
with significantly lower body temperature and RER values during nighttime. In addition, the 
absence of PGC-1α in AgRP neurons reduces food intake in the fed and fasted states, and alters 
the response to leptin. Finally, both in vivo and in immortalized AgRP cell line, PGC-1α 
modulates AgRP expression induction upon fasting. 
 
Conclusions.  
Collectively, our results highlight a role for PGC-1α in the regulation of AgRP neuronal functions 
in the control of food intake and peripheral metabolism. 
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B. Introduction 
The arcuate nucleus of the hypothalamus receives and integrates different inputs from 
peripheral organs and subsequently controls food intake and energy expenditure according to 
the energy status of the body It (Cone, Cowley et al. 2001, Sandoval, Cota et al. 2008, Woods 
2009, Joly-Amado, Cansell et al. 2014). Two major cell populations in the ARC nucleus, namely 
the orexigenic agouti-related protein (AgRP) and anorexigenic pro-opiomelanocortin (POMC) 
neurons, secrete diverse neuropeptides including AgRP, neuropeptide Y (NPY), α-melanocyte 
stimulating hormone (α-MSH) and cocaine- and amphetamine-regulated transcript (CART), 
respectively. The activity of both AgRP and POMC neurons are regulated by hormonal inputs 
such as ghrelin (Ruan, Dietrich et al. 2014, Wang, Liu et al. 2014), leptin and insulin (Varela and 
Horvath 2012) and nutrients such as glucose (Stanley, Wynne et al. 2005). As a result, in the 
fasted state, AgRP neurons stimulate appetite and decrease energy expenditure while POMC 
neuron activation in the fed state leads to food satiety and enhanced energy production (Neary, 
Small et al. 2003, Stanley, Wynne et al. 2005, Coll, Farooqi et al. 2007). Interestingly, different 
energy sensors have been implicated in the cellular mechanisms in the ARC nucleus that 
ultimately regulate whole-body metabolism. For example, AMP-activated protein kinase (AMPK) 
is necessary for glucose sensing in both AgRP and POMC neurons and thereby for the control of 
energy balance (Claret, Smith et al. 2007, Mountjoy and Rutter 2007). Deletion of the NAD+-
dependent protein deacetylase sirtuin-1 (SIRT1) in AgRP neurons impairs the response to ghrelin 
and thus affects energy homeostasis (Dietrich, Antunes et al. 2010). Finally, the forkhead 
protein FoxO1 mediates leptin inhibition of AgRP expression and food intake (Kitamura, Feng et 
al. 2006). 
 
The peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) is a major 
coregulator of transcription factors involved in the control of cellular metabolism (Martinez-
Redondo, Pettersson et al. 2015). Intriguingly, key energy sensors that are part of the 
hypothalamic network controlling energy balance engage PGC-1α in peripheral tissues. For 
example, SIRT1 interacts with and deacetylates PGC-1α to coordinately induce the expression of 
gluconeogenic and mitochondrial genes in the liver (Rodgers, Lerin et al. 2005). Similarly, AMPK 
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activation leads to transcriptional induction and activating phosphorylation events of the PGC-
1α gene and protein, respectively (Jager, Handschin et al. 2007). In hepatocytes, Foxo1 engages 
PGC-1α in the context of insulin-regulated gluconeogenesis (Puigserver, Rhee et al. 2003). 
Importantly, global as well as deletion of PGC-1α specifically in the brain protects mice from 
diet-induced obesity (Lin, Wu et al. 2004, Ma, Li et al. 2010). Furthermore, PGC-1α levels in the 
hypothalamus are increased in response to fasting (Ma, Li et al. 2010), suggesting that PGC-1α 
may act as a metabolic integrator of different signaling pathways in the ARC nucleus for the 
regulation of whole body energy homeostasis (Coppari, Ramadori et al. 2009). However, due to 
the phenotypic complexity of global and brain-specific PGC-1α knockout animals, it is unclear 
whether this coactivator exerts a direct role in AgRP and POMC neurons. 
 
The present study aimed at investigating the contribution of PGC-1α expression in the 
ARC nucleus to whole-body energy balance. We therefore generated mouse models with 
specific deletions of PGC-1α either in AgRP or in POMC neurons and studied their energy 
homeostasis and their response to different metabolic challenges. 
  
II. Manuscript 1: PGC-1α expression in murine AgRP neurons regulates food 
intake and energy balance 
 
106 
C. Experimental procedures 
Animals 
Male mice were kept under a 12h/12h light/dark cycle with lights on from 06:00 to 18:00 
humidity-controlled rooms at 23°C. All animals had free access to regular chow diet (Provimi 
Kliba 3432) or High Fat Diet (HFD) (Provimi Kliba 2127) and water. Animals with a specific PGC-
1α knock-out in AgRP and POMC neurons, (AgRP- and POMC-PGC1α KO), were generated by 
crossing PGC-1αloxP/loxP mice with transgenic AgRPCre/+ and POMCCre/+ mice, respectively. 
The PGC-1αloxP/loxP mice have been described previously (Lin, Wu et al. 2004). AgRPCre/+ 
(Agrptm1(cre)Lowl, Jax #012899) and POMCCre/+ (STOCK tg(Pomc1-cre)16Lowl/J, Jax #005965) 
were purchased from Jackson Laboratories. AgRP- and POMC-PGC1α KO or AgRPCre/+ and 
POMCCre/+ were crossed with Rosa26-EGFP reporter mice carrying an EGFP sequence in the 
Rosa26 locus to generate AgRP- or POMC-EGFP-Cre and AgRP- or POMC-EGFP-Cre-PGC1α KO 
mice expressing EGFP in AgRP or POMC neurons. Animals used in all experiments besides 
weight curves measurement were between 16 and 20 weeks old, except for ghrelin and leptin 
experiments, for which 8 weeks old mice were used. PGC-1αloxP/loxP littermates mice without 
AgRPCre/+ and POMCCre/+ sites were used as controls (ctr). The genotype of AgRP-, POMC-
PGC1α KO and littermate control animals was assessed by PCR using specific primer pairs (listed 
in the DNA/RNA extraction and qPCR section) to detect the presence of AgRPCre/+, POMCCre/+ 
and loxP sites. Aberrant expression of the Cre transgene is sporadically detected in germ cells in 
both AgRP and POMC lines. Whole body PGC-1α knock-out animals were therefore identified by 
PCR and excluded from the experiments (approximately 50% of AgRP-PGC1α KO and 2% of 
POMC-PGC1α KO mice). All experiments were performed in accordance with the federal 
guidelines for animal experimentation and were approved by the Kantonales Veterinäramt of 
the Kanton Basel-Stadt. 
 
Body weight curves and composition analysis 
Body weight was measured the same day of the week in the morning from 4 to 22 weeks 
of age and subsequently every month until the age of 50 weeks. Body composition was 
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evaluated with an EchoMRI-100 analyzer (EchoMRI Medical Systems). Fat and lean mass were 
normalized to body weight. A HFD experiment was started with 6 weeks old mice and body 
composition was evaluated after 8 weeks of HFD treatment. 
 
COBAS blood analysis 
Blood was harvested after the mice were killed. Blood samples were centrifuged for 10 
min at 2000g in tri-potassium-EDTA tubes and plasma was collected. Plasma glucose and 
triglycerides levels were measured with a COBAS c111 analyzer (Roche Diagnostics). 
 
Glucose tolerance test 
A bolus of 2g (glucose)/kg (body weight) was injected intraperitoneally into mice fasted 
for 16 hours. Blood glucose was measured in the tail vein 0, 15, 30, 45, 60, 90 and 120 minutes 
after glucose injection with a glucose meter (Accu-Chek, Roche Diagnostics). All mice were 
acclimatized to handling before the experiment. 
 
Comprehensive laboratory animal monitoring system (CLAMS) 
Whole body metabolism was assessed with an indirect calorimetric system (CLAMS, 
Columbus Instruments). Food intake, locomotor activity, VO2 and VCO2 were recorded in 15 
min intervals. Data were analyzed after one day of acclimatization. The plotted values represent 
3 days of measurements in fed, 24-h fasted and 24-h refed animals. 
 
Voluntary wheel-running activity and body temperature measurements 
Mice were given free access to running wheels. The number of wheel revolutions was 
recorded in 30 min intervals. Plotted values represent two weeks of measurements after two 
weeks of acclimatization. In separate experiments, Anipill capsules (Animal Monitoring) were 
implanted intraperitoneally under isoflurane anesthesia for body temperature measurements. 
After a recovery period of 2 weeks, body temperature was recorded in 15 min intervals. 
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Ghrelin and leptin sensitivity 
Animals were acclimatized to handling before the experiment. Intraperitoneal injections 
were performed with 2 and 5 mg/kg body weight of rat ghrelin (Bachem H-4862) and rat leptin 
(R&D 498-OB-05M), respectively, in PBS vehicle. Vehicle control, ghrelin and leptin, respectively, 
were injected in subsequent experiments into the same animals. Food pellets were weighed and 
exchanged after injections. Ghrelin injections were done at 12:00. Food intake was measured 1, 
2 and 3 hours after injection. Two consecutive leptin injections were made at 17:30 and at 07:30 
on the next day. Food intake and body weight were measured 16 and 24 hours later. 
 
Cell culture 
The MHypoA-59 cell line (Bioconcept CLU468) was grown in monolayer cultures in 
regular DMEM (Sigma-Aldrich D 5796) supplemented with 5% fetal bovine serum (FBS) (HyClone 
Laboratories, Inc., Logan, UT), 4.5 mg/ml glucose and 1% penicillin/streptomycin. Cells were 
maintained at 37°C with 5% CO2. Cells were grown to 50% confluence before infection. PGC-1α 
knock-down was induced using adenoviral vectors expressing specific short hairpin RNA (shRNA) 
against PGC-1α or scrambled control shRNA. Both viruses expressed EGFP to allow infection 
efficiency monitoring. Two days after infection, regular growth medium was exchanged with 
fresh regular growth medium or with low glucose DMEM (1 mg/ml, Sigma-Aldrich D 6046) 
without FBS to induce cell starvation. After 4 hours, the medium was exchanged with low 
glucose DMEM supplemented with 5% FBS to mimic refeeding. Cells were harvested 4h after 
starvation and 1 h after refeeding. Cells exposed to normal growth medium were used as a fed 
state. 
 
ARC nucleus punch isolation and imaging 
Mice were killed by CO2 inhalation. Mouse brains were harvested and directly frozen in 
2-methylbutane (M32631). Brain tissue was embedded in optimal cutting temperature medium 
(OCT, Tissue-Tek 25608-930). For arcuate nucleus isolation 100-200 µm sections containing the 
region of interest were cut with a cryostat (Leica). Sections were placed in RNA later solution 
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(Qiagen 76104) and the hypothalamic region containing the ARC nucleus was isolated using a 
punch needle (Leica 39443001). For AgRP and POMC neuron imaging, 15µm sections containing 
the arcuate nucleus of AgRP- or POMC-EGFP-Cre and AgRP- or POMC-EGFP-Cre-PGC1α KO mice 
expressing EGFP in AgRP or POMC neurons were visualized with a Zeiss point scanning confocal 
microscope. 
 
DNA/RNA extraction and PCR 
For DNA extraction, ARC nuclei were put in DNA extraction buffer (50 mM Tris-HCL pH-
8.0, 100 mM NaCl, 10 mM EDTA, 0.5 % Nonidet P-40, 20 mg/ml Proteinase K) and vortexed for 
30 seconds. DNA was extracted in an overnight incubation at 55°C under a constant agitation at 
400 rpm in an Eppendorf Thermomixer. On the next day, proteinase K was heat-deactivated for 
10 min at 95°C. The presence of AgRP Cre/+, POMC Cre/+ allele and the deletion of PGC-1α was 
then assessed using the PCR primers listed in Supplemental Table 1 
 
Total RNA from ARC and non-ARC nucleus punches was isolated using the RNeasy Micro 
Kit (Qiagen 74004). RNA quality and concentration were measured with an Agilent Bioanalyzer 
(Agilent 2100 Bioanalyzer, Agilent Technologies). 50 ng of RNA were used for reverse 
transcription using the SuperScript II reverse transcriptase (Invitrogen 18064-014). Total RNA 
from mHypoA-59 cell and whole hypothalamus was extracted using the TRI reagent (Sigma-
Aldrich T9424) according to the manufacturer’s instructions. RNA concentration and purity were 
measured with a NanoDrop 1000 spectrophotometer (Thermo Scientific). 1ug of RNA was used 
for cDNA synthesis as described above.  
 
Quantitative real-time PCR 
The level of relative mRNA was quantified by real-time PCR on a StepOnePlus system 
(Applied Biosystems) using Fast SYBR green PCR master mix (Applied Biosystems 4385612). 
Relative quantification was performed with the ΔΔCT method using the TATA binding protein 
(TBP) as housekeeping control. All primers used have similar PCR efficiency. TBP levels were 
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similar between genotypes in a given experimental condition. Primers sequences are listed in 
Supplemental Table S1. 
 
Statistical analysis 
Data were analyzed with Student’s t test or with two-way ANOVA (GraphPad Prism 
software). Bonferroni post-test were used to do multiple comparison analysis following two-
way ANOVA. All data are plotted as mean ± SEM. 
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D. Results 
ARC nucleus specific deletion of PGC-1α in AgRP- and POMC-PGC1α KO mice  
To investigate the role of PGC-1α in the ARC nucleus, animals with specific ablations of 
PGC-1α expression in AgRP or POMC neurons were generated by crossing PGC-1αloxP/loxP with 
transgenic AgRPCre/+ or POMCCre/+ mice, respectively. The presence of the Cre transgene 
under the control of either the AgRP or the POMC promoter was identified by PCR (Fig. 1a) in 
punches targeting the ARC nucleus. In both animal models, excision of the floxed PGC-1α allele 
was detected in areas isolated from the ARC nucleus, but not from other hypothalamic regions 
(Fig. 1b). 
 
PGC-1α ablation in AgRP but not in POMC neurons promotes fat storage and reduced 
food intake 
To assess the role of PGC-1α in AgRP and POMC neurons in whole body energy 
homeostasis, we evaluated body composition, food intake and glucose tolerance in both AgRP- 
and POMC-PGC1α KO mice. Of these, neither animals with PGC-1α deletion in AgRP or in POMC 
neurons did show differences in total body mass (Fig. 2a and b). Nevertheless, a significant shift 
in body composition from lean to fat mass was observed in AgRP-PGC1α KO mice compared to 
their control littermates (Fig. 2b and Fig. S1a). In association with elevated fat mass, higher 
triglycerides levels were detected in AgRP-PGC1α KO mice (Fig. 2e), while we observed no 
significant alteration of blood glucose levels (Fig. 2f) or glucose tolerance (Fig. 3a and c) even 
though a trends towards higher blood glucose was seen in both tests. Surprisingly, despite the 
increase in adiposity, PGC-1α deletion in AgRP neurons was not associated with increased food 
intake. On the contrary, food intake was reduced during nighttime in AgRP-PGC1α KO mice (Fig. 
4a). None of these parameters, including body composition, food intake or glucose tolerance, 
were affected by PGC-1α deletion in POMC neurons (Fig. 2b and d, Fig. S1b, Fig. 3b and d and 
Fig. 4b). 
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PGC-1α deletion in AgRP, but not in POMC neurons, affects RER values, spontaneous 
locomotor activity and body temperature. 
To further evaluate the metabolic phenotype of both AgRP- and POMC-PGC1α KO 
animals we used a Comprehensive Laboratory Animal Monitoring System (CLAMS). In line with 
the absence of changes in body composition and food intake, our CLAMS analysis did not reveal 
any changes in VO2 consumption (Fig. 4d), energy substrate utilization (Fig. 4f) or locomotor 
activity (Fig. 4h) in fed POMC-PGC1α mice. Similarly, VO2 levels (Fig. 4c) were unchanged in 
AgRP-PGC1α KO mice. We however observed a significant reduction in the respiratory exchange 
ratio (RER) in the AgRP-PGC1α KO mice during nighttime (Fig. 4e). In addition, a trend towards 
overall reduction of locomotor activity was noted in the AgRP-PGC1α KO animals (Fig. 4g). To 
further assess spontaneous locomotor activity in the absence of AgRP specific PGC-1α 
expression, voluntary wheel running was quantified over a period of 14 days. As for CLAMS in-
cage movements, AgRP-PGC1α KO mice showed a trend towards reduced wheel-running activity 
(Fig. 5a). Interestingly, reduced RER values and locomotor activity at night were also associated 
with significantly lower body temperature levels in these mice in the absence of running wheels 
(Fig. 5b). 
 
PGC-1α ablation in AgRP neurons affects leptin sensitivity 
Because AgRP-PGC1α KO animals showed reduced food intake, we hypothesized that 
PGC-1α could be important for the response of AgRP neurons to hormones that regulate food 
intake. To test this, we first studied the effect of peripheral injection of ghrelin, an orexigenic 
peptide that is secreted upon starvation and that promotes food intake via AgRP neuronal 
activation (Andrews 2011). A strong increase of food intake 1, 2 and 3 hours after ghrelin 
injections in both ctr and AgRP-PGC1α KO animals was observed (Fig. 6a), indicating that PGC-
1α deletion in AgRP neurons did not impair ghrelin signaling. 
 
We next evaluated the response of AgRP-PGC1α KO animals to leptin, a hormone known 
to inhibit AgRP and activate POMC neurons to reduce food intake (Stanley, Wynne et al. 2005). 
In line with our previous observation, food intake over a 24-h time period was significantly 
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lower in AgRP-PGC1α KO mice compared to control mice upon vehicle injection (Fig. 6b). 
Interestingly, leptin injections significantly lowered food intake and body mass changes (Fig. 6b 
and c) in control animals but not in AgRP-PGC1α KO mice, thus indicating impaired leptin 
signaling upon specific ablation of PGC-1α in AgRP neurons. 
 
PGC-1α in AgRP neurons controls fasting-induced AgRP expression 
In light of the modulation of basal energy homeostasis and leptin response in AgRP-
PGC1α KO animals, we then decided to assess their ability to adapt energy intake and 
expenditure to metabolic challenges such as a 24-h fasting followed by a 24-h refeeding period. 
As in ad libitum feeding conditions, the amount of food consumed after a 24-h fast was 
significantly reduced in AgRP-PGC1α KO compared to ctr mice, most notably in the second part 
of the re-feeding period (Fig. 7a). Of note, while RER was not changed in AgRP-PGC1α KO mice 
upon fasting, spontaneous activity again exhibited a trend towards lower values in the refed 
AgRP-PGC1α KO animals (Fig. 7b and c). 
 
Since feeding activity is regulated by different neuropeptides in the hypothalamus, we 
measured the expression of the AgRP, NPY and POMC genes in fasted and fed conditions. In fed 
animals, no changes in orexigenic or anorexigenic gene expression levels were detected in the 
absence of PGC-1α (Fig. 7d). In stark contrast, the induction of AgRP gene expression by fasting 
was significantly blunted in AgRP-PGC1α KO mice (Fig. 7e). Of note, while fed and fasting NPY 
expression levels were similar between genotypes, a trend towards higher POMC expression 
was also observed in mice lacking PGC-1α in AgRP neurons (Fig. 7e). 
 
To test if the reduction of AgRP-induction was due to a direct or an indirect effect of 
PGC-1α deletion in AgRP neurons, PGC-1α was knocked down in hypothalamic immortalized 
cells using siRNA-based approaches (Fig. S2). Similar to our in vivo results, PGC-1α reduction did 
not alter AgRP expression in fed hypothalamic cells. Conversely, a significantly reduced 
transcriptional induction of the AgRP gene was found under starvation conditions in cells with a 
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knockdown of PGC-1α (Fig. 7f). Taken together, our in vivo and in vitro data indicate that PGC-
1α regulates the levels of AgRP expression in response to fasting. 
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E. Discussion 
The ARC nucleus is crucial for the maintenance of whole-body energy balance. PGC-1α is 
one of the key regulators of cellular energy homeostasis and strongly affects mitochondrial 
biogenesis and oxidative metabolism. In addition, PGC-1α regulates various metabolic processes 
in peripheral organs such as brown-adipose tissue thermogenesis (Puigserver, Wu et al. 1998), 
hepatic gluconeogenesis (Puigserver, Rhee et al. 2003) and endurance-training adaptation of 
skeletal muscle (Lin, Wu et al. 2002, Handschin, Chin et al. 2007). Interestingly, PGC-1α 
expression is important in hippocampus for dendritic spines maintenance (Jager, Handschin et 
al. 2007), in hypothalamic cells to protect against high fat diet-induced pathological changes 
(Morselli, Fuente-Martin et al. 2014) and exhibits daily oscillations in the hypothalamus 
(Gerhart-Hines, Rodgers et al. 2007). Moreover, brain-specific PGC-1α deletion in mice induces 
a hypermetabolic state (Ma, Li et al. 2010), pointing towards a key role for PGC-1α in the 
neuronal network controlling energy balance. 
 
Absence of PGC-1α in POMC neurons does not alter energy balance 
We thus further examined the contribution of central PGC-1α to the regulation of 
peripheral metabolism by generating mice with specific deletion of PGC-1α in AgRP and POMC 
neurons. POMC-PGC1α KO mice displayed no difference in feeding behavior, locomotor activity, 
basal metabolism, energy substrate utilization or glucose tolerance. Moreover, we did not 
observe any significant change in fasted or ghrelin-treated POMC-PGC1α KO animals (data not 
shown). In our experimental conditions, PGC-1α might thus simply be dispensable for POMC 
neuron, which are less sensitive to change in food intake than AgRP neurons (Henry, Sugino et 
al. 2015). Therefore, different physiological contexts might have to be identified in order to 
discover a role for PGC-1α in POMC neurons. For example, the neuropeptides that are secreted 
from POMC neurons are not only important to induce satiety, but are also involved in regulating 
sexual behavior (α-melanocyte-stimulating hormone), stress-related release of hormones from 
the adrenal gland (adrenocorticotropic hormone) or endogenous opioid effects, e.g. in 
strenuous exercise (β-endorphin) (Solomon 1999). Accordingly, a role for PGC-1α in regulating 
POMC neuronal function in other contexts, e.g. stress induced by exercise or other stimuli, 
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cannot be excluded based on the current data and thus should be the subject of future studies. 
Similarly, we cannot rule out that PGC-1α ablation could be compensated by PGC-1β in POMC 
neurons as both PGC1 coactivators are active and share redundant functions in different cell 
types (Wareski, Vaarmann et al. 2009, Egger, Samardzija et al. 2012). Hence, specific ablation 
of PGC-1β and double knockout mice for both coactivators in POMC neurons should provide 
further insights into the specific and redundant effects of PGC-1α and -1β in this neuronal 
population. Previous studies revealed that multiple lineages of hypothalamic neurons express 
POMC (Padilla, Carmody et al. 2010). In addition, pre- and postnatal ablation of AgRP neurons 
leads to different feeding behavior phenotypes (Luquet, Perez et al. 2005) that may be 
influenced by developmental compensation in central pathways that regulate food intake. 
Therefore, a comparative study with tamoxifen-inducible AgRP- and POMC-cre mouse models 
developed by Elmquist and colleagues (Berglund, Liu et al. 2013, Wang, Liu et al. 2014) to allow 
the deletion of PGC-1α in adult neurons might be of interest to assess the different behavioral 
phenotypes. 
 
PGC-1α deletion in AgRP neurons impairs whole body energy homeostasis 
In contrast to the POMC neuron-specific ablation, our results show that specific deletion 
of PGC-1α in AgRP cells results in significant changes in whole-body energy homeostasis. We 
found that AgRP-PGC1α KO mice display increased body fat in association with elevated 
circulating triglycerides levels. The increased adiposity could be a consequence of lower energy 
expenditure, as indicated by the decrease in basal body temperature and spontaneous 
locomotion in these mice. Previous studies showed that AgRP neurons rely on the expression of 
specific genes to regulate locomotor activity (Mesaros, Koralov et al. 2008, Ren, Orozco et al. 
2012, Huang, Lee et al. 2013). PGC-1α could be thus part of the hypothalamic network 
modulating spontaneous locomotion. Incidentally, the behavioral phenotype of AgRP-PGC-1α 
KO mice is dramatically different from the global and the brain-specific knockouts. For example, 
the trend towards hypoactivity in AgRP-PGC1α KO mice is diametrically opposite to the 
hyperactivity of the global and brain-specific knockout animals where neuronal degeneration in 
the striatum is thought to trigger a Huntington’s-like phenotype (Lin, Wu et al. 2004, Ma, Li et 
II. Manuscript 1: PGC-1α expression in murine AgRP neurons regulates food 
intake and energy balance 
 
117 
al. 2010). Similarly, increased adiposity in AgRP-PGC1α KO animals contrasts with the decreased 
fat mass observed in global and brain-specific knockout mice. Thus, collectively, the results 
obtained in animals with an AgRP specific deletion of PGC-1α now allow us to demonstrate that 
PGC-1α in AgRP neurons is intimately involved in the regulation of whole body energy 
homeostasis. This particular function of PGC-1α in AgRP neurons was likely masked by 
confounding alterations in brain-specific and global knockout animals. The cause of these 
differences remains to be established and probably reflects specific functions in different 
neuronal populations, e.g. those involved in the control of locomotion and energy balance. Of 
similar surprise, we found that in spite of an increased adiposity, AgRP-PGC1α KO mice 
displayed a lower RER, implying higher lipid oxidation, as well as hypophagia. Even though 
reduced locomotor activity and decreased body temperature could contribute to the observed 
phenotype, further investigation should be attempted to elucidate these seemingly paradoxical 
findings. Intriguingly, our findings recapitulated many aspects of the paradoxical phenotype of 
AgRP-neuron-ablated mice that display increased adiposity and increased feeding efficiency in 
spite of enhanced lipid utilization as well as a reduced feeding response upon fasting (Joly-
Amado, Denis et al. 2012). Mice with ablated AgRP neurons also showed a reduced fat gain 
upon HFD feeding (Joly-Amado, Denis et al. 2012), reminiscent of the AgRP-PGC1α KO animals 
where a HFD normalized the differences in body weight between the genotypes (Fig. S3a and b). 
In contrast however, the reduction in RER was observed during the whole dark period in the 
AgRP-PGC1α KO mice and correlated with the change in locomotor activity are different from 
the early drop in RER in the AgRP-neuron-ablated mice (Joly-Amado, Denis et al. 2012) (Fig. S3c 
and d). Collectively, even though the absence of PGC-1α did not affect the integrity of AgRP 
neurons (Fig. S3e), the numerous similarities between the two mouse models suggest that 
increased adiposity of mice lacking PGC-1α in AgRP neurons might also be due to other 
mechanisms than impaired caloric consumption. Further studies should thus assess the 
regulation exerted by the sympathetic nervous system on lipid storage, synthesis and utilization 
in AgRP-PGC1α KO animals analogous to the previous characterization of AgRP-neuron-ablated 
mice (Joly-Amado, Denis et al. 2012). Moreover, since recent studies have shown that AgRP 
neurons are also important for non-feeding behavioral responses linked to motivation and 
stereotypic behaviors (Dietrich, Bober et al. 2012, Betley, Xu et al. 2015, Dietrich, Zimmer et al. 
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2015), the decreased spontaneous locomotion of the AgRP-PGC1α KO mice might also be 
unrelated to the reduced feeding and body mass changes but emerge from a modulation of 
anxiety and non-food associated behavioral phenotypes. 
 
PGC-1α is important for response of AgRP neurons to food and energy challenges 
We demonstrated that AgRP-PGC1α KO mice exhibit reduced food intake in the fed and in 
the fasted state. This occurs together with lower AgRP induction in fasted animals, in line with 
results obtained in global and brain-specific PGC-1α knockout animals (Ma, Li et al. 2010). We 
moreover demonstrate in a hypothalamus-derived cell line that PGC-1α directly influences AgRP 
expression in a fasted-like state. Interestingly, PGC-1α has been shown to colocalize with AgGP 
neurons (Draper, Kirigiti et al. 2010) and its expression is elevated in the hypothalamus (Ma, Li 
et al. 2010) and AgRP cell line upon fasting (Fig. S1), further supporting a direct role for PGC-1α 
in AgRP neurons for their response to fasting. Therefore, importantly, our work now also 
suggests that the alteration of AgRP expression regulation in fasted global and brain-specific 
knockout animals is driven by the specific deletion of PGC-1α in AgRP neurons. Intriguingly, we 
observed that leptin injection does not reduce food intake in AgRP-PGC-1α KO animals. This 
absence of effect could be due to enhanced endogenous leptin signaling in the absence of PGC-
1α, in line with the reduced food intake that we observed in the fed state and upon vehicle 
injection. Alternatively, increased fat mass is often associated with higher leptin production 
which could also lead to altered central signaling (El-Haschimi, Pierroz et al. 2000, Lin, Thomas 
et al. 2000, Lee, Reed et al. 2001). Collectively, these results suggest that PGC-1α, in AgPR 
neurons might participate in the integration of the collective output of peripheral hormonal 
signals through AMPK (Claret, Smith et al. 2007), SIRT1 (Dietrich, Antunes et al. 2010) and 
signaling cascades (Andrews, Liu et al. 2008, Dieguez, Vazquez et al. 2011, Shadel and Horvath 
2015), and engage various transcription factors, including those of the FoxO family (Kitamura, 
Feng et al. 2006, Ren, Orozco et al. 2012) as in other cell types (Puigserver, Rhee et al. 2003, 
Rodgers, Lerin et al. 2005, Jager, Handschin et al. 2007). Moreover, PGC-1α-dependent 
remodeling of mitochondrial number and dynamics, known to be crucial for AgRP neurons 
control of energy balance (Dietrich, Liu et al. 2013, Schneeberger, Dietrich et al. 2013, 
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Nasrallah and Horvath 2014), could also contribute to the consequence of PGC-1α ablation in 
these neurons on food intake, locomotor activity and body temperature. However, the exact 
molecular mechanisms that are engaged by PGC-1α in AgRP neurons remain to be determined. 
 
Conclusion 
In summary, we now demonstrate that PGC-1α is directly involved in the regulation of 
feeding, activity and body temperature by modulating the activity of AgRP neurons. Notably, 
these changes are associated with an increase in fat and a decrease in lean mass. Importantly, 
for the first time, the role of PGC-1α in the regulation of appetite can be dissociated from 
confounding effects of knockout of PGC-1α in peripheral tissues and in other areas of the brain. 
Finally, this study identifies PGC-1α as potential integrator of various signaling pathways in AgRP 
neurons and thereby sheds additional light on the regulation of whole body energy balance by 
hypothalamic neurons, which are attractive targets for therapeutic approaches in metabolic 
diseases (Donato 2012). 
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F. Figures 
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Figure 1: Specific deletion of PGC-1α in the ARC nucleus of AgRP and POMC mice.(a) Detection 
of AgRP-Cre and POMC-Cre expression in punches targeting the ARC nucleus. Genotyping PCR 
with specific primers was used to detect the presence of the AgRP-cre or POMC-cre allele in 
isolated hypothalamic region. (b) Genotyping PCR using specific primers showing the specific 
deletion of PGC-1α in the ARC. 
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Figure 2: PGC-1α deletion in AgRP, but not in POMC neurons promotes fat storage. (a and b) 
Body weight curves (n = 10-14) (c and d) body composition (n = 7-8) and (e and f) blood 
triglycerides and glucose levels (n=5-7) in AgRP-, POMC-PGC1α KO and WT mice. Values and 
error bars represent the mean ± SEM. *p<0.05; **p<0.01. 
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Figure 3: Glucose homeostasis is not altered in AgRP- and POMC-PGC1α KO mice. (a and b) 
Blood glucose curve during glucose tolerance test and (c and d) calculated area under the 
curves in AgRP-, POMC-PGC1α KO and WT mice (n = 7-8). Values and error bars represent the 
mean ± SEM. *p<0.05. 
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Figure 4 PGC-1α is required by AgRP but not POMC neurons to control basal metabolism. (a 
and b) Food intake, (c and d) oxygen consumption (e and f) respiratory exchange ratio and (g 
and h) spontaneous locomotion of AgRP-, POMC-PGC1α KO and WT mice (n = 7-8). Values and 
error bars represent the mean ± SEM. **p<0.01; ***p<0.001. 
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Figure 5 PGC-1α deletion in AgRP neurons reduces energy expenditure. (a) Voluntary activity 
measured by running wheel revolutions in AgRP-PGC1α KO and WT mice (n = 5-6). Values 
represent 2 weeks of measurements. (b) Basal body temperature measured during 48-h in 
AgRP-PGC1α KO and WT mice (n = 7-8) in the absence of running wheel. Values and error bars 
represent the mean ± SEM. *p<0.05; ***p<0.001. 
  
II. Manuscript 1: PGC-1α expression in murine AgRP neurons regulates food 
intake and energy balance 
 
130 
 
  
II. Manuscript 1: PGC-1α expression in murine AgRP neurons regulates food 
intake and energy balance 
 
131 
 
Figure 6 PGC-1α deletion in AgRP neurons alters response to leptin. (a) Food intake AgRP-
PGC1α KO and WT 1, 2 and 3 hours after ghrelin or vehicle injection (n = 8). (b and c) Feeding 
response and body weight changes of 8 weeks old AgRP-PGC1α KO and WT individually housed 
mice 16 and 24 hours after leptin or vehicle injection (n = 8). A second injection was performed 
16 hours later. Values and error bars represent the mean ± SEM. *p<0.05 indicates statistically 
significant differences between genotypes, ## p<0.01; ### p<0.001 indicate statistically 
significant differences between vehicle and ghrelin or leptin injections. 
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Figure 7 PGC-1α deletion in AgRP neurons impairs energy homeostasis and hypothalamic 
signaling in response to fasting. (a) Food intake, (b) respiratory exchange ratio and (c) 
spontaneous locomotion in AgRP-PGC1α KO and WT mice measured with CLAMS during fasting 
and refeeding (n = 7-8). (d and e) AgRP, NPY and POMC mRNA levels in the hypothalamus of 
AgRP-PGC1α KO and WT in fed and overnight fasted mice measured by qPCR (n = 4-8). Data are 
normalized by mRNA values of fed animals. (f) AgRP mRNA level in fed, 4-hours starved and 1-
hour refed hypothalamic cells measured by qPCR (n = 3). Values and error bars represent the 
mean ± SEM. *p<0.05; ***p<0.001 indicate statistically significant differences between 
genotypes, ## p<0.01; #### p<0.001 indicate statistically significant differences between fed 
and fasted conditions. 
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Figure S1 Raw body mass values (a and b) Fat and lean mass absolute values of AgRP- and 
POMC-PGC1α KO and ctr mice (n=7-8) corresponding to relative body composition shown in 
figure 2. Values and error bars represent the mean ± SEM. *p<0.05 
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Figure S2 PGC-1α deletion in AgRP expressing hypothalamic cell. PGC-1α mRNA level in fed, 4-h 
starved and 1-h refed hypothalamic cells measured by qPCR (n = 3). Values and error bars 
represent the mean ± SEM. ***p<0.001 indicates statistically significant differences between si-
PGC-1α and si-scrambled control viruses. # p<0.05; ### p<0.001 indicate statistically significant 
differences between fed and fasted conditions. 
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Figure S3 PGC-1α deletion in AgRP-/POMC-neurons. (a and b) Body weight curve on high fat 
diet (HFD) and relative body composition after 8 weeks of HFD in AgRP-PGC1α KO and ctr mice 
(n=4-6). (c and d) Time course representation of AgRP-PGC1α KO and ctr mice locomotor activity 
and RER shown in figure 4 (n=7-8). (e) Expression of EGFP under AgRP/POMC promoters in 
AGRP/POMC neurons of ctr and AgRP/POMC-PGC-1α KO mice. Values and error bars represent 
the mean ± SEM. ***p<0.001 
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A. Abstract 
Age-related impairment of muscle function severely impacts the health of a growing 
elderly population. While mitochondrial dysfunction correlates with muscle aging, the 
underlying pathological mechanisms remain poorly understood. Using mouse models with 
overexpressed or abolished peroxisome proliferator-activated receptor γ coactivator 1α (PGC-
1α) expression in skeletal muscle, we investigated the impact of modulation of this key 
mitochondrial function regulator on age-associated skeletal muscle plasticity. We show that in 
addition to preserving oxidative metabolism, PGC-1α also regulates mitochondrial calcium 
buffering and SR interaction during aging. As a consequence, the formation of tubular 
aggregates is reduced and age- and ceramide-induced muscle cell death blunted by PGC-1α in 
muscle. Collectively, our data highlight the important contribution of PGC-1α-dependent 
mitochondrial calcium buffering, ER stress and apoptosis to the aging process in this tissue.  
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B. Introduction 
Muscle strength and mass progressively decline with age, leading to physical disability, 
and ultimately higher morbidity and mortality (Szulc, Beck et al. 2005, Hirani, Blyth et al. 2015). 
Although the cause of muscle aging is multifactorial (Walston 2012), reduced mitochondrial 
function is a commonly observed epiphenomenon associated with muscle deterioration during 
aging (Short, Bigelow et al. 2005, Peterson, Johannsen et al. 2012). For example, a reduction in 
mitochondrial biogenesis (Vina, Gomez-Cabrera et al. 2009), decreased mitochondrial mass (Ji 
and Kang 2015) and aberrant fission to fusion rates (Iqbal, Ostojic et al. 2013) concomitant with 
a mitochondrial turnover drop (Gaziev, Abdullaev et al. 2014) have been observed in muscle 
aging. Together with increased mitochondrial DNA damage, depolarized and swollen 
mitochondria (Short, Bigelow et al. 2005), diminished rates of oxidative phosphorylation 
(OXPHOS) as well as Krebs cycle activity (Short, Bigelow et al. 2005, Wenz, Rossi et al. 2009, 
Kang, Chung et al. 2013, Ji and Kang 2015), these pathological changes collectively lead to 
reduced mitochondrial respiration and lower ATP synthesis (Short, Bigelow et al. 2005). 
Consequently, reduced ATP production (Wanagat, Cao et al. 2001), impaired calcium 
homeostasis (Doonan, Chandramoorthy et al. 2014), elevated apoptosis (Wang and Youle 
2009) or increased levels of reactive oxygen species (ROS) (Harman 2006) represent key cellular 
alterations that might be triggered by age-associated mitochondrial impairments and that could 
all contribute to age-associated muscle dysfunction. 
 
Importantly, mitochondria, together with the sarcoplasmic reticulum (SR), control 
cellular calcium homeostasis (Marin, Encabo et al. 1999, Rizzuto, De Stefani et al. 2012). These two 
organelles communicate via contact sites, termed mitochondria-associated ER membranes 
(MAMs), focal hotspots for the synthesis and transfer of phospholipids, initiation of 
mitochondrial fission and mitophagy, signal transduction events, and exchange of calcium 
(Marchi, Patergnani et al. 2014). Aging impairs mitochondria-SR association and mitochondrial 
calcium uptake (Fernandez-Sanz, Ruiz-Meana et al. 2014, Pietrangelo, D'Incecco et al. 2015), 
which can contribute to a dysregulation of cellular calcium homeostasis (Duchen 2000). All 
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three structures, mitochondria, MAMs and the SR, have been linked to the initiation of cell 
death in general (Grimm 2012) and increased apoptosis levels in old muscle (Dirks and 
Leeuwenburgh 2002, Dirks and Leeuwenburgh 2004, Whitman, Wacker et al. 2005). For 
example, apoptosis can be initiated in mitochondria via caspase-dependent and -independent 
pathways (Danial and Korsmeyer 2004), both of which are increased with age (Danial and 
Korsmeyer 2004, Dirks and Leeuwenburgh 2004, Siu, Pistilli et al. 2005). In addition, the rise of 
mitochondrial and nuclear DNA damage due to increased level of ROS also contributes to age-
related muscle apoptosis (Harman 2006). Finally, endoplasmic reticulum stress is also a strong 
promoter of apoptotic events (Szegezdi, Logue et al. 2006). 
 
Important regulators of mitochondrial biogenesis and function, most notably the 
peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), are reduced in skeletal 
muscle in the aging process and have been linked to the decrease in mitochondrial function 
(Ling, Poulsen et al. 2004). Importantly, this deterioration can partly be restored by exercise 
(Kang, Chung et al. 2013). Likewise, transgenic overexpression of PGC-1α reduces sarcopenia 
and other skeletal muscle dysfunctions in the mouse (Wenz, Rossi et al. 2009) and extends 
lifespan in the drosophila (Rera, Bahadorani et al. 2011). Inversely, muscle-specific PGC-1α 
knockout animals suffer from exacerbated age-related glucose intolerance and systemic 
inflammation (Sczelecki, Besse-Patin et al. 2014). It is however unclear how modulation of PGC-
1α affects skeletal muscle function in aging. We now show that muscle PGC-1α regulates and 
dramatically improves mitochondrial and cellular calcium handling, SR stress, and prevents 
tubular aggregates formation as well as cell death in the old muscle. 
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C. Experimental procedures  
Animals 
Mice with muscle specific PGC-1α deletion (mKO-PGC-1α) or overexpression (mTg-PGC-
1α) driven by the human alpha-skeletal actin and muscle creatine kinase promoters, 
respectively, were previously described (Lin, Wu et al. 2002, Handschin, Choi et al. 2007). 
C57/Bl6 wild-type (WT) mice were obtained from Janvier (Janvier sas, cs 4105, le genest St-isle f-
53941, St Berthevin Cedex). Only male mice were studied at 3, 12 and 24 month-old (3Mo 12Mo 
and 24Mo). Animals were kept under a 12h/12h light-dark cycle with lights on from 06:00 to 
18:00 in humidity-controlled rooms at 23°C. All animals had free access to regular chow diet 
(Provimi Kliba 3432) and water. All experiments were performed in accordance with the federal 
guidelines for animal experimentation and were approved by the Kantonales Veterinäramt of 
the Kanton Basel-Stadt.  
 
Mouse muscle preparation 
Mice were sacrificed by CO2 inhalation. Muscles were directly harvested and either 
snap-frozen in liquid nitrogen for protein and RNA extraction, frozen in cooled-isopentane and 
embedded in 7% tragacanth for cryosection staining, immediately used for determination of 
respiration or calcium uptake in isolated mitochondria or fixed for electron microcopy.  
 
2.3 Genomic DNA/RNA extraction and qPCR 
• Genomic DNA  
For genomic DNA extraction, crushed gastrocnemius muscles were shaken overnight at 
55° in 600 µl lysis buffer (10mM TrisHCl, 1mM EDTA, 0.1% SDS 5% Proteinase). Lysates were 
centrifuge at 8000g for 15 min at room temperature and supernatants were transferred in fresh 
tubes. Residual RNA was removed by incubation with RNase A (20mg/ml) for 30 min at 37°C 
under constant agitation. RNase A was inactivated for 10 min at 95°C and samples were cooled-
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down to room temperature. One volume of Phenol/Chloroform/Isoamylalcohol 25:24:1 was 
added and samples were centrifuged at 8000g for 15 min at room temperature. The aqueous 
phase was transferred to a new tube before addition of one volume of chloroform. The 
centrifugation step was repeated and the new aqueous phase was transferred again to a new 
tube where one volume of isopropanol containing 0.3M of sodium acetate was added. Samples 
were gently mixed and placed at -20°C for 30 min. DNA was recovered by centrifugation at 
8000g for 15 min at 4°C. DNA pellets were washed 2 times with 1ml of ice-cold 75% ethanol, 
dried during few minutes and finally resuspended in ddH2O. An amount of 0.1ug of gDNA was 
used for qPCR. 
 
• RNA extraction and qPCR  
Total RNA was isolated from powdered muscles using lysing matrix tubes (MP 
Biomedicals 6913-500) and TRI Reagent (Sigma-Aldrich T9424). Total RNA from cells using the 
Direct-zol RNA MiniPrep kit (Zymo Research R2050 according to the manufacturer’s 
instructions). After treatment with RNase-free DNase (Invitrogen 18068-015), one microgram of 
RNA was used for reverse transcription using the SuperScript II reverse transcriptase (Invitrogen 
18064-014).  
 
The level of relative genomic DNA or mRNA was quantified by real-time PCR on a Light 
Cycler 480 system (Roche Diagnostics) using FastStart essential DNA probe master mix (Roche 
Diagnostics 06402682001). Relative quantification of mRNA for gene expression comparison 
was performed with the ΔΔCT method using the TATA binding protein (TBP) gene as reference. 
The quantification of mitochondrial DNA copy number was done using the same method by 
normalizing the average of COX1 ATP6 and ND1 DNA copy number by the average copy number 
of the nuclear genes beta globin and 34B6. Beta globin and TBP levels were similar between 
genotypes in a given experimental condition. Primers sequences are listed in supplemental table 
1. 
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Histology 
Tragacan-embedded muscles were cut to 8 µm sections with a cryostat (Leica, CM1950). 
H&E staining was performed as described in the DMD_M.1.2.007 SOP (http://www.treat-
nmd.eu/downloads). For SDH staining, sections were incubated in SDH buffer (phosphatbuffer 
0,035M, Na-Succinate 0.1M, teranitro blue trezolium salt 0.1%, phenazin methosulfat 0.1%), 
rinsed with water, fixed with 4% formalin and rinsed with water again before being mounted 
with CC/Mount (Sigma, C9368). For calsequestrin 1 labelling, cryosections were fixed 20 min 
with 4%PFA in PBS (Sigma-Aldrich, D8537) at room temperature. Sections were blocked in PBS 
supplemented with 0.4% Triton X-100 (Sigma-Aldrich, 93426), 3% Goat Serum (Sigma-Aldrich, 
G9023), 1% bovine serum albumin (BSA) (Sigma-Aldrich, A9418). Sections were blocked for 30 
min at room temperature and incubated with primary and secondary antibodies for one hour at 
room temperature. 3 washes of 5 min in PBS were performed before and after antibodies 
incubation. Primary and secondary antibodies were diluted in blocking solution. Calsequestrin 1 
(ThermoScientific, MA3-913) and laminin (Sigma, L9393) antibodies dilutions were 1/250 and 
1/5000 respectively. AlexaFluor 488 (Life Technology, A-11008) and 647 (A-21242) secondary 
antibodies dilutions were 1/500 and 1/250 respectively. Labelled sections were mounted with 
ProLong Gold Antifade reagent with dapi (Life Technologies, P36931). Images of calsequestrin 1 
immunolabellings and H&E stainings were taken at the imaging core facility of the Biozentrum 
with the FEI MORE microscope using a 20x or 40X magnification lens with the same acquisition 
settings. Numbers of tubular aggregates were quantified in all fibers of each stained muscles 
using ImageJ software with unaltered images. Representative images were however adjusted 
for brightness and contrast. 
 
Protein extraction and Western Blot 
Total proteins were extracted from quadriceps muscles as described in (Perez-Schindler, 
Summermatter et al. 2013). Total proteins from C2C12 cells were extracted after an ice-cold 
PBS wash following the same procedure. Equal amounts of protein were separated on mini-TGX 
4-20% stain free pre-cast gel (Biorad, 4568096). Proteins were labelled with trihalo compounds 
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of the stain-free gel by exposing the gel to UV for 1 min. Gel and nitrocellulose membranes were 
equilibrated for 5 min in transfer buffer and protein were transferred on the nitrocellulose 
membrane during 1h under a constant voltage of 100V. Membranes were then blocked 1 h at 
room temperature with 5% milk or BSA diluted in TBS-T and washed 2 times 5 min with TBS-T. 
Proteins of interest were then labelled overnight at 4°C with primary antibodies diluted in TBS-T 
containing 0.02% sodium azide and either 3% milk or 3% BSA. Membranes were washed three 
times 5 min with TBS-T. Membranes were then incubated 1 h at room temperature with 
peroxidase-conjugated secondary antibodies diluted in TBS-T containing 3% milk or BSA. 
Membranes were then washed 3 times for a total of 15 min. Antibody binding was revealed 
using enhanced chemiluminescence HRP substrate detection kits and imaged using a fusion FX 
imager. Proteins of interest were normalized against total protein content determined using the 
trihalo compounds labeling. Two reference samples were loaded in the different gels for inter-
gel normalization. Quantification of proteins was done with fusion FX software. Blocking and 
antibodies solutions, antibodies information and dilutions and ECL detection kits are described 
for each protein of interest in supplemental table 2. All primary antibodies were diluted at 
1/1000 except Calsequestrin 1 antibody that was diluted at 1/3000. All secondary antibodies 
were diluted at 1/10000. 
 
Transmission electronic microscopy 
Samples were prepared for transmission electronic microscopy as in (Arnold, Gill et al. 
2014). Volume density of mitochondria was calculated according to methods previously 
described by Weibel and digitally adapted to Adobe Photoshop (Baranska, Baran et al. 1997), in 
micrographs taken from transversal sections. Volume density is classically defined as the ratio of 
test points residing within mitochondria and the total amount of test points within the field of 
view. Mitochondria were identified and outlined manually and, using the Measurement tool in 
Photoshop, the number of pixels in each image contained in each mitochondrion were counted 
and compared to the total number of pixels in the image. In total, 5 images were quantified per 
block of stained muscle tissue, for a total of 5 blocks per mouse.  
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Mitochondrial respiration assay 
Quadriceps muscles were quickly rinsed in PBS and in PBS with 10 mM EDTA and finely 
minced in Petri dishes filled with 2ml of isolation buffer 1 (EDTA 10 mM, D-mannitol 215 mM, 
sucrose (0.075M), free-fatty acid BSA (Sigma-Aldrich) 0.1%, HEPES 2 mM pH 7.4 in distilled 
water). Muscle solutions were transferred in Potter-Elvehjem grinders for homogenization with 
manual pestle. Homogenates were centrifuged for 10 min at 700g. Supernatants were 
transferred and centrifuge for 10 min at 10500g. Pellets were resuspended in 500µl of isolation 
buffer 2 (EGTA 3 mM, D-mannitol 215 mM, sucrose 0.075M, free-fatty acid BSA (Sigma-Aldrich) 
0.1%, HEPES 2 mM pH 7.4 in distilled water), centrifuged again at 10500g for 10 min and finally 
resuspended in 100 µl of isolation buffer 2. Mitochondrial protein concentrations were 
determined by Bradford assay. Mitochondrial proteins were diluted in a 37°C warm 
mitochondrial assay buffer (MgCl2 5 mM, D-Mannitol 220 mM, KH2PO4 10mM, EGTA 1 mM, 
free-fatty acid BSA 0.2%, HEPES 2 mM, sucrose 70 mM  pH 7.0 in distilled water) and 1µg was 
loaded in a 96-well plate and centrifuged at 2000g for 20 min. After centrifugation 135 µl of 
mitochondrial assay buffer completed with 20mM succinate and 2µM rotenone were gently 
added to each well and the plate was warmed up to 37°C for 10 min. The plate was then loaded 
into a calibrated Seahorse XF96 Extracellular Flux Analyzer for mitochondrial respiration assay 
using the mito stress test kit (Seahorse Bioscience, # 103015-100). Mitochondrial respiration 
assay consisted in equilibration, 1 min mixing, 3 min pause, 1 min mixing, 3 min waiting, 0.5 min 
mix, 3 min measure, 1 min mixing, 3 min measure, 0.5 min mixing, injection of 4 mM ADP, 1 min 
mixing, 3 min measure, 1 min mixing, injection of 3.125 µM Oligomycin, 0.5 min mixing, 3 min 
measure, 1 min mixing, injection of 4 µM FCCP, 0.5 min mixing, 3 min measure, 1 min mixing, 
injection of 4 µM Antimycin, 0.5 min mixing, 3 min measure. All steps before plate loading were 
performed at 4°C. 
 
Mitochondrial calcium uptake assay 
Quadriceps, tibialis anterior (TA) and EDL muscles of both legs from one mouse were 
pooled together, rinsed 2 times with PBS and minced finely with scissors in 0.5 ml of 
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mitochondrial isotonic buffer (Mannitol 225 mM, Sucrose 75 mM, MOPS 5 mM, EGTA 0.5 mM, 
Taurine 2 mM, pH 7.25). The resulting muscle homogenates were incubated 3 min in 10ml of 
mitochondrial isotonic buffer containing nargase at 0.1 mg/ml (Sigma-Aldrich, P8038) before the 
addition of BSA at 0.2%. Muscles solutions were then transferred in Potter-Elvehjem grinders 
and homogenized with manual pestles. Homogenates were centrifuged for 6 min at 1200g for 2 
times, discarding fat and cellular debris between centrifugations. Obtained supernatants were 
centrifuged for 10 min at 9000g. Residual fat was discarded and mitochondrial pellets were 
washed with 15ml of mitochondrial isolation buffer before a second centrifugation at 9000g for 
10 min. Final mitochondrial pellets were gently resuspended in a final volume of 150 µl of 
mitochondrial isotonic buffer. Mitochondrial protein concentrations were determined by 
Bradford method and 275 µg of mitochondria were centrifuged and gently resuspended in 100 
µl of mitochondrial calcium assay buffer (KCl 120 mM, Tris 10 mM, MOPS 5 mM, K2HPO4 5 mM, 
pH 7.4). 100 µl of calcium buffer containing 5 µM of the fluorescent calcium indicator calcium 
geen 5N (molecular probes, C3737) was loaded in a 96-well black plate (Nunc) and baseline 
fluorescence was measured using a Tecan infinite M1000 multiplate reader. When the signal 
was stable, mitochondrial preparations were added and calcium green 5N fluorescence was 
continuously recorded during subsequent addition of calcium.  
 
C2C12 growth, differentiation and viral infection  
C2C12 myoblasts were cultured Dulbecco's modified Eagle's medium (DMEM) (Sigma-
Aldrich D 5796), supplemented with 10% fetal bovine serum (HyClone Laboratories, Inc., Logan, 
UT), 4.5 mg/ml glucose and 1% penicillin/streptomycin and were incubated at 37 °C with 5% 
CO2. Myotube differentiation was achieved by incubation of 95% confluent myoblast in 
differentiation medium consisting of DMEM containing 2% horse serum, 4.5 mg/ml glucose and 
1% penicillin/streptomycin during 4 days. PGC-1α overexpression experiments were done using 
adenoviral vectors expressing the green fluorescent protein (GFP) alone or bicistronic GFP-PGC-
1α. GFP was used to monitor infection efficiency. Infection was initiated in 50% confluent 
myoblast or in myotubes after 4 days of differentiation. Knock-down of estrogen related 
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receptor α (ERRα) combined with PGC-1α overexpression was achieved in C2C12 myoblasts by 
infecting cells with adenoviral vectors containing specific short hairpin RNA (shRNA) sequences 
against ERRα (shERRα) or Lacz (shLacz) simultaneously with viruses used to study PGC-1α 
upregulation. 
 
For gene and protein expression experiments, 2 days after infection, myoblast or 
myotubes were treated during 8 hours with 100 µM ceramide (Sigma-Aldrich 01912) or 0.1% 
DMSO diluted in growth or differentiation medium respectively. Pictures of myotubes after the 
treatment were taken using Leica DMI4000B microscope. For cell death assay, myoblast were 
treated with 0.1% DMSO or with 50 and 100 µM ceramide during 8 hours. Treatment medium 
was then exchanged for growth medium containing 5 µM of propidium ioide. After an 
incubation of 30 min at 37°C with 5% CO2, propidium ioide incorporation reflecting cell death 
was measured using a tecan infinite M1000 multiplate reader.  
 
Treadmill experiment and spontaneous locomotor activity 
To assess locomotor performance, mice ran in an open treadmill (Columbus instrument). 
Mice were acclimatized to the treadmill for 5 min at 8 m/min followed by 5 min at 10 m/min, at 
an incline of 5° during two consecutive days. After one resting day, an exhaustion test was 
performed at an inclination of 5° and a starting running speed of 4.8 m/min which was then 
increased by 1.6 m/min every 3 min until a maximum speed of 29 m/min. Maximal running 
speed were recorded when exhaustion was reached. Blood lactate levels were measured from 
the tail vein before and 10 min after the endurance test with a lactate plus meter (Nova 
biomedical).  
Spontaneous locomotor activity was recorded by counting number of beam breaks in an 
indirect calorimetric system (CLAMS, Columbus Instruments) in 15 min intervals. Data were 
analyzed after one day of acclimatization for 2 days. 
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Statistical analysis 
Data were analyzed with two-way ANOVA (GraphPad Prism software). Sidak post-tests were 
used to do multiple comparison analysis following two-way ANOVA. All data are plotted as 
mean ± SEM. 
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D. Results 
Muscle PGC-1α overexpression prevents aged-related mitochondrial and muscle 
dysfunction 
To assess the impact of aging on muscle PGC-1α and mitochondrial function, we first 
measured PGC-1α mRNA levels in different muscles of young (3 month-old) and aged (24 
month-old) WT, mKO-PGC-1α and mTg-PGC-1α mice. We observed that aging reduced PGC-1α 
gene expression by approximately 90% in soleus, 50% in TA and 25% in gastrocnemius muscles 
of WT animals (Fig. 1a).  
 
OXPHOS transcripts were not affected by aging, but strongly controlled by gain- and loss-
of-function of PGC-1α (Fig. S1a). Importantly however, despite the lack of a discernible effect on 
transcript levels, aging dramatically reduced mitochondrial protein content in WT muscles (Fig. 
1b). Absence of PGC-1α in muscles of young mKO-PGC-1α animals mimicked while muscle-
specific PGC-1α overexpression fully prevented this reduction of mitochondrial OXPHOS 
proteins in aged muscle tissues.  
 
Consistent with the diminished OXPHOS protein levels, mitochondrial respiration, ATP 
production and mitochondrial maximal respiration capacities were remarkably reduced with age 
in muscles of WT mice, but fully preserved in mTg-PGC-1α mice (Fig. 1c). Similarly, while 
mitochondria biogenesis gene expression and mitochondrial mass were not altered by age or 
PGC-1α deletion, there were both significantly increased by PGC-1α overexpression (Fig. 1d and 
S1b and c). 
 
Correlating with their preserved mitochondrial function, elevated levels of muscle PGC-
1α protected mTg-PGC-1α mice against the age-related decrease in spontaneous locomotor 
activity and maximal running capacity (Fig. 1e and f). Blood lactate measurements indicated that 
old WT and young mKO-PGC-1α animals exhibit higher lactate production post-exercise, while 
this shift was severely blunted in the mTg-PGC-1α mice (Fig. 1g). An impairment in lipid 
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oxidation was further suggested by the downregulation of the muscle expression of genes 
involved in mitochondrial fatty acid β-oxidation, such as carnitine palmitoyltransferase 1B 
(Cpt1b), medium-chain acyl-CoA dehydrogenase (Mcad), and uncoupling protein 3 (Ucp3) in 
aged vs. young WT and young mKO-PGC-1α mice. The expression of these genes was markedly 
upregulated in young and maintained in old mice overexpressing PGC-1α. 
 
PGC-1α modulates alterations of mitochondrial dynamics and SR association in the aging 
muscle 
To a large extent, healthy mitochondrial function is ensured by mitochondrial fission and 
fusion. Dysregulation of mitochondrial dynamics in aging was indicated by decreased and 
increased gene expression of fusion and fission genes, respectively, in WT muscles (Fig. 2a). 
Mimicking the aging phenotype, muscle mitofusin 1 gene expression was reduced in young 
mKO-PGC-1α animals relative to age-matched WT mice. In contrast, PGC-1α overexpression 
upregulated the expression of genes related to both mitochondrial fusion and fission. 
Mechanistically, our results in C2C12 cells show that overexpression of PGC-1α induces the 
expression of the mitofusin genes as well as dynamin-related protein 1 (Drp1), fission 1 (Fis1) 
and optic atrophy 1 (Opa1) only in the presence of ERRα, demonstrating that PGC-1α effects are 
dependent on Estrogen Related Receptor α (ERRα) expression (Fig. 2c and d). In contrast, PGC-
1α-dependent induction of BCL2/Adenovirus E1B 19kDa Interacting Protein 3 (BNIP3) was not 
affected by the knockdown of ERRα (Fig. 2c). 
 
In addition to regulating mitochondrial dynamics, mitofusin proteins also constitute 
essential elements of the MAM, linking the SR and the mitochondrial compartments. In parallel 
with reduced expression of mitofusins during aging, other MAM proteins such as GRP75 and 
voltage-dependent anion channel (VDAC) were likewise downregulated at the transcript and 
protein level with age (Fig. 2a and b). As for Mfn1, young mKO-PGC-1α mice already exhibited 
the age-related VDAC protein reduction observed in WT mice, and muscle PGC-1α 
overexpression abolished the decreased expression of both VDAC and GRP75 during aging. As 
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shown for the mitochondrial dynamic gene expression, our cell experiments indicate that the 
modulation of the MAM transcription by PGC-1α is ERRα dependent (Fig. 2d and e). 
 
PGC-1α improves mitochondrial calcium buffering during aging 
Intriguingly, not only OXPHOS, but also mitochondrial calcium buffering capacities are 
reduced in aging due to lower mitochondrial calcium uptake and impaired mitochondrial-SR 
association (Fraysse, Desaphy et al. 2006). While it has been demonstrated that PGC-1α affects 
SR-controlled calcium homeostasis in skeletal muscle (Summermatter, Thurnheer et al. 2012), 
the functional link between PGC-1α and mitochondrial calcium handling in young or old muscle 
is poorly understood. We therefore evaluated mitochondrial calcium buffering capacity in our 
mouse models. In WT muscles, aging significantly reduced the expression of genes involved in 
mitochondrial calcium uptake and calcium transfer from the SR, including leucine zipper and EF-
hand containing transmembrane protein 1 (Letm1) and inositol 1,4,5-trisphosphate (IP3) 
receptor type1 (IP3R1) (Fig. 3a). Except for IP3R1, mRNA levels of mitochondrial calcium 
buffering genes in muscles of old mKO-PGC-1α mice were similar to levels found in old WT mice. 
PGC-1α upregulation abolished age-associated downregulation of IP3R1 and Letm1 and 
significantly upregulated all genes related to mitochondrial calcium buffering in the muscle of 
old animals. Importantly, VDAC is also a key protein regulating the entry of calcium and 
metabolites into the mitochondria in addition to its role in maintaining MAM integrity. 
Increased expression of both VDAC protein and mitochondrial calcium buffer genes by PGC-1α 
was not only observed in mouse muscle in vivo (Fig. 2b), but also in C2C12 cells, and is 
dependent on ERRα activity (Fig. 2d and e and Fig.3b).  
 
To complement the analysis of transcript and protein levels, we then evaluated calcium 
uptake in isolated mitochondria from muscles of young mTg-PGC-1α and WT mice (Fig. 3d). We 
demonstrated that after injection of 130 and 150 mM of calcium, mitochondrial calcium uptake 
was elevated by 100% in mTg-PGC-1α mitochondria compared to WT (Fig. 3e). It is important to 
note that a total amount of 275 µg of mitochondria were used for calcium uptake 
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measurements, representing 100% of mitochondria from WT muscles but only 13% of 
mitochondria from muscles overexpressing PGC-1α (Fig. 3f). The increased calcium buffering 
capacity of the individual mTg-PGC-1α mitochondria is thus multiplied by the elevated number 
of total mitochondria to reflect the overall higher mitochondrial calcium buffering capacity 
during aging in this mouse model. 
 
PGC-1α prevents ER stress and tubular aggregate formation in the aging muscle  
Controlled calcium transfer from the ER to mitochondria is important to alleviate 
endoplasmic reticulum stress (ER stress) and reduce cell death (Malhotra and Kaufman 2011). 
To test whether the modulation in mitochondrial-SR interaction and mitochondrial calcium 
buffering affected the SR, we studied ER stress in our conditions. Measurements of the 
expression of genes and proteins responding to ER stress, such as the ER stress marker XBP1 
and the chaperon protein BIP, indicated that ER stress increases with age in WT and mKO-PGC-
1α muscles (Fig. 4a and b). PGC-1α overexpression reduced XBP1 mRNA levels and fully 
abolished BIP protein upregulation during aging. Interestingly, PGC-1α muscle deletion led to an 
increased activation of the calcium stress marker caspase 12, which was exacerbated with age 
(Fig. 4b). Consistently, poly-ubiquitination of proteins, indicating proteasomal degradation of 
potentially misfolded proteins, was dramatically increased in mKO-PGC-1α muscles with age and 
reduced in both young and old muscles of mTg-PGC-1α mice, respectively (Fig. S2a). Finally, the 
in vivo reduction of XBP1 mRNA levels and protein poly-ubiquitination by PGC-1α were 
recapitulated in C2C12 cells (Fig. S2b and c). 
 
Functional dysregulation of SR function is linked to the development of tubular 
aggregates of SR membranes in muscle fibers of old mice (Agbulut, Destombes et al. 2000). 
H&E staining of the TA muscle revealed the presence of eosin-labeled structures in old WT and 
mKO-PGC-1α animals (Fig 4c) that were confirmed to be tubular aggregates by CSQ1 protein 
staining (Fig. 4d) and electron microscopy (Fig. S3a). While the age-dependent increase in WT 
muscles was striking, TA muscles of old mKO-PGC-1α mice exhibited a further 2 fold-elevation in 
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tubular aggregates compared to age-matched WT mice (Fig 4e). Strikingly, we could not detect 
any tubular aggregates in fast muscles of aged mTg-PGC-1α mice (Fig. 4c and e and Fig. S3a). 
Moreover, soleus muscles (Fig. S3b) or SDH-positive fibers of other muscle beds in old WT and 
mKO-PGC-1α mice were likewise devoid of tubular aggregates, suggesting a link to the 
metabolic fiber type (Fig. S3c). Abnormal calcium homeostasis and accumulation of 
calsequestrin 1 (CSQ1) and other SR proteins in skeletal muscle have been linked to the 
formation of tubular aggregates (Chevessier, Marty et al. 2004, Bohm, Chevessier et al. 2013). 
Accordingly, in line with the absence of tubular aggregate formation in muscle of old mTg-PGC-
1α mice, elevation of muscle PGC-1α levels fully prevented the age-related increase of CSQ1 
protein observed in WT mice (Fig 4f). Cellular experiments furthermore revealed that PGC-1α 
acutely regulates CSQ1 protein in a cell autonomous-manner (Fig 4g). Of note, in addition to the 
tubular aggregates, electronic microscopy also revealed other abnormal structures in muscles 
fibers of aged mKO-PGC-1α and WT mice (Fig. S3d) that were absent from any of the young 
animals and from old mTg-PGC-1α mice. 
 
PGC-1α alleviates cell death during aging 
Dysregulated mitochondrial function, ER stress, mitochondrial-SR interaction and 
calcium homeostasis have all been linked to increased cell death (Shiraishi, Tatsumi et al. 2001, 
Chen, Won et al. 2002, Gomez-Cabrera, Sanchis-Gomar et al. 2012). We therefore assessed 
whether age-associated apoptosis in skeletal muscle was affected by modulation of PGC-1α. 
P53, a major regulator of cell death induction upon DNA damage and stress conditions was 
massively upregulated during aging of WT and mKO-PGC-1α muscles, but not in muscle 
overexpressing PGC-1α (Fig. 5a). Compared to aged WT animals, muscles of old mKO-PGC-1α 
and mTg-PGC-1α mice exhibited a trends toward a 2-fold increased (p=0.06) and a 2-fold 
decrease (p=0.05), respectively, in P53 protein levels. Interestingly, mRNA levels of insulin like 
growth factor binding protein 5 (IGFBP5) and the p53 targets p21 and PUMA followed a similar 
pattern of expression (Fig. 5b). The expression of the cell survival-related gene X-linked inhibitor 
of apoptosis protein (XIAP) was down-regulated with age in WT and mKO-PGC-1α muscles and 
Cyclin A transcript expression was lower in old mKO-PGC-1α muscles relative to age-matched 
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WT muscles. PGC-1α significantly elevated the expression of all pro-survival genes in young, and 
XIAP mRNA levels in old mTg-PGC-1α mice (Fig. 5b). Caspase 3 cleavage, a main marker of cell 
death, was increased with age in mKO-PGC-1α mice and significantly higher in muscles of old 
mKO-PGC-1α mice relative to muscles of age-matched WT animals (Fig. 5c). Additionally, in old 
muscle tissues, the smallest cleavage product of caspase 3 was reduced by PGC-1α 
overexpression. Taken together, our findings suggest a protective function of muscle PGC-1α 
against age-induced muscle cell death. 
 
PGC-1α protects against ceramide-induced cell death 
To evaluate the direct impact of PGC-1α on cell death initiation, we used ceramide to promote 
cell death in C2C12 cells expressing endogenous and elevated PGC-1α levels. Ceramide acts as a 
second messenger for apoptosis linked to ER stress, mitochondrial impairment and 
dysregulation of calcium homeostasis (Jarvis, Grant et al. 1996). We observed that PGC-1α 
markedly protected C2C12 cells against cell death induced by ceramide treatment as evaluated 
by microscopy and by a propidium ioide-based cell death assay (Fig. 6a and b). Similar findings 
have previously been reported in HeLa cells (Bianchi, Vandecasteele et al. 2006). Furthermore, 
PGC-1α overexpression abolished the induction of p53 and the cleavage of caspase 3 proteins 
upon ceramide treatment, as well as the expression of the DNA damage marker phospho-H2A 
Histone Family Member X (pH2AX) and the ceramide-associated decrease in phosphorylation of 
the phosphor-Prepro-Retinoblastoma-Associated Protein (ppRB) protein in muscle cells (Fig 6c). 
Moreover, PGC-1α upregulation abrogated ceramide-dependent changes of gene expression 
related to cell death and cell survival (Fig 6d). The protective effect of PGC-1α against the 
deleterious outcome of ceramide exposure in muscle cells suggests an important role for this 
gene in the prevention of cellular death. 
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E. Discussion 
The deterioration of mitochondrial function and PGC-1α expression in the aging skeletal 
muscle has been well documented (Ling, Poulsen et al. 2004, Short, Bigelow et al. 2005, Vina, 
Gomez-Cabrera et al. 2009, Ghosh, Lertwattanarak et al. 2011, Johnson, Robinson et al. 2013, 
Kang, Chung et al. 2013). PGC-1α is a key regulator of mitochondrial biogenesis, dynamics and 
function. Moreover, the effects of this transcriptional coactivator extend to other organelles 
and cell structures, e.g. the unfolded protein response after exercise (Wu, Ruas et al. 2011) or 
SR-controlled calcium homeostasis (Summermatter, Thurnheer et al. 2012). We now show that 
PGC-1α collectively controls the function and interaction between mitochondria and the SR, and 
thereby prevents the decline during aging. Even though the SR is the main buffering site for 
intramyocellular calcium, mitochondrial calcium uptake is not only important for electron 
transport chain function, but also contributes to resting calcium levels (Rizzuto, De Stefani et al. 
2012). An age-related decline in mitochondrial calcium buffering capacity therefore likely 
contributes to the rise of intracellular calcium level in the aging muscle (Fraysse, Desaphy et al. 
2006, Fernandez-Sanz, Ruiz-Meana et al. 2014, Pietrangelo, D'Incecco et al. 2015). The greatly 
increased calcium buffering capacity of mitochondria in the PGC-1α muscle-specific transgenic 
animals could therefore alleviate much of the stress exerted by increased intracellular calcium 
in the old muscle. Moreover, improved mitochondrial function and ATP production help to 
maintain calcium re-uptake into the SR via the ATP-dependent calcium pumps in this animal 
model (Allen, Lamb et al. 2008). At the same time, the reduction in polyubiquinated proteins 
and several genes encoding ER stress mediators indicate a PGC-1α-dependent reduction of the 
SR burden. PGC-1α-controlled abrogation of the accumulation of both age-related Csq1 protein 
and tubular aggregates further illustrates the preserved calcium homeostasis and muscle 
protection from ER stress development by PGC-1α during aging. 
 
Due to their calcium loading capacity (Salviati, Pierobon-Bormioli et al. 1985), tubular 
aggregates are alternatively thought to be a compensatory mechanism to counteract age-
associated cellular calcium increase, rather than a consequence of calcium metabolism 
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dysregulation. However, these aggregates are always observed in contexts of pathologically 
impaired muscle function (Chevessier, Bauche-Godard et al. 2005, Ghosh, Narayanappa et al. 
2010). Tubular aggregates are predominantly composed of densely small packed tubules arising 
from sarcoplasmic reticulum (Chevessier, Marty et al. 2004). We report that PGC-1α fully 
protects muscle from tubular aggregate formation during muscle aging, while ablation of the 
PGC-1α gene in muscle markedly exacerbates tubular aggregate occurrence. Tubular aggregates 
are associated with both natural and premature aging in mouse (Ludatscher, Silbermann et al. 
1983, Agbulut, Destombes et al. 2000, Zhou, Freeman et al. 2013). In humans, tubular 
aggregates have been observed in several myopathies including peripheral neuropathy, 
amyotrophic lateral sclerosis or myotonic dystrophy (Chevessier, Bauche-Godard et al. 2005, 
Ghosh, Narayanappa et al. 2010, Schiaffino 2012), and are the main symptom that 
accompanies myalgia in tubular aggregate myopathy (Schiaffino 2012). Interestingly, mice with 
muscle PGC-1α deletion also display tubular aggregates upon muscle denervation which are 
absent in WT mice (Vainshtein, Desjardins et al. 2015). A link between mitochondrial calcium 
handling and tubular aggregate formation was furthermore suggested by results obtained in 
young MCU1 knockout mice, which recapitulate some of the phenotype of old and PGC-1α 
knockout muscle, including mitochondrial dysfunctions, increased blood lactate levels, impaired 
muscle function and the formation of tubular aggregates (Liu, Liu et al. 2016). A central role for 
PGC-1α in this context is finally implied by our SDH staining and electronic microscopic data as 
well as various other studies that revealed a strong preference of tubular aggregate formation 
for glycolytic fibers (Chariot, Benbrik et al. 1993, Funk, Ceuterick-de Groote et al. 2013). The 
potent effect of PGC-1α on driving an oxidative muscle fiber shift could thus furthermore 
contribute to the inhibition of tubular aggregate formation. It thus would be interesting to study 
whether increased muscle PGC-1α prevents tubular aggregates formation in mice prematurely 
displaying tubular aggregates and associated myopathies (Schubert, Sotgia et al. 2007, Zhou, 
Freeman et al. 2013).  
Mitochondrial dysfunction, ATP depletion and ER stress, as observed in old WT and the 
mKO-PGC-1α mice, are strong promoters of cell death (Lemasters, Qian et al. 1999, Shiraishi, 
Tatsumi et al. 2001, Malhotra and Kaufman 2011). For example, increased expression of 
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caspase-12 is furthermore linked to elevated apoptosis during muscle aging (Dirks and 
Leeuwenburgh 2004). The protective effect of muscle PGC-1α on mitochondrial and SR function 
could thus secondarily result in reduced cell death initiation. Importantly however, the ex vivo 
experiments using ceramide, a pro-apoptotic stimulus that acts through induction of ER stress 
and mitochondrial dysfunction (Arora, Jones et al. 1997, Liu, Xia et al. 2014), indicate a potent 
role for PGC-1α to directly decrease the induction of apoptosis. An anti-apoptotic function of 
PGC-1α has previously been suggested in different cell types, including the retina (Egger, 
Samardzija et al. 2012), vascular endothelial cells (Valle, Alvarez-Barrientos et al. 2005), 
neurons (Luo, Zhu et al. 2009) or skeletal muscle (Adhihetty, Uguccioni et al. 2009, Wenz, Rossi 
et al. 2009). Our findings now provide direct evidence of a broader PGC-1α-controlled program 
that links functional mitochondria, SR and calcium handling to cell death regulation in muscle, 
which becomes compromised with decreased PGC-1α expression during aging, and ultimately 
leads to higher rates of myofiber apoptosis (Wenz, Rossi et al. 2009). Of note, our findings on 
P53 and pH2AX suggest an even broader role for muscle PGC-1α in constraining DNA damage. 
Similar findings have been reported in vascular endothelial cells while other studies have 
postulated a telomere-P53-PGC-1α signaling axis to be involved in apoptosis and senescence 
(Sahin, Colla et al. 2011, Xiong, Patrushev et al. 2015). Future studies will thus indicate whether 
cellular senescence is likewise affected by PGC-1α expression in old skeletal muscle. 
 
In summary, we now describe how modulation of PGC-1α levels in young and old 
skeletal muscle has broad ranging consequences on the maintenance of mitochondrial and SR 
functions, including the coordinated control of calcium homeostasis. Intriguingly, this control is 
exerted in a context-specific manner: for example, while PGC-1α upregulates the unfolded 
protein response to deal with the acute consequences of exercise (Wu, Ruas et al. 2011), 
increased muscle PGC-1α in old muscle alleviates the aging-related burden on the SR. 
Accordingly, mKO-PGC-1α mice in many regards exhibit a premature aging phenotype while 
preventing the decrease of muscle PGC-1α expression alleviates many age-related pathological 
changes. Our findings now provide an explanation for this observation, which has already been 
phenotypically described in the respective animal models (Wenz, Rossi et al. 2009, Sczelecki, 
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Besse-Patin et al. 2014). More importantly, since exercise is a powerful intervention to 
ameliorate health span in old individuals, and physical activity exerts many of the health 
beneficial effects through control of PGC-1α levels in this context (Kang, Chung et al. 2013), our 
findings reveal novel avenues that could be exploited to reduce muscle weakness, frailty and 
other pathological alterations associated with aging.  
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F. Figures 
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Figure 1: mPGC-1α prevents mitochondrial dysfunction and dysregulation and muscle 
disorders during aging (a) Relative PGC-1α mRNA levels in different muscle (n=6). (b) Relative 
protein levels of OXPHOS genes (n=6). (c) Mitochondrial respiration ATP production and 
maximal respiratory capacity (n=3-6). (d) Quantification and electronic microscopic pictures 
representative of mitochondrial mass (e). Age-related reduction in spontaneous locomotor 
activity measured by the CLAMS system. Values represent 48h of recording (n=8-9) (f) Age-
related reduction in mice maximal running speed during treadmill exhaustion test (n=10-12) (g) 
Blood lactate levels before and after exercise (n=8-10). Values are mean ± SEM. *P < 0.05; **P < 
0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant differences between young 
and old animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate 
statistically significant differences between genotypes of age-matched animals, @ P < 0.05; @@ 
P < 0.01; @@@@p<0.0001 indicat statistically significant differences between pre- and post-
exercise.  
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Figure 2: mPGC-1α improves mitochondrial dynamics and SR association in old muscle and 
C2C12 cell in a ERRα dependent manner (a and b) Relative muscle mRNA and protein levels of 
genes related to mitochondrial dynamics and SR-association (n=6). (c-e) Relative C2C12 cell 
mRNA and protein levels of PGC-1α and ERRα targets and of genes related to mitochondrial 
dynamics and SR-association (n=3 independent experiments with 3 technical replicates). Values 
are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically 
significant differences between young and old animals of the same genotype or between cells 
with endogenous and overexpressed ERRα levels, # p<0.01; ## p<0.01; ### p<0.01; #### 
p<0.001 indicate statistically significant differences between genotypes of age-matched animals 
or between cells with endogenous and overexpressed PGC-1α levels.  
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Figure 3: mPGC-1α ameliorates mitochondrial calcium buffering (a) Relative muscle mRNA 
levels of mitochondrial calcium buffering genes (n=6). (b) Relative C2C12 myoblasts mRNA levels 
of mitochondrial calcium buffering gene (n=3 independent experiments with 3 technical 
replicates). (d and e) Representative cytosolic calcium traces upon calcium injection and 
quantification of relative cytosolic calcium levels after 130 and 150 μm calcium has been 
injected (n=4; 2 independent experiments with 2 muscles of each genotype used in each 
experiments). (f) Representative pictures of mitochondrial pellets after mitochondria isolation 
from hind limb muscles and measure of isolated mitochondrial quantity. Values are mean ± 
SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant 
differences between young and old animals of the same genotype or between cells with 
endogenous and overexpressed ERRα levels, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 
indicate statistically significant differences between genotypes of age-matched animals or 
between cells with endogenous and overexpressed PGC-1α levels. 
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Figure 4: mPGC-1α reduces ER stress during aging and fully prevents age-related tubular 
aggregate formation (a and b) Relative muscle mRNA and protein levels of ER stress related 
genes (n=6). (c) Representative pictures of H&E stained tibialis anterior cryosection including 
aggregates, scale bars represent 50 µm (d). Colocalization of H&E labelled aggregates (left 
picture) with calsequestrin 1 staining (right picture) indicated by arrows, scale bars represent 
100 µm. (e) Representative pictures of tubular aggregates stained with calsequestrin 1 antibody 
scale bars represent 50 µm and quantification of the percentage of fibers containing tubular 
aggregates (n=6). (f and g) Calsquestrin 1 protein levels in young and old animals and in C2C12 
myotubes. Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate 
statistically significant differences between young and old animals of the same genotype, # 
p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate statistically significant differences 
between genotypes of age-matched animals or between cells with endogenous and 
overexpressed PGC-1α levels.  
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
175 
 
  
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
176 
 
Figure 5: mPGC-1α improves age-related muscle cell death (a-c) Relative muscle mRNA and 
protein levels of cell death and survival related genes (n=6). Values are mean ± SEM. *P < 0.05; 
**P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant differences between 
young and old animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 
indicate statistically significant differences between genotypes of age-matched animals. 
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Figure 6: PGC-1α protects from ceramide-induced cell death (a) Representative picture of 
C2C12 myotubes expressing endogenous or increased PGC-1α levels after ceramide or DMSO 
treatment. (b) Relative propidium ioide incorporation in C2C12 myoblasts. (c) Relative C2C12 
protein levels of P53 and ppRB in C2C12 myotubes and Caspase 3 and pH2AX in C2C12 
myoblasts. (d) Relative C2C12 myotubes mRNA levels of cell death and cell survival markers 
(n=3 independent experiments with 3 technical replicates). Values are mean ± SEM. *P < 0.05; 
**P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant differences between 
cells treated with DMSO and ceramide, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate 
statistically significant differences between cells with endogenous and overexpressed PGC-1α 
levels. 
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Figure S1: PGC-1α improves mitochondrial biogenesis and gene expression of mitochondrial 
metabolism (a) Relative muscle mRNA levels of mitochondrial genes (n=6). (b) Relative muscle 
mRNA levels of mitochondrial biogenesis genes (n=6). (c) Relative mitochondrial DNA copy 
number (n=6). (d) Relative muscle mRNA levels of fatty acid oxidation genes (n=6). Values are 
mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant 
differences between young and old animals of the same genotype, # p<0.01; ## p<0.01; ### 
p<0.01; #### p<0.001 indicate statistically significant differences between genotypes of age-
matched animals. 
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Figure S2: PGC-1α lowers ER stress markers in muscle during aging and in C2C12 cells (a) 
Relative muscle protein poly-ubiquitinilation during aging (n=6). (b and c) Relative myotube 
xbp1 gene expression and protein poly-ubiquitinilation (n=3 independent experiments with 3 
technical replicates). Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; 
****p<0.0001 indicate statistically significant differences between young and old animals of the 
same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate statistically significant 
differences between genotypes of age-matched animals or between cells with endogenous and 
overexpressed PGC-1α levels. 
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Figure S3: Tubular aggregates form preferentially in fast fibers and PGC-1α prevents the 
formation of abnormal structures (a-b) Representative electronic microscopic pictures of 
gastrocnemius and soleus muscles of old animals. The presence of tubular aggregates is 
indicated by arrows. (c) Representative pictures of SDH staining in the tibialis anterior of old 
muscles. (d) Representative electronic microscopic pictures of abnormal structures in 
gastrocnemius muscles of old animals .  
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name forward primer reverse primer 
βglobin GAAGCGATTCTAGGGAGCAG GGAGCAGCGATTCTGAGTAGA 
14-3-3d CGAAGACTAGGAGGAGGCAG CTCTCCATGACTGCGAGGAT 
36B4 ACTGGTCTAGGACCCGAGAAG TCAATGGTGCCTCTGGAGATT 
ATP6 AGTATGAGCTGGAGCCGTAATTACA TGGAAGGAAGTGGGCAAGTG 
BIRC5 GAGGCTGGCTTCATCCACTG CTTTTTGCTTGTTGTTGGTCTCC 
BNIP3 AAATTAAAGGGTGCGTGCGG CAAAGTGGGGTTCGTGGGTA 
CDK1 AGGTACTTACGGTGTGGTGTAT CTCGCTTTCAAGTCTGATCTTCT 
CDK6 GGCGTACCCACAGAAACCATA AGGTAAGGGCCATCTGAAAACT 
COX1 TGCTAGCCGCAGGCATTACT GCGGGATCAAAGAAAGTTGTG 
COX5a CGCCGCTGTCTGTTCCAT AAACTCCTCATCTGTCTCGTGTGA 
COX5b CTTCAGGCACCAAGGAAGAC TTCACAGATGCAGCCCACTA 
CPT1β ATCATGTATCGCCGCAAACT CCATCTGGTAGGAGCACATGG 
CSQ1 ACTCAGAGAAGGATGCAGCT CTCTACAGGGTCTTCTAGGA 
CSQ2 AGCTTGTGGAGTTTGTGAAG GGATTGTCAGTGTTGTCCC 
CyclinA GCCTTCACTCATTGCTGGAG TGTTGTGCCAATGACTCAGG 
CyclinD GTTCATTTCCAACCCACCCTC AGAAAGTGCGTTGTGCGGTAG 
cyclinE CCCTCTGACCATTGTGTCCT TCGCACCACTGATAACCTGA 
cyclinG1 GTTCACGACACCTTGCCATT AGAAGGTCAAATCTCGGCCA 
DRP1 GCGCTGATCCCGCGTCAT CCGCACCCACTGTGTTGA 
ERRα CGGTGTGGCATCCTGTGA CTCCCCTGGATGGTCCTCTT 
FBOX32 AAAGCCCTCTCTTGGTTCTGACT GAGAAGAGGTGCAGGGACTGA 
FIS1 GCCCCTGCTACTGGACCAT CCCTGAAAGCCTCACACTAAGG 
GDF11 ACAGAGCAACTGGGGAATCG AGTGTTCATCGCAGTCCAGG 
GRP75 TGACCAAAGACAACATGGCG TAGCTTTCTGACACGGAGCA 
IP3R1 GCCTTGCTAGAGAAGAACGC CATTGCAGCCTGGGTTATCC 
IGFBP5 ATACAACCCAGAACGCCAGCT ACCTGGGCTATGCACTTGATG 
LETM1 CTCTGAGGCTGTGAAGGACA CACCCTTCAGACCTTCCAGT 
MCAD AACACTTACTATGCCTCGATTGCA CCATAGCCTCCGAAAATCTGAA 
MCU AAAGGAGCCAAAAAGTCACG AACGGCGTGAGTTACAAACA 
MFN1 CTGCTTCCTGAGTGTCGAGG GCATGGGCCAGCTGATTAAC 
MFN2 GGTCAGGGGTATCAGCGAAG TTGTCCCAGAGCATGGCATT 
MICU1 ACACCCTCAAGTCTGGCTTAT TTCCCATCTTTGAAGTGCTTCTT 
MSTN GCTGGCCCAGTGGATCTAAA GCCCCTCTTTTTCCACATTTT 
Murf1 AGGCAGCCACCCGATGT TCACACGTGAGACAGTAGATGTTGA 
NCX CTTCCCTGTTTGTGCTCCTGT AGAAGCCCTTTATGTGGCAGTA 
ND1 TCTGCCAGCCTGACCCATA GGGCCCGGTTTGTTTCTG 
NOXA ACTGTGGTTCTGGCGCAGAT TGAGCACACTCGTCCTTCAAGT 
NRF1 TCCCCCGAGGACACTTCTT ATCAGCTGCCGTGGAGTTG 
OPA1 CTTGCCAGTTTAGCTCCCGA CAATTTGGGACCTGCAGTGAA 
OPA2 CCCAGCTCAGAAGACCTTGC CCAGGTGAACCTGCAGTGAA 
p21 GACACCACTGGAGGGTGACT GGATTAGGGCTTCCTCTTGG 
P53 GGGACAGCCAACTCTGTTATG CTGTCTTCCAGATACTCGGGA 
PGC-1α AGCCGTGACCACTGACAACGAG GCTGCATGGTTCTGAGTGCTAAG 
PGC-1β CCATGCTGTTGATGTTCCAC GACGACTGACAGCACTTGGA 
PUMA ATGGCGGACGACCTCAAC AGTCCCATGAAGAGATTGTACATGAC 
SDH GCTGGTGTGGATGTCACTAAGG CCCACCCATGTTGTAATGCA 
SERCA1 AGCCAGTGATGGAGAACTCG CACCACCAACCAGATGTCAG 
SERCA2 GAGAACGCTCACACAAAGACC CAATTCGTTGGAGCCCCAT 
TBP ATATAATCCCAAGCGATTTGC GTCCGTGGCTCTCTTATTCTC 
TFAM GGTCGCATCCCCTCGTCTA GGATAGCTACCCATGCTGGAAA 
TRIADIN ATGACTGAGATCACTGCTGAAGG ATGTTGTCACAATGTCTTCGGT 
UCP3 TTTTGCGGACCTCCTCACTT TGGATCTGCAGACGGACCTT 
XBP1 TGGCCGGGTCTGCTGAGTCCG GTCCATGGGAAGATGTTCTGG 
XIAP GCTTGGCGCGAAAAGGTGG TTGCACGGTGTCTCCTTCAC 
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Labelling Bloking solution Antibody name Product # Company Solution
Calsequestrin 1 milk Calsequestrin Antibody (VIIID12) MA3-913 Thermoscientific BSA
pH2AX BSA Anti-gamma H2A.X (phospho S139) antibody ab11174 Abcam BSA
pprB milk phospho-RB(ser780)(C84F6) Rabbit mAB 3590 Cell signaling BSA
Caspase 3 milk Caspase-3 Antibody 9662 Cell signaling BSA
P53 milk p53 (1C12) Mouse mAb 2524 Cell signaling milk 
VDAC BSA VDAC (D73D12) Rabbit mAb 4661 Cell signaling BSA
Oxphos protein BSA Total OXPHOS Rodent WB Antibody Cocktail ab110413 Abcam BSA
poly-ubiquitinilation BSA Mono- and polyubiquitinylated conjugates monoclonal antibody Enzo BML-PW8810-0500 BSA
BIP BSA Anti-GRP78 BiP antibody ab21685 Abcam BSA
Caspase 12 BSA Caspase-12 Antibody 2202 Cell signaling BSA
Primary antibodies
Labelling Antibody name Product # Company Solution ECL 
Calsequestrin 1 Gt anti-ms 115-035-146 Jackson immunoresearch milk West Dura
pH2AX Goat anti-mouse 115-035-146 Jackson immunoresearch BSA West Femto
pprB Swine anti-rb P0399 Dako milk West Dura
Caspase 3 Swine anti-rb P0399 Dako milk West Femto
P53 Goat anti-mouse 115-035-146 Jackson immunoresearch milk West Dura
VDAC Swine anti-rb P0399 Dako BSA West Dura
Oxphos protein Rb anti-ms P0260 Dako BSA West Dura
poly-ubiquitinilation Rb anti-ms P0260 Dako BSA West Dura
BIP Swine anti-rb P0399 Dako BSA West Dura
Caspase 12 Swine anti-rb P0399 Dako BSA West Dura
SuperSignal™ West Dura Extended Duration Substrate
SuperSignal™ West Femto Maximum Sensitivity Substrate  Thermoscientific #34095
Secondary antibodies
Thermoscientific #34076 
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
187 
 
G. References 
Adhihetty, P. J., G. Uguccioni, L. Leick, J. Hidalgo, H. Pilegaard and D. A. Hood (2009). "The role of PGC-
1alpha on mitochondrial function and apoptotic susceptibility in muscle." American journal of 
physiology. Cell physiology 297(1): C217-225. 
Allen, D. G., G. D. Lamb and H. Westerblad (2008). "Skeletal muscle fatigue: cellular mechanisms." 
Physiological reviews 88(1): 287-332. 
Arnold, A. S., J. Gill, M. Christe, R. Ruiz, S. McGuirk, J. St-Pierre, L. Tabares and C. Handschin (2014). 
"Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-
1alpha." Nature communications 5: 3569. 
Arora, A. S., B. J. Jones, T. C. Patel, S. F. Bronk and G. J. Gores (1997). "Ceramide induces hepatocyte cell 
death through disruption of mitochondrial function in the rat." Hepatology 25(4): 958-963. 
Baranska, W., W. Baran, P. Skopinski and H. Ziemba (1997). "Morphometric analysis of satellite cells in 
rat skeletal muscles: soleus and extensor digitorum longus." Acta Anat (Basel) 160(2): 88-94. 
Bianchi, K., G. Vandecasteele, C. Carli, A. Romagnoli, G. Szabadkai and R. Rizzuto (2006). "Regulation of 
Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator PGC-1alpha." Cell death 
and differentiation 13(4): 586-596. 
Bohm, J., F. Chevessier, A. Maues De Paula, C. Koch, S. Attarian, C. Feger, D. Hantai, P. Laforet, K. Ghorab, 
J. M. Vallat, M. Fardeau, D. Figarella-Branger, J. Pouget, N. B. Romero, M. Koch, C. Ebel, N. Levy, M. 
Krahn, B. Eymard, M. Bartoli and J. Laporte (2013). "Constitutive activation of the calcium sensor STIM1 
causes tubular-aggregate myopathy." American journal of human genetics 92(2): 271-278. 
Chariot, P., E. Benbrik, A. Schaeffer and R. Gherardi (1993). "Tubular aggregates and partial cytochrome c 
oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine." Acta 
neuropathologica 85(4): 431-436. 
Chen, M., D. J. Won, S. Krajewski and R. A. Gottlieb (2002). "Calpain and mitochondria in 
ischemia/reperfusion injury." The Journal of biological chemistry 277(32): 29181-29186. 
Chevessier, F., S. Bauche-Godard, J. P. Leroy, J. Koenig, M. Paturneau-Jouas, B. Eymard, D. Hantai and M. 
Verdiere-Sahuque (2005). "The origin of tubular aggregates in human myopathies." Journal of Pathology 
207(3): 313-323. 
Chevessier, F., I. Marty, M. Paturneau-Jouas, D. Hantai and M. Verdiere-Sahuque (2004). "Tubular 
aggregates are from whole sarcoplasmic reticulum origin: alterations in calcium binding protein 
expression in mouse skeletal muscle during aging." Neuromuscular disorders : NMD 14(3): 208-216. 
Danial, N. N. and S. J. Korsmeyer (2004). "Cell death: Critical control points." Cell 116(2): 205-219. 
Dirks, A. and C. Leeuwenburgh (2002). "Apoptosis in skeletal muscle with aging." American Journal of 
Physiology-Regulatory Integrative and Comparative Physiology 282(2): R519-R527. 
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
188 
 
Dirks, A. J. and C. Leeuwenburgh (2004). "Aging and lifelong calorie restriction result in adaptations of 
skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, 
and caspase-12." Free Radical Biology and Medicine 36(1): 27-39. 
Doonan, P. J., H. C. Chandramoorthy, N. E. Hoffman, X. Q. Zhang, C. Cardenas, S. Shanmughapriya, S. 
Rajan, S. Vallem, X. W. Chen, J. K. Foskett, J. Y. Cheung, S. R. Houser and M. Madesh (2014). "LETM1-
dependent mitochondrial Ca2+ flux modulates cellular bioenergetics and proliferation." Faseb Journal 
28(11): 4936-4949. 
Duchen, M. R. (2000). "Mitochondria and calcium: from cell signalling to cell death." The Journal of 
physiology 529 Pt 1: 57-68. 
Egger, A., M. Samardzija, V. Sothilingam, N. Tanimoto, C. Lange, S. Salatino, L. Fang, M. Garcia-Garrido, S. 
Beck, M. J. Okoniewski, A. Neutzner, M. W. Seeliger, C. Grimm and C. Handschin (2012). "PGC-1alpha 
determines light damage susceptibility of the murine retina." PloS one 7(2): e31272. 
Fraysse, B., J. F. Desaphy, J. F. Rolland, S. Pierno, A. Liantonio, V. Giannuzzi, C. Camerino, M. P. Didonna, 
D. Cocchi, A. De Luca and D. Conte Camerino (2006). "Fiber type-related changes in rat skeletal muscle 
calcium homeostasis during aging and restoration by growth hormone." Neurobiology of disease 21(2): 
372-380. 
Funk, F., C. Ceuterick-de Groote, J. J. Martin, A. Meinhardt, A. L. Taratuto, J. De Bleecker, R. Van Coster, 
B. De Paepe, U. Schara, M. Vorgerd, M. Hausler, S. Koppi, M. Maschke, P. De Jonghe, L. Van Maldergem, 
S. Noel, C. W. Zimmermann, S. Wirth, S. Isenmann, R. Stadler, J. M. Schroder, J. B. Schulz, J. Weis and K. 
G. Claeys (2013). "Morphological spectrum and clinical features of myopathies with tubular aggregates." 
Histology and histopathology 28(8): 1041-1054. 
Gaziev, A. I., S. Abdullaev and A. Podlutsky (2014). "Mitochondrial function and mitochondrial DNA 
maintenance with advancing age." Biogerontology 15(5): 417-438. 
Ghosh, A., G. Narayanappa, A. B. Taly, Y. T. Chickbasavaiya, A. Mahadevan, V. Santosh, N. Atchayaram, I. 
Mohapatra and S. K. Shankar (2010). "Tubular aggregate myopathy: A phenotypic spectrum and 
morphological study." Neurology India 58(5): 747-751. 
Ghosh, S., R. Lertwattanarak, N. Lefort, M. Molina-Carrion, J. Joya-Galeana, B. P. Bowen, J. Garduno-
Garcia Jde, M. Abdul-Ghani, A. Richardson, R. A. DeFronzo, L. Mandarino, H. Van Remmen and N. Musi 
(2011). "Reduction in reactive oxygen species production by mitochondria from elderly subjects with 
normal and impaired glucose tolerance." Diabetes 60(8): 2051-2060. 
Gomez-Cabrera, M. C., F. Sanchis-Gomar, R. Garcia-Valles, H. Pareja-Galeano, J. Gambini, C. Borras and J. 
Vina (2012). "Mitochondria as sources and targets of damage in cellular aging." Clinical chemistry and 
laboratory medicine : CCLM / FESCC 50(8): 1287-1295. 
Grimm, S. (2012). "The ER-mitochondria interface: the social network of cell death." Biochim Biophys 
Acta 1823(2): 327-334. 
Handschin, C., C. S. Choi, S. Chin, S. Kim, D. Kawamori, A. J. Kurpad, N. Neubauer, J. Hu, V. K. Mootha, Y. 
B. Kim, R. N. Kulkarni, G. I. Shulman and B. M. Spiegelman (2007). "Abnormal glucose homeostasis in 
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
189 
 
skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell 
crosstalk." The Journal of clinical investigation 117(11): 3463-3474. 
Harman, D. (2006). "Free Radical Theory of Aging: An Update Increasing the Functional Life Span." 
Understanding and Modulating Aging 1067: 10-21. 
Hirani, V., F. Blyth, V. Naganathan, D. G. Le Couteur, M. J. Seibel, L. M. Waite, D. J. Handelsman and R. G. 
Cumming (2015). "Sarcopenia Is Associated With Incident Disability, Institutionalization, and Mortality in 
Community-Dwelling Older Men: The Concord Health and Ageing in Men Project." Journal of the 
American Medical Directors Association 16(7): 607-613. 
Iqbal, S., O. Ostojic, K. Singh, A. M. Joseph and D. A. Hood (2013). "Expression of Mitochondrial Fission 
and Fusion Regulatory Proteins in Skeletal Muscle during Chronic Use and Disuse." Muscle & Nerve 
48(6): 963-970. 
Jarvis, W. D., S. Grant and R. N. Kolesnick (1996). "Ceramide and the induction of apoptosis." Clinical 
cancer research : an official journal of the American Association for Cancer Research 2(1): 1-6. 
Ji, L. L. and C. Kang (2015). "Role of PGC-1alpha in sarcopenia: etiology and potential intervention - a 
mini-review." Gerontology 61(2): 139-148. 
Johnson, M. L., M. M. Robinson and K. S. Nair (2013). "Skeletal muscle aging and the mitochondrion." 
Trends in endocrinology and metabolism: TEM 24(5): 247-256. 
Lemasters, J. J., T. Qian, C. A. Bradham, D. A. Brenner, W. E. Cascio, L. C. Trost, Y. Nishimura, A. L. 
Nieminen and B. Herman (1999). "Mitochondrial dysfunction in the pathogenesis of necrotic and 
apoptotic cell death." J Bioenerg Biomembr 31(4): 305-319. 
Lin, J., H. Wu, P. T. Tarr, C. Y. Zhang, Z. Wu, O. Boss, L. F. Michael, P. Puigserver, E. Isotani, E. N. Olson, B. 
B. Lowell, R. Bassel-Duby and B. M. Spiegelman (2002). "Transcriptional co-activator PGC-1 alpha drives 
the formation of slow-twitch muscle fibres." Nature 418(6899): 797-801. 
Ling, C., P. Poulsen, E. Carlsson, M. Ridderstrale, P. Almgren, J. Wojtaszewski, H. Beck-Nielsen, L. Groop 
and A. Vaag (2004). "Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha 
and PGC-1beta gene expression in twins." The Journal of clinical investigation 114(10): 1518-1526. 
Liu, J. C., J. Liu, K. M. Holmstrom, S. Menazza, R. J. Parks, M. M. Fergusson, Z. X. Yu, D. A. Springer, C. 
Halsey, C. Liu, E. Murphy and T. Finkel (2016). "MICU1 Serves as a Molecular Gatekeeper to Prevent In 
Vivo Mitochondrial Calcium Overload." Cell Rep 16(6): 1561-1573. 
Liu, Z., Y. Xia, B. Li, H. Xu, C. Wang, Y. Liu, Y. Li, C. Li, N. Gao and L. Li (2014). "Induction of ER stress-
mediated apoptosis by ceramide via disruption of ER Ca(2+) homeostasis in human adenoid cystic 
carcinoma cells." Cell Biosci 4: 71. 
Ludatscher, R., M. Silbermann, D. Gershon and A. Reznick (1983). "The effects of enforced running on the 
gastrocnemius muscle in aging mice: an ultrastructural study." Experimental gerontology 18(2): 113-123. 
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
190 
 
Luo, Y., W. Zhu, J. Jia, C. Zhang and Y. Xu (2009). "NMDA receptor dependent PGC-1alpha up-regulation 
protects the cortical neuron against oxygen-glucose deprivation/reperfusion injury." Journal of molecular 
neuroscience : MN 39(1-2): 262-268. 
Malhotra, J. D. and R. J. Kaufman (2011). "ER stress and its functional link to mitochondria: role in cell 
survival and death." Cold Spring Harb Perspect Biol 3(9): a004424. 
Marchi, S., S. Patergnani and P. Pinton (2014). "The endoplasmic reticulum-mitochondria connection: 
one touch, multiple functions." Biochim Biophys Acta 1837(4): 461-469. 
Marin, J., A. Encabo, A. Briones, E. C. Garcia-Cohen and M. J. Alonso (1999). "Mechanisms involved in the 
cellular calcium homeostasis in vascular smooth muscle: calcium pumps." Life Sci 64(5): 279-303. 
Perez-Schindler, J., S. Summermatter, G. Santos, F. Zorzato and C. Handschin (2013). "The transcriptional 
coactivator PGC-1alpha is dispensable for chronic overload-induced skeletal muscle hypertrophy and 
metabolic remodeling." Proceedings of the National Academy of Sciences of the United States of 
America 110(50): 20314-20319. 
Peterson, C. M., D. L. Johannsen and E. Ravussin (2012). "Skeletal muscle mitochondria and aging: a 
review." Journal of aging research 2012: 194821. 
Rera, M., S. Bahadorani, J. Cho, C. L. Koehler, M. Ulgherait, J. H. Hur, W. S. Ansari, T. Lo, Jr., D. L. Jones 
and D. W. Walker (2011). "Modulation of longevity and tissue homeostasis by the Drosophila PGC-1 
homolog." Cell Metab 14(5): 623-634. 
Rizzuto, R., D. De Stefani, A. Raffaello and C. Mammucari (2012). "Mitochondria as sensors and 
regulators of calcium signalling." Nat Rev Mol Cell Biol 13(9): 566-578. 
Sahin, E., S. Colla, M. Liesa, J. Moslehi, F. L. Muller, M. Guo, M. Cooper, D. Kotton, A. J. Fabian, C. Walkey, 
R. S. Maser, G. Tonon, F. Foerster, R. Xiong, Y. A. Wang, S. A. Shukla, M. Jaskelioff, E. S. Martin, T. P. 
Heffernan, A. Protopopov, E. Ivanova, J. E. Mahoney, M. Kost-Alimova, S. R. Perry, R. Bronson, R. Liao, R. 
Mulligan, O. S. Shirihai, L. Chin and R. A. DePinho (2011). "Telomere dysfunction induces metabolic and 
mitochondrial compromise." Nature 470(7334): 359-365. 
Salviati, G., S. Pierobon-Bormioli, R. Betto, E. Damiani, C. Angelini, S. P. Ringel, S. Salvatori and A. 
Margreth (1985). "Tubular aggregates: sarcoplasmic reticulum origin, calcium storage ability, and 
functional implications." Muscle & nerve 8(4): 299-306. 
Schiaffino, S. (2012). "Tubular aggregates in skeletal muscle: just a special type of protein aggregates?" 
Neuromuscular disorders : NMD 22(3): 199-207. 
Schubert, W., F. Sotgia, A. W. Cohen, F. Capozza, G. Bonuccelli, C. Bruno, C. Minetti, E. Bonilla, S. 
Dimauro and M. P. Lisanti (2007). "Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display 
numerous skeletal muscle abnormalities, with tubular aggregate formation." The American journal of 
pathology 170(1): 316-333. 
Sczelecki, S., A. Besse-Patin, A. Abboud, S. Kleiner, D. Laznik-Bogoslavski, C. D. Wrann, J. L. Ruas, B. Haibe-
Kains and J. L. Estall (2014). "Loss of Pgc-1alpha expression in aging mouse muscle potentiates glucose 
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
191 
 
intolerance and systemic inflammation." American journal of physiology. Endocrinology and metabolism 
306(2): E157-167. 
Shiraishi, J., T. Tatsumi, N. Keira, K. Akashi, A. Mano, S. Yamanaka, S. Matoba, J. Asayama, T. Yaoi, S. 
Fushiki, H. Fliss and M. Nakagawa (2001). "Important role of energy-dependent mitochondrial pathways 
in cultured rat cardiac myocyte apoptosis." American journal of physiology. Heart and circulatory 
physiology 281(4): H1637-1647. 
Short, K. R., M. L. Bigelow, J. Kahl, R. Singh, J. Coenen-Schimke, S. Raghavakaimal and K. S. Nair (2005). 
"Decline in skeletal muscle mitochondrial function with aging in humans." Proceedings of the National 
Academy of Sciences of the United States of America 102(15): 5618-5623. 
Siu, P. M., E. E. Pistilli and S. E. Alway (2005). "Apoptotic responses to hindlimb suspension in 
gastrocnemius muscles from young adult and aged rats." American Journal of Physiology-Regulatory 
Integrative and Comparative Physiology 289(4): R1015-R1026. 
Summermatter, S., R. Thurnheer, G. Santos, B. Mosca, O. Baum, S. Treves, H. Hoppeler, F. Zorzato and C. 
Handschin (2012). "Remodeling of calcium handling in skeletal muscle through PGC-1alpha: impact on 
force, fatigability, and fiber type." American journal of physiology. Cell physiology 302(1): C88-99. 
Szegezdi, E., S. E. Logue, A. M. Gorman and A. Samali (2006). "Mediators of endoplasmic reticulum 
stress-induced apoptosis." EMBO Rep 7(9): 880-885. 
Szulc, P., T. J. Beck, F. Marchand and P. D. Delmas (2005). "Low skeletal muscle mass is associated with 
poor structural parameters of bone and impaired balance in elderly men--the MINOS study." Journal of 
bone and mineral research : the official journal of the American Society for Bone and Mineral Research 
20(5): 721-729. 
Vainshtein, A., E. M. Desjardins, A. Armani, M. Sandri and D. A. Hood (2015). "PGC-1alpha modulates 
denervation-induced mitophagy in skeletal muscle." Skeletal muscle 5: 9. 
Valle, I., A. Alvarez-Barrientos, E. Arza, S. Lamas and M. Monsalve (2005). "PGC-1alpha regulates the 
mitochondrial antioxidant defense system in vascular endothelial cells." Cardiovascular research 66(3): 
562-573. 
Vina, J., M. C. Gomez-Cabrera, C. Borras, T. Froio, F. Sanchis-Gomar, V. E. Martinez-Bello and F. V. 
Pallardo (2009). "Mitochondrial biogenesis in exercise and in ageing." Advanced Drug Delivery Reviews 
61(14): 1369-1374. 
Walston, J. D. (2012). "Sarcopenia in older adults." Current opinion in rheumatology 24(6): 623-627. 
Wanagat, J., Z. J. Cao, P. Pathare and J. M. Aiken (2001). "Mitochondrial DNA deletion mutations 
colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, 
and oxidative damage in sarcopenia." Faseb Journal 15(2): 322-332. 
Wang, C. and R. J. Youle (2009). "The role of mitochondria in apoptosis*." Annual review of genetics 43: 
95-118. 
III. Manuscript 2: Modulation of skeletal muscle aging through PGC-1α-
controlled mitochondrial calcium metabolism and cell death  
 
192 
 
Wenz, T., S. G. Rossi, R. L. Rotundo, B. M. Spiegelman and C. T. Moraes (2009). "Increased muscle PGC-
1alpha expression protects from sarcopenia and metabolic disease during aging." Proceedings of the 
National Academy of Sciences of the United States of America 106(48): 20405-20410. 
Whitman, S. A., M. J. Wacker, S. R. Richmond and M. P. Godard (2005). "Contributions of the ubiquitin-
proteasome pathway and apoptosis to human skeletal muscle wasting with age." Pflugers Archiv-
European Journal of Physiology 450(6): 437-446. 
Wu, J., J. L. Ruas, J. L. Estall, K. A. Rasbach, J. H. Choi, L. Ye, P. Bostrom, H. M. Tyra, R. W. Crawford, K. P. 
Campbell, D. T. Rutkowski, R. J. Kaufman and B. M. Spiegelman (2011). "The unfolded protein response 
mediates adaptation to exercise in skeletal muscle through a PGC-1alpha/ATF6alpha complex." Cell 
metabolism 13(2): 160-169. 
Xiong, S., N. Patrushev, F. Forouzandeh, L. Hilenski and R. W. Alexander (2015). "PGC-1alpha Modulates 
Telomere Function and DNA Damage in Protecting against Aging-Related Chronic Diseases." Cell reports 
12(9): 1391-1399. 
Zhou, J., T. A. Freeman, F. Ahmad, X. Shang, E. Mangano, E. Gao, J. Farber, Y. Wang, X. L. Ma, J. 
Woodgett, R. J. Vagnozzi, H. Lal and T. Force (2013). "GSK-3alpha is a central regulator of age-related 
pathologies in mice." The Journal of clinical investigation 123(4): 1821-1832. 
Uncategorized References 
Agbulut, O., J. Destombes, D. Thiesson and G. Butler-Browne (2000). "Age-related appearance of tubular 
aggregates in the skeletal muscle of almost all male inbred mice." Histochemistry and cell biology 114(6): 
477-481. 
Fernandez-Sanz, C., M. Ruiz-Meana, E. Miro-Casas, E. Nunez, J. Castellano, M. Loureiro, I. Barba, M. 
Poncelas, A. Rodriguez-Sinovas, J. Vazquez and D. Garcia-Dorado (2014). "Defective sarcoplasmic 
reticulum-mitochondria calcium exchange in aged mouse myocardium." Cell Death & Disease 5. 
Kang, C. H., E. Chung, G. Diffee and L. L. Ji (2013). "Exercise training attenuates aging-associated 
mitochondrial dysfunction in rat skeletal muscle: Role of PGC-1 alpha." Experimental Gerontology 48(11): 
1343-1350. 
Pietrangelo, L., A. D'Incecco, A. Ainbinder, A. Michelucci, H. Kern, R. T. Dirksen, S. Boncompagni and F. 
Protasi (2015). "Age-dependent uncoupling of mitochondria from Ca2+ release units in skeletal muscle." 
Oncotarget 6(34): 35358-35371.
IV. Manuscript 3: Muscle PGC-1α potentiates exercise and blunts the aging-
induced deterioration of muscle function and motor coordination 
 
 
193 
 
IV. Manuscript 3: Muscle PGC-1α potentiates exercise and 
blunts the aging-induced deterioration of muscle function and 
motor coordination 
Jonathan F. Gill, Gesa Santos, Svenia Schnyder and Christoph Handschin 
 
1Biozentrum, Division of Pharmacology/Neurobiology, University of Basel, Klingelbergstrasse 
50/70, CH-4056 Basel, Switzerland 
 
This manuscript is in preparation  
IV. Manuscript 3: Muscle PGC-1α potentiates exercise and blunts the aging-
induced deterioration of muscle function and motor coordination 
 
 
194 
 
A. Abstract 
Sarcopenia, age-related loss of muscle mass and function results in a drastic decline in 
motor function and mobility in elderly individuals. Regular physical activity is the only efficient 
intervention to prevent and treat sarcopenia. However, the mechanisms that underlie the 
therapeutic effect of exercise in this context remain unclear. Muscle peroxisome proliferator-
activated receptor γ coactivator 1α (PGC-1α) is a key regulatory hub in endurance exercise 
adaptation with decreased expression in old muscle. We therefore assessed whether PGC-1α is 
required for the exercise-controlled plasticity of old muscle and studied the extent to which 
PGC-1α elevation can substitute for bona fide physical activity. Using mouse models, we showed 
that PGC-1α muscle specific genetic ablation mimicked its age-related decline and triggered pre-
mature sarcopenia, while its overexpression mildly alleviated the metabolic syndrome in old 
mice. Surprisingly, we additionally found that muscle PGC-1α was not only involved in the 
endurance and mitochondrial remodeling of exercise, but also phenocopied and contributed to 
balance and motor coordination improvements observed in old, trained animals. Our data 
therefore suggest that many of the beneficial effects of exercise on muscle mass and function in 
aging are modulated by activation of PGC-1α.  
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B. Introduction 
Aging is a progressive and inevitable biological process leading to a decay and 
dysfunction of organs. Skeletal muscle tissue is prominently affected by this decline, as 
characterized by a loss of strength and mass starting in the 4th decade in humans, a process 
known as sarcopenia (Nair 2005). Age-related loss of muscle function is further exacerbated by 
reduced balance and motor coordination resulting in avoidance of physical ability, increased 
frailty, elevated number of falls and thus bone fractures (Lord, Clark et al. 1991), highly 
predictive for hospitalization and morbidity (Rolland, Czerwinski et al. 2008). In addition, 
muscle dysfunction is associated with many age-associated metabolic disorders such as insulin 
resistance, type 2 diabetes or hypertension, thereby increasing the risk of cardiovascular death 
(Nair 2005). While multiple events are involved in muscle aging (Marcell 2003), mitochondrial 
dysfunction has been strongly linked to sarcopenia (Short, Bigelow et al. 2005). 
 
Exercise training is the most efficient intervention to improve muscle function and whole 
body metabolism (Egan and Zierath 2013), while physical inactivity increases the risk for many 
chronic diseases associated with aging (Booth, Roberts et al. 2012). Physical activity accordingly 
helps to ameliorate age-related skeletal muscle dysfunctions (Cartee, Hepple et al. 2016), not 
only by preserving muscle mass and strength but also balance, motor coordination and mobility 
(Garatachea, Pareja-Galeano et al. 2015). Furthermore, exercise also reduces the age-related 
decline in insulin sensitivity (Cartee, Hepple et al. 2016). Finally, physical activity maintains 
normal mitochondrial function in older adults (Gouspillou, Sgarioto et al. 2014). Mitochondrial 
activity and other exercise-induced phenotypic changes of skeletal muscle are controlled by the 
peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α). For example, PGC-1α is a 
master regulator of mitochondrial biogenesis (Wu, Puigserver et al. 1999, Schreiber, Emter et 
al. 2004), mitochondrial function (Wu, Puigserver et al. 1999), mitochondrial dynamics 
(Cannavino, Brocca et al. 2015), fatty acids oxidation (Hoeks, Arany et al. 2012) and anti-
oxidative processes (St-Pierre, Drori et al. 2006). Interestingly PGC-1α levels are increased by 
exercise in muscle (Safdar, Little et al. 2011) and PGC-1α is considered to be a key player in 
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mitochondrial changes induced by exercise (Ventura-Clapier, Mettauer et al. 2007, Safdar, 
Little et al. 2011). In addition, PGC-1α improves muscle dysfunction of mice with a mitochondria 
myopathy (Wenz, Diaz et al. 2008) and extends health- and life-span of a mouse model of pre-
mature aging arising from mitochondria defects (Sahin, Colla et al. 2011). Interestingly, in line 
with mitochondrial decline, PGC-1α expression decreases during muscle aging in different 
species including humans (Short, Bigelow et al. 2005, Vina, Gomez-Cabrera et al. 2009, Ghosh, 
Lertwattanarak et al. 2011, Kang, Chung et al. 2013). Moreover PGC-1α regulates many 
processes involved in age-related diseases (Wenz 2011) and improves different muscular 
disorders including sarcopenia, fiber atrophy (Sandri, Lin et al. 2006) or Duchenne muscular 
dystrophy (Handschin, Kobayashi et al. 2007). 
 
In this work, we investigated the impact of life-long PGC-1α modulation on sarcopenia, 
age-related motor dysfunctions and whole-body metabolism in 2-years old mice. While a 
number of effects of muscle-specific overexpression (Wenz, Rossi et al. 2009) and gene ablation 
of PGC-1α (Sczelecki, Besse-Patin et al. 2014) on muscle physiology in aging have been 
demonstrated, we now studied the beneficial effects of treadmill exercise during muscle aging 
and assessed whether these effects were mimicked and/or dependent on muscle PGC-1α 
expression. We observed that reduced and elevated PGC-1α levels accelerate and delay, 
respectively, distinct aspects of muscle aging. Moreover, we found that PGC-1α slightly 
improves whole-body metabolism and that many beneficial effects of exercise on mitochondria 
and muscle function are potentiated by and dependent on the transcriptional coactivator. 
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C. Experimental procedures  
Animals 
Mice with muscle ablation (mKO) and overexpression (mTg) of PGC-1α were described 
previously (Lin, Wu et al. 2002, Handschin, Choi et al. 2007). C57/Bl6 wild-type (WT) mice were 
obtained from Janvier (Janvier sas, cs 4105, le genest St-isle f-53941, St Berthevin Cedex). 
Animals were fed ad libitum with regular chow diet (Provimi Kliba 3432) and kept under a 
12h/12h light-dark cycle (06:00 to 18:00) at 23°C. Studies were performed with 3, 12 and 24 
month-old male mice (3 mo 12 mo and 24 mo). At 21 months, groups of mice were trained on a 
treadmill during 12 weeks, 3 times per week, for 30 min. Maximal speed was determined prior 
to the beginning of the training by an exhaustion test. The exercise protocol started at 50% of 
maximal speed in the first week and was gradually increased each week to reach 80%. All 
experiments were performed in accordance with the federal guidelines for animal 
experimentation and were approved by the Kantonales Veterinäramt of the Kanton Basel-Stadt.  
 
Mice phenotyping 
For all behavioral experiments, mice were acclimatized to the room for 1h prior to the 
tests.  
• Balance performance  
Mice were placed on one side of an inclined 6mm diameter beam and were motivated to 
walk across the bar towards a red house used as a positive stimulus. A lamp was placed at the 
starting point as an adverse stimulus. Mice were acclimatized to the apparatus for one day with 
3 beam crossing including 15 second of rest in the red house between trials. Time required to 
cross the beam and number of foot slips made during the crossing were recorded during the 3 
following days with 3 trials per day. 
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• Motor coordination and planning  
Mice were placed on a horizontally oriented, rotating cylinder (rod). For 3 consecutive 
days, mice were acclimatized 3x1 minute per day on the rotarod instrument set to rotate at 5 
rpm. On the 5 following days, mice were tested with accelerating speed (5-68 rpm in 7 minutes 
with directional reversal). Mice were tested 3 times in a row with 10 min of rest between each 
trial. The time the mice spend on the rod before falling was recorded and averaged over the 5 
days.  
 
• Maximal and isometric muscle force 
Maximal grip strength was measured using a grip strength meter (Chatillon). Five 
measurements of the maximal force were performed with 1 min recovery periods between the 
repetitions. The maximum value obtained was used for the analysis. Fatigue resistance and 
isometric force were measured by placing mice on an elevated inverted grid and measuring the 
maximum time until the mice released and felt. 
 
• Endurance exercise capacity 
Mice were acclimatized to treadmill running (Columbus Instruments) for two days. 
Acclimatization was done with an inclination of 5% at a speed of 8 m/min for 5 min followed by 
5 min of 10 m/min. The exhaustion test was performed one day after acclimatization, starting at 
a speed of 4.8 m/min and a subsequent an increased by 1.6 m/min every 3 min until a speed of 
29 m/min was reached. When mice reached exhaustion, the maximal running distance was 
recorded. Blood was drawn from the tail vein before and 10 min after the test and blood lactate 
levels were measured with a lactate plus meter (Nova biomedical). 
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Metabolism measurements 
• Body composition 
Body composition was assessed with an EchoMRI-100analyzer (EchoMRI Medical 
Systems). Fat and lean mass were adjusted to body weight. 
• Glucose homeostasis 
All mice were acclimatized to handling before the experiment. Mice were fasted for 16 h 
overnight before intraperitoneal injection of a bolus of 2 g (glucose)/kg (body weight). Blood 
glucose levels were recorded from the tail vein with a glucose meter (Accu-Chek, Roche 
Diagnostics) at 0, 15, 30, 45, 60, 90 and 120 min after glucose injection. 
 
• Blood pressure 
Blood pressure was measured with a tail cuff BP-2000 Blood Pressure Analysis System 
(Visitech Systems) on 5 consecutive days. 5 pre-measurements and 15 measurements were 
performed in a row. The average values of the 15 measurements over the 5 days were used for 
analysis. 
 
Mouse muscle preparation 
Body weight of the mice was measured before sacrifice by CO2 inhalation. Muscles were 
directly collected and weighed before being either snap-frozen in liquid nitrogen for protein and 
RNA extraction, embedded in 7% tragacanth using cooled-isopentane for cryosection staining or 
directly processed for mitochondrial respiration experiments.  
 
Mitochondria DNA copy number and gene expression 
• Genomic DNA 
Powdered muscles were incubated overnight at 55° in lysis buffer (10mM TrisHCl, 1mM 
EDTA, 0.1% SDS 5% Proteinase). After a 15 min centrifugation step at 8000g, residual RNA of the 
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re-suspended lysate was removed with a RNase A treatment (20mg/ml) during 30 min at 37°C. 
RNase A was heat-inactivated at 95°C for 30 min. Samples were mixed with one volume of 
phenol/chloroform/isoamylalcohol (25:24:1) and centrifuged at 8000g for 15 min. The aqueous 
phase was transferred to a fresh tube and one volume of chloroform was added. After an 
identical centrifugation step, one volume of isopropanol containing 0.3M of sodium acetate was 
added. Samples were then kept at -20°C for 30 min. A centrifugation step was repeated at 4°C. 
DNA pellets were washed 2 times with 1ml of ice-cold 75% ethanol and finally recovered in 
ddH2O. 0.1ug of gDNA was analyzed by qPCR to measure mitochondrial DNA copy numbers. 
 
• RNA extraction and qPCR  
Lysing matrix tubes (MP Biomedicals 6913-500) and TRI Reagent (Sigma-Aldrich T9424) 
were used to isolate RNA from crushed muscle. NanoDrop 1000 spectrophotometer (Thermo 
Scientific) was used to measure RNA concentration and purity to ensure that the ratios of 
260/280 and 260/230 were above 1.8. An Agilent Bioanalyzer (Agilent 2100 Bioanalyzer, Agilent 
Technologies) determined the level of RNA degradation. DNA was removed with RNase-free 
DNase (Invitrogen 18068-015) and one microgram of RNA was used for reverse transcription 
using SuperScript II reverse transcriptase (Invitrogen 18064-014).  
 
Relative DNA copy number or mRNA levels were determined using a Light Cycler 480 
system (Roche Diagnostics) with FastStart essential DNA probe master mix (Roche Diagnostics 
06402682001). Relative mRNA quantification was done with the ΔΔCT method using the TATA 
binding protein (TBP) gene as reference. Mitochondrial DNA copy number was evaluated by 
normalizing the average of COX1 ATP6 and ND1 DNA copy number with the average copy 
number of the nuclear genes beta globin and 34B6. Beta globin, 34B6 and TBP levels were 
similar in all samples. Primer used: PGC-1α for 5’-AGCCGTGACCACTGACAACGAG-’3, PGC-1α rev 
5’-GCTGCATGGTTCTGAGTGCTAAG-‘3’ ; TBP for 5’-ATATAATCCCAAGCGATTTGC-’3, TBP rev ; 5’-
GTCCGTGGCTCTCTTATTCTC-’3; COX1 for 5’-TGCTAGCCGCAGGCATTACT-’3, COX1 rev 5’-
GCGGGATCAAAGAAAGTTGTG-’3; ATP6 for 5’-AGTATGAGCTGGAGCCGTAATTACA-’3, ATP6 rev 5’-
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TGGAAGGAAGTGGGCAAGTG-’3; ND1 for 5’-TCTGCCAGCCTGACCCATA-’3, ND1 rev 5’-
GGGCCCGGTTTGTTTCTG-’3 ; 36B4 for 5’-ACTGGTCTAGGACCCGAGAAG-’3, 36B4 rev 5’-
TCAATGGTGCCTCTGGAGATT-’3; βGlobin for 5'-GAAGCGATTCTAGGGAGCAG-‘3, βGlobin rev 5'-
GGAGCAGCGATTCTGAGTAGA-‘3 
 
Immunostaining 
8 µm muscle cryosections were cut with a cryostat (Leica, CM1950). Sections were 
blocked for 30min at ambient temperature in PBS containing 0.4% Triton X-100 (Sigma, 93426) 
and 10% goat serum (Sigma, G9023). Fiber types were labeled with primary and secondary 
antibodies for one hour at room temperature in PBS with 10% goat serum (antibody dilutions 
and information are described in table 1). Incubation with secondary antibodies was performed 
in the dark. All secondary antibodies were from Life technologies. 3 washes of 5 min in PBS were 
performed before and after antibody incubation. Nuclei were stained using ProLong Gold 
Antifade mounting medium with Dapi (Life Technologies, P36931). Images were taken using the 
FEI MORE microscope with a 20x magnification lens. Fiber type percentages and diameters were 
quantified in whole muscle sections using the ImageJ and cell^P software (Olympus Soft Imaging 
Solution). 
 
Table 1:  
Primary antibodies Secondary antibodies 
Product# Company Labelling Dilution Product# Labelling Dilution 
BA-F8 DSHB m IgG b2 MHC type 1  1:25 A-21242  AF647 IgG GaM   1:250 
SC-71  DSHB m IgG1 MHC type 2a   1:200 A-21124  AF568 IgG1 GaM   1:100 
BF-F3 DSHB m IgM MHC type 2b   1:100 A-21042  AF488 IgM GaM   1:400 
L9393  Sigma r IgM Laminin   1:5000 A-11008  AF488 IgG GaR   1:500 
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Protein levels 
Total protein was recovered from quadriceps muscles as described in (Perez-Schindler, 
Summermatter et al. 2013). Equal amounts of protein were migrated on mini-TGX 4-20% stain 
free pre-cast gel (Biorad, 4568096) and labelled with the in-gel trihalo compounds under UV for 
1 min. Gel and nitrocellulose membranes were allowed to equilibrate for 5 min in transfer 
buffer. Protein transfer was performed at a constant voltage of 100V for 1h. Membranes were 
blocked for 1 h at room temperature with 5% BSA diluted in TBS-T and washed 2x for 5 min with 
TBS-T. Membranes were then incubated overnight at 4°C with primary antibodies (Abcam, 
ab110413, 1/1000) diluted in TBS-T containing 0.02% sodium azide and 3% BSA. Membranes 
were washed 3x for 5 min with TBS-T and incubated 1 h at room temperature with peroxidase-
conjugated secondary antibodies (Dako, P0260, 1/10000) diluted in TBS-T plus 3% BSA. The 
same washing step was repeated before antibody binding was revealed using an enhanced 
chemiluminescence HRP substrate detection kit (Thermoscientific, 34076) and imaged using a 
Fusion FX imager. Total protein content was determined using the trihalo compounds labeling. 
Two reference samples were loaded in the different gels for inter-gel normalization. Proteins 
quantification was performed using the Fusion FX software. 
 
Mitochondrial respiration 
Isolated muscles were consecutively rinsed with PBS and PBS containing10 mM EDTA. 
Muscles were put in 2 ml of isolation buffer 1 (EDTA 10 mM, D-mannitol 215 mM, sucrose 
(0.075M), free-fatty acid BSA (Sigma-Aldrich) 0.1%, HEPES 2 mM pH 7.4 in distilled water) and 
thoroughly minced. Muscle solutions were homogenized with manual pestle in Potter-Elvehjem 
grinders and centrifuged for 10 min at 700g. The resulting supernatants were centrifuged for 10 
min at 10500g and pellets were re-suspended in 500µl of isolation buffer 2 (EGTA 3 mM, D-
mannitol 215 mM, sucrose 0.075M, free-fatty acid BSA (Sigma-Aldrich) 0.1%, HEPES 2 mM pH 
7.4 in distilled water) before another centrifugation step at 10500g for 10 min. Mitochondria 
were finally re-suspended in 100 µl of isolation buffer 2 and protein concentrations were 
assessed by Bradford assay before being diluted in 37°C pre-warmed mitochondrial assay buffer 
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(MAS) (MgCl2 5 mM, D-Mannitol 220 mM, KH2PO4 10mM, EGTA 1 mM, free-fatty acid BSA 
0.2%, HEPES 2 mM, sucrose 70 mM  pH 7.0 in distilled water). 1µg of mitochondrial protein was 
loaded into a 96-well plate and centrifuged at 2000g for 20 min. 135 µl of mitochondrial assay 
buffer with 20mM succinate and 2µM rotenone were gently added to each well and the plate 
was warmed up to 37°C for 10 min. A calibrated Seahorse XF96 Extracellular Flux Analyzer was 
used to measure mitochondrial respiration using the Mito Stress Test Kit (Seahorse Bioscience, # 
103015-100). Mitochondrial respiration assay consisted of an equilibration, 1 min mixing, 3 min 
pause, 1 min mixing, 3 min pause, 0.5 min mixing, 3 min measurement, 1 min mixing, 3 min 
measurement, 0.5 min mixing, injection of 4 mM ADP, 1 min mixing, 3 min measurement, 1 min 
mixing, injection of 3.125 µM Oligomycin, 0.5 min mixing, 3 min measurement, 1 min mixing, 
injection of 4 µM FCCP, 0.5 min mixing, 3 min measurement, 1 min mixing, injection of 4 µM 
Antimycin, 0.5 min mixing, 3 min measurement. All of the experimental steps prior to plate 
loading were performed at 4°C. 
 
Blood cholesterol  
Blood was collected from the tail vein or post-mortem from heart puncture. Blood 
samples were centrifuged for 10 min at 2000 g in tri-potassium-EDTA tubes before plasma was 
recovered. Plasma cholesterol levels were measured with a COBAS c111 analyzer (Roche 
Diagnostics). 
 
Statistical analysis 
Data were analyzed with two-way ANOVA (GraphPad Prism software). Sidak post-tests 
were used to do multiple comparison analysis following two-way ANOVA. All data are plotted as 
mean ± SEM. 
IV. Manuscript 3: Muscle PGC-1α potentiates exercise and blunts the aging-
induced deterioration of muscle function and motor coordination 
 
 
204 
 
D. Results 
 Exercise-associated mitochondrial improvement in old muscle is dependent on muscle 
PGC-1α 
Mitochondrial number and function are boosted by endurance training, while inversely 
reduced mitochondrial activity has been associated with muscle aging. We therefore 
investigated the impact of exercise and modulation of muscle PGC-1α expression in old skeletal 
muscle in vivo. As expected, endurance training induced PGC-1α expression in the 
gastrocnemius and tibialis anterior (TA) muscle of WT animals (Fig. 1a). Surprisingly however, 
the genotype effect of overexpression and knockout of PGC-1α on mitochondrial gene 
expression was not replicated by exercise (Fig. 1b). Nevertheless, oxidative phosphorylation 
(OXPHOS) protein levels were elevated by PGC-1α and exercise (Fig. 1c). Importantly, the 
exercise-controlled increase in OXPHOS proteins was blunted in the mKO animals. Even though 
mitochondrial gene expression and protein levels were already substantially boosted in mTg 
mice beyond the levels that were achieved by endurance exercise in WT animals, an additional 
training-effect was still observed in the mTg model in regard to mitochondrial DNA copy number 
(Fig. 1d) and oxygen consumption rates of isolated mitochondria (Fig. 1e). 
 
 Muscle PGC-1α affects endurance capacity of untrained and trained skeletal muscle in 
old mice 
Mitochondrial function is closely linked to endurance performance in skeletal muscle. 
Based on the observed modulation of mitochondrial properties by exercise and muscle PGC-1α, 
we next studied the impact the corresponding interventions on muscle endurance during aging. 
In all three genotypes, exercise training improved endurance performance of old mice, even 
though at lower and higher levels in mKO and mTg animals, respectively (Fig. 2a). Similarly, 
circulating lactate was affected in a genotype-dependent manner (Fig. 2b). Surprisingly, an 
additional lactate-lowering effect of exercise was only observed in mKO and mTg, but not WT 
mice. At least for the muscle-specific overexpression of PGC-1α, this observation could be based 
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on the exercise-linked potentiation of the proportion of type I muscle fibers, which was not 
recorded in WT or mKO animals (Fig. 2c). 
 
Aging, exercise and muscle PGC-1α modulate muscle mass and metabolic parameters 
Besides reduced muscle function, a loss of muscle mass and force are the key hallmarks 
of sarcopenia. An assessment of grip strength accordingly revealed an age-dependent 
diminution in maximal and isometric force in all genotypes (Fig. 3a and b). Correlating with 
reduced muscle force, loss of individual muscles masses with age further suggested the onset of 
sarcopenia in the WT group, while no changes could be observed in lean mass or fiber size in 
those animals (Fig. 3 c, d and e). Strikingly, old mice deficient for muscle PGC-1α presented an 
accelerated age-related loss of isometric strength, in addition to diminished maximal force, lean 
mass, muscle weights and fibers size compared to WT animals, highlighting the development of 
a pre-mature sarcopenia in those mice. Although mTg animals exhibited a slight age-related loss 
of lean mass, it was not significantly different from WT animals and the impact of PGC-1α 
overexpression on individual muscle weights reduction was muscle specific. Even though 
endurance training is not the most efficient intervention to improve muscle mass, exercise 
partially rescued the loss maximal grip strength, lean mass and muscle weight in old mKO mice, 
although maxiimal force and lean mass remained lower than in the trained and untrained WT 
groups (Fig. 4a, b and d). In WT animals, only gastrocnemius was similarly affected by exercise. 
Interestingly, exercise however improved isometric strength in old WT mice, but not in mice 
lacking muscle PGC-1α (Fig. 4b), possibly because of their reduced maximal force and muscle 
mass. Surprisingly, this absence of exercise effect was also found in mice overexpressing PGC-1α 
and likely originates from distinct alteration in mTg and mKO animals. In an opposite manner 
PGC-1α overexpression potentiated the effect of exercise on maximal force in old animals (Fig. 
4a). 
 
Muscle mass and function are important predictors of metabolic homeostasis. Thus, the 
age-associated decrease in muscle mass and function was linked to a deterioration of glucose 
tolerance in WT and mTg animals, whereas young mKO mice already exhibited a glucose 
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tolerance similar to the one of 2 years old animals (Fig. S1a). While blood cholesterol remained 
largely unchanged (Fig. S1b), down- and upregulation of PGC-1α both lowered diastolic blood 
pressure. However, more importantly, blood pressure increased in old WT and mKO, but not in 
mTg mice (Fig. S1c). Exercise dramatically reversed age-associated glucose intolerance in the WT 
group and failed to significantly improve glucose clearance in mTg animals, whereas it did not 
lead to any changes in mKO mice (Fig. S2a). Blood cholesterol levels were not affected to a large 
extent by exercise, even though a slight elevation and a significant reduction were observed in 
the mKO and mTg mice, respectively (Fig. S2b). Diastolic blood pressure was not affected by 
exercise in any of the genotypes (Fig. S2c). 
 
Exercise and PGC-1α improve age-related impairments in motor coordination and 
balance 
The detrimental effects of sarcopenia in elderly individuals are compounded by a loss of motor 
coordination and balance. We thus recorded how motor coordination and balance in old mice can be 
modulated by exercise and muscle PGC-1α using balance beam- and Rotarod-based tests. The number of 
foot slips and the time needed to cross the balance beam rise dramatically with increasing age in all 
three genotypes (Fig. 5a). Strikingly however, the mKO mice exhibited the phenotype of 24-months old 
WT mice already at the age of 12 months. Inversely, the age-dependent increase in both parameters was 
blunted in mTg animals. Curiously, young mKO and mTg mice performed better in Rotarod tests at young 
age (Fig. 5b). Exercise training improved the balance performances in old WT and mKO mice to the level 
observed in sedentary mTg mice (Fig. 6a). Similarly, Rotarod performance in WT mice after exercise 
reached the level of sedentary mTg animals (Fig. 6b). Strikingly, mKO mice did not respond to exercise in 
the Rotarod-based assessment of motor coordination. 
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E. Discussion 
Exercise is widely accepted as one of the most efficient treatment against whole-body 
and muscle aging (Gremeaux, Gayda et al. 2012, Garatachea, Pareja-Galeano et al. 2015). 
While evidences has been presented that demonstrate a role for PGC-1α modulation in the 
muscle of old animals (Wenz, Rossi et al. 2009, Sczelecki, Besse-Patin et al. 2014), we now have 
studied the role of this coactivator in muscle aging in the context of exercise. Most surprisingly, 
we observed a strong involvement of muscle PGC-1α in the control of motor coordination and 
balance. An improvement of these parameters has been shown in exercise, which exerts 
pleiotropic effects on different organs and cell types. Our findings now demonstrate that 
muscle-intrinsic changes in PGC-1α expression are sufficient to affect motor coordination and 
balance in old mice. Prior work revealed that central nervous system-specific expression of PGC-
1α is essential for motor function (Zhao, Varghese et al. 2011, Lucas, Dougherty et al. 2012). 
Our present data indicate that skeletal muscle can initiate a retrograde signaling to the nervous 
system with a similar outcome. Analogous findings have been reported in the remodeling of the 
neuromuscular junction (Arnold, Gill et al. 2014). Several muscle intrinsic and extrinsic factors 
contribute to maintenance of motor coordination and balance besides neuronal changes, 
including motor planning, strength and endurance, all of which are decreased with age 
(Garatachea, Pareja-Galeano et al. 2015). Thus, reduced muscle mass in aged mKO-PGC-1α 
mice compared to age-matched WT animals and the ensuing reduction in maximal force could 
be important for balance and motor coordination (Schultz, Ashton-Miller et al. 1997). 
Additionally, muscle fiber contraction speed is essential to counteract disequilibrium or to 
initiate adaptations to changes in motor planning (Schultz, Ashton-Miller et al. 1997). This 
parameter is highly dependent on calcium homeostasis (Berchtold, Brinkmeier et al. 2000). 
Interestingly, our group demonstrated that muscle PGC-1α remodel sarcoplasmic reticulum and 
mitochondrial calcium handling (Summermatter, Thurnheer et al. 2012) and thereby possibly 
affects muscle contraction and ultimately locomotor function. On top of that, muscle PGC-1α 
overexpression ameliorates neuromuscular junction morphology and function, which might also 
contribute to the amelioration of age-related motor dysfunction (Arnold, Gill et al. 2014). 
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Finally the proprioceptive and the vestibular systems are key players for motor coordination and 
balance performance (Baloh 1996) and decline with age (Johnsson 1971). Vestibulo-spinal 
neuronal projections preferentially connect to slow over fast motor neurons that innervate slow 
type muscles (Basaldella, Takeoka et al. 2015). Inversely, proprioceptive projections are more 
predominantly linked to fast motor neurons and hence fast fibers. By promoting a shift towards 
slow fiber types (Lin, Wu et al. 2002), PGC-1α might also consequently improve vestibular-
muscle connection and ultimately balance performance. Of note, ablation of muscle PGC-1α 
abolished the effect of exercise on motor coordination and bunted exercise-associated increase 
in endurance. Conversely, overexpression of muscle PGC-1α boosted the effect of exercise on 
both muscle endurance and maximal strength. Those data indicate that exercise effects on 
motor coordination, endurance and maximal force rely on muscle PGC-1α levels. Interestingly, 
similarly to PGC-1α, exercise influences age-related neuromuscular junction alterations (Wenz, 
Rossi et al. 2009, Valdez, Tapia et al. 2010) and drives a shift toward a more oxidative muscle 
metabolism (Holloszy and Coyle 1984) which could thereby also improve vestibulo-muscular 
communication (Basaldella, Takeoka et al. 2015). In the light of those elements, it would be 
interesting to investigate if exercise affects motor function through those types of remodeling in 
a PGC-1α dependent manner. 
 
In our experimental paradigm, exercise did not affect whole body muscle mass and only 
quadriceps muscle mass in our WT animals. In line with these results, maximal strength was 
likewise unaffected. Resistance exercise would probably be more effective in improving these 
parameters. Nevertheless, endurance exercise training boosted isometric muscle force and 
running capacity in WT mice. Endurance exercise might thus be sufficient to improve sarcopenia 
at a later age and upon higher muscle strength loss. This is supported by the partial restoration 
of both muscle mass and muscle force in mKO mice, which displayed an advanced stage in 
sarcopenia.  
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Interestingly, even though exercise improved PGC-1α muscle gene expression in some 
muscles, no changes in mitochondrial mRNA levels were observed. In contrast, an elevation in 
OXPHOS protein levels correlated with the increased endurance performance of these mice. 
Strikingly, PGC-1α muscle deletion blunted exercise induction of OXPHOS proteins and PGC-1α 
overexpression potentiated the effects of exercise on mitochondrial mass, mitochondria 
respiration and on the proportion of type I fibers. This demonstrates that exercise improves 
mitochondrial fitness and oxidative metabolism in a PGC-1α-dependent manner, also in old 
muscles. Correlating with our results, previous work showed that global and muscle-specific 
PGC-1α deletion prevents exercise-associated amelioration of mitochondria (Leick, Lyngby et al. 
2010). 
 
Skeletal muscle is the largest tissue responding to insulin and therefore is a primary site 
for whole body glucose uptake, utilization and storage. Glucose intolerance, increased blood 
pressure and altered cholesterol levels are all hallmarks of the age-related metabolic syndrome 
(Hildrum, Mykletun et al. 2007). Conversely to the aggravated glucose intolerance in old mKO 
animals described previously (Sczelecki, Besse-Patin et al. 2014), we observed that absence of 
muscle PGC-1α accelerated glucose intolerance during aging. However, the fact that only 
genotype and not age association was evaluated and presented in the previous work makes the 
comparison with the present study difficult. For example, in the data presented in the earlier 
work, glucose tolerance seems unexpectedly lower in 12 months than in 24 months old WT 
mice. In mTg mice, even though no overt amelioration in glucose tolerance was observed, 
overexpression of muscle PGC-1α improved cholesterol levels and abolished the age-associated 
blood pressure increase. Therefore overall, muscle PGC-1α mildly reduces the development of 
an age-related metabolic syndrome. Since the metabolic syndrome is highly predictive for heart 
disorders and failure (Perrone-Filardi, Paolillo et al. 2015), it would be interesting to study the 
effect of exercise combined with modulation of muscle PGC-1α on the aging heart. 
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In conclusion, our findings demonstrate that many of the beneficial effects of exercise 
involve the action of muscle PGC-1α. Of note, some parameters show an additive effect of 
endurance exercise with overexpression of PGC-1α, suggesting an obvious therapeutic 
relevance. While an improvement of motor coordination and balance could have been expected 
from the exercise intervention, the striking effect of overexpression and ablation of muscle PGC-
1α reveal a hitherto unsuspected contribution of muscle fibers to these neuronally controlled 
processes. More work is required to identify the molecular mechanisms that underlie this 
observation. Nevertheless, our data highlight the importance of proper muscle function on 
aging-related deteriorations that transcend the immediate effects on muscle fibers.  
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F. Figures  
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Figure 1: mPGC-1α levels determine exercise-related mitochondrial improvements (a) Relative 
mPGC-1α gene expression (n=3-6). (b) Relative mRNA levels of mitochondrial genes (n=6) (c) 
Mitochondrial OXPHOS protein levels (n=6). (d) Mitochondrial mass (n=6) and (e) mitochondrial 
basal and maximal respiration capacities (n=5-6). Values are mean ± SEM. *P < 0.05; **P < 0.01; 
***; P < 0.001; ****p<0.0001 indicate statistically significant differences between sedentary 
and exercised animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 
indicate statistically significant differences between genotypes for sedentary and exercised 
animals. 
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Figure 2: mPGC-1α potentiates exercise-dependent endurance increase (a) Endurance level of 
mice challenged on a treadmill (n=8-10). (b) Pre- and post-exercise blood lactate levels (n=8-10) 
(c) Representative pictures and quantification of fiber type staining (red = type 1 fibers; blue = 
type 2A fibers ; green = type 2B fibers ; black = type 2X fibers) (n=4-6). Values are mean ± SEM. 
*P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant differences 
between sedentary and exercised animals of the same genotype, # p<0.01; ## p<0.01; ### 
p<0.01; #### p<0.001 indicate statistically significant differences between genotypes for 
sedentary and exercised animals. 
.  
IV. Manuscript 3: Muscle PGC-1α potentiates exercise and blunts the aging-
induced deterioration of muscle function and motor coordination 
 
 
215 
 
  
IV. Manuscript 3: Muscle PGC-1α potentiates exercise and blunts the aging-
induced deterioration of muscle function and motor coordination 
 
 
216 
 
Figure 3: Absence of mPGC-1α accelerates sarcopenia (a) Maximal force (n=10-12), (b) 
isometric force (n=10-12), (c) lean relative to body mass (n=10) and (d) muscle mass relative to 
body weight (n=5-6) and (e) Fiber type specific minimum ferret diameter (n=3-4) Values are 
mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant 
differences between young and old animals of the same genotype, # p<0.01; ## p<0.01; ### 
p<0.01; #### p<0.001 indicate statistically significant differences between genotypes of age-
matched animals. 
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Figure 4: Exercise reduces pre-mature sarcopenia in the absence of mPGC-1α (a) Maximal 
force (n=8-10), (b) isometric force (n=8-10), (c) lean relative to body mass (n=8-10) and (d) 
muscle mass relative to body weight (n=5-6). Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; 
P < 0.001; ****p<0.0001 indicate statistically significant differences between sedentary and 
exercised animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 
indicate statistically significant differences between genotypes for sedentary and exercised 
animals. 
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Figure 5: mPGC-1α delays locomotor dysfunction during aging (a) Balance performances 
measured during balance beam crossing (n=10-12). (b) Motor coordination of mice challenged 
with a rotarod (n=10-12). Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; 
****p<0.0001 indicate statistically significant differences between young and old animals of the 
same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate statistically significant 
differences between genotypes of age-matched animals. 
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Figure 6: mPGC-1α elevation mimics exercise to improve motor function in aged mice (a) 
Balance performances measured during balance beam crossing (n=8-10). (b)Mmotor 
coordination of mice challenged with a rotarod (n=10). Values are mean ± SEM. *P < 0.05; **P < 
0.01; ***; P < 0.001; ****p<0.0001 indicate statistically significant differences between 
sedentary and exercised animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### 
p<0.001 indicate statistically significant differences between genotypes for sedentary and 
exercised animals. 
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Figure S1: mPGC-1α slightly improves systemic aging (a) Glucose tolerance test curves and area 
under the curves (n=10), (b) total blood cholesterol levels (n=9-10) and (c) diastolic blood 
pressure (n=10). Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 
indicate statistically significant differences between young and old animals of the same 
genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate statistically significant 
differences between genotypes of age-matched animals. 
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Figure S2: Exercise and mPGC-1α  modulation impacts on systemic aging (a) Glucose tolerance 
test curves and area under the curves (n=8-10), (b)  total blood cholesterol levels (n=8-10) and 
(c) diastolic blood pressure (n=10-12) Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 
0.001; ****p<0.0001 indicate statistically significant differences between sedentary and 
exercised animals of the same genotype, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 
indicate statistically significant differences between genotypes for sedentary and exercised 
animals. 
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V. Discussion and outlook 
A. The role of PGC-1α in the arcuate nucleus 
Since its identification and characterization as an important regulator of BAT 
thermogenesis in 1998 (Puigserver, Wu et al. 1998), PGC-1α has been defined as a key player 
for cellular metabolic transcriptional adaptation in various tissues in response to different 
environmental conditions such as cold exposure, fasting and exercise. For example, for more 
than a decade, it has been extensively described in the muscle as an inducer of mitochondrial 
biogenesis and oxidative metabolism (Lin, Wu et al. 2002, Pagel-Langenickel, Bao et al. 2008). 
Interestingly, identification of a broad panel of novel functions in multiple tissues has been 
made regarding this coactivator of transcription and the list keeps increasing even today. 
Notably, while it was largely described as a major regulator of muscle metabolism, its recent 
association with the regulation and secretion of emerging myokines indicates that PGC-1α also 
regulates whole body metabolism and homeostasis via crosstalks between muscle and other 
tissues. Importantly, the secretion of several muscle factors induced by PGC-1α  triggers whole 
body homeostasis adaptations upon exercise (Schnyder and Handschin 2015). Muscle PGC-1α is 
therefore not only used to promote a response to exercise in myofibers but also acts as a 
physical activity sensor for the whole body. For example, the release of irisin, BAIBA and Metrnl 
from the muscle, controlled by PGC-1α and induced upon exercise, all increase WAT browning 
and energy expenditure and improve whole body glucose homeostasis (Bostrom, Wu et al. 
2012, Lee, Linderman et al. 2014, Rao, Long et al. 2014, Roberts, Bostrom et al. 2014). In 
addition, PGC-1α further influences glucose homeostasis and insulin sensitivity by regulating 
insulin-stimulated glucose uptake and disposal in the muscle (Pagel-Langenickel, Bao et al. 
2008, Bonen 2009) and hepatic gluconeogenesis upon fasting (Lin, Handschin et al. 2005). The 
role of muscle and liver PGC-1α as a metabolic sensor and regulator of whole body glucose 
homeostasis raised the question as to whether it could have a similar function in other tissues 
that require sensing of metabolic signals to control whole body energy homeostasis. 
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1. PGC-1α is important for energy balance regulation in AgRP 
neurons 
Since the arcuate nucleus is a main regulator of systemic energy balance, we generated 
mouse models with PGC-1α ablation in AgRP and POMC neurons and unraveled its importance 
in the control of feeding and energy expenditure by this brain region. We and others found that 
PGC-1α is induced in the hypothalamus upon fasting (Coppari, Ramadori et al. 2009) and in an 
immortalized AgRP cell line upon serum starvation. This is reminiscent of its regulation in the 
liver. Interestingly, FOXO1 is necessary for PGC-1α mediated insulin stimulation of 
gluconeogenesis in the liver (Puigserver, Rhee et al. 2003) and also required for insulin and 
leptin induction of food intake in AgRP neurons (Kitamura, Feng et al. 2006). Moreover, PGC-1α 
deletion in AgRP neurons prevents leptin-mediated inhibition of food intake. It is therefore 
tempting to hypothesize that PGC-1α works together with FOXO1 to regulate food intake 
through the integration of hormonal signaling in the arcuate nucleus. In addition to inhibiting 
leptin action on AgRP neurons, fasting induction of both food intake and AgRP expression are 
blunted in mice lacking PGC-1α in AgRP neurons. Interestingly, as PGC-1α, Sirt1 is induced in 
AgRP neurons upon fasting and its inhibition diminishes fasting-stimulated AgRP expression 
(Cakir, Perello et al. 2009). Since SIRT1 is a very well-known activator of PGC-1α, the similarities 
between the phenotypes triggered by SITR1 and PGC-1α inhibition suggest that food intake 
stimulation upon fasting is mediated by a SIRT1-PGC-1α axis that promotes AgRP upregulation. 
On the other hand, AMPK, another regulator of PGC-1α, increases fasting-induced AgRP 
expression (Minokoshi, Alquier et al. 2004). Its activation upon food deprivation in AgRP 
neurons also drives fasting-induced synaptic remodeling that is required to promote feeding 
(Kong, Dagon et al. 2016). PGC-1α, in addition to allowing fasting induction of AgRP expression, 
also regulates synaptic plasticity in muscle (Arnold, Gill et al. 2014) and in neurons (Cheng, Wan 
et al. 2012) and might thus be involved in AMPK control of AgRP synaptic remodeling upon 
fasting.  
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Intriguingly, despite observing hypophagia in both ad-libitum and fasting conditions, we 
found that mice with deletion of PGC-1α in AgRP neurons exhibit an increase in body weight and 
fat mass. This paradoxical phenotype was reminiscent of alterations observed in AgRP neurons 
ablated mice, which display higher feeding efficiency and higher body weight in spite of lower 
feeding response upon food intake stimulation (Joly-Amado, Denis et al. 2012). Thus, similarly 
to AgRP neurons ablated mice, increased body mass observed in our mice could be due to 
altered nutrient partitioning and utilization in peripheral tissues, such as muscle or WAT. Of 
note, whole brain deletion of PGC-1α leads to hepatic steatosis, which can be caused by 
alterations in nutrient and especially lipid partitioning in the liver. It might therefore be of 
interest to evaluate any potential liver damage in our AgRP-PGC1α KO mice to determine if the 
liver steatosis observed in mice with whole brain deletion of PGC-1α arises from arcuate nucleus 
alterations. Aside from nutrient partitioning, reduction of locomotor activity and body 
temperature in mice lacking PGC-1α in AgRP neurons indicate that they waste less energy. This 
may also contribute to their increase in fat mass. It is worth noting that AgRP neurons have 
been shown to regulate BAT thermogenesis and WAT browning (Ruan, Dietrich et al. 2014). It 
would thus be interesting to further determine whether alterations of AgRP neurons upon PGC-
1α deletion lead to reduced BAT thermogenesis and WAT browning, which might result in the 
observed diminished body temperature. 
 
At the time of this thesis, other studies were unraveling novel processes involved in the 
arcuate nucleus' control of energy homeostasis, which could be impaired by PGC-1α deletion. 
For example, mitofusin 1 and 2 have been implicated in the regulation of energy homeostasis 
and obesity by AgRP neurons (Dietrich, Liu et al. 2013). Interestingly, while studying the role of 
PGC-1α in muscle aging we observed that PGC-1α strongly regulates mitofusins in myofibers, as 
it was previously described (Cartoni, Leger et al. 2005). It has been reported that hepatic PGC-
1α elevation upon leptin treatment stimulates Mfn1 activity to improve hyperlipidemia (Hsu, 
Lee et al. 2015). Thus, the control of mitochondrial fusion and fission regulating energy 
homeostasis within AgRP neurons could also be impaired by PGC-1α deletion in those neurons 
and contribute the disruption of energy balance that we observed in our mice. Also, 
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mitochondrial content is increased in AgRP neurons, which is activated by a negative energy 
balance and is decreased in diet induced obese animals (Dietrich, Liu et al. 2013). Given the 
master role of PGC-1α in mitochondrial biogenesis, one could postulate that it is also involved in 
the regulation of mitochondrial mass in AgRP neurons which is important for energy balance 
regulation. Likewise, PPARγ, an important regulator of FAO that interacts with PGC-1α 
(Puigserver, Wu et al. 1998), has been recently shown to control energy balance in the arcuate 
nucleus. Its activation is sufficient to promote AgRP/NPY gene expression and increase food 
intake through AgRP neurons (Garretson, Teubner et al. 2015). Whether it is also interacting 
with PGC-1α in AgRP neurons to modulate food intake remains unclear and would be worth 
studying. 
 
2. Limitation of the study and potential complementary 
experiment 
Although we reported alterations in energy balance upon PGC-1α deletion in AgRP 
neurons, we observed only a mild phenotype in this mouse model and no phenotype upon PGC-
1α ablation in POMC neurons. This could be due to residual expression of PGC-1α in 
AgRP/POMC neurons. Indeed, even though we detected a recombination indicating the deletion 
of PGC-1α in arcuate nucleus punches and the restriction of this deletion to the arcuate nucleus, 
this does not preclude that some AgRP/POMC neurons still express normal PGC-1α levels and 
does not indicate how much PGC-1α expression is reduced in the targeted neurons. Multiple 
methods have been used to determine the efficiency of PGC-1α deletion with a lack of success 
for different reasons. In a first attempt, we measured PGC-1α mRNA levels in arcuate nucleus 
punches without observing a significant reduction. This is likely due to non-AgRP/POMC neurons 
present in the cell extract that still express the coactivator. Reporter mouse lines expressing 
EGFP in AgRP or POMC neurons have been generated to visualize PGC-1α content in those 
neurons after immunostaining. Unfortunately, several PGC-1α antibodies have been tested and 
none of them was specific as indicated by the positive signal detected in the arcuate nucleus of 
PGC-1α global knock-out mice. Therefore, residual PGC-1α expression might still enable most of 
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its activity and mask a more serious phenotype. On the other hand, we experienced difficulties 
in generating large groups of animals for the AgRP-PGC-1α KO line because half of the 
littermates were genotyped as global knock out animals. This forced us to conduct experiments 
with several cohorts of animals when high numbers of mice were required, which increased 
variability and reduced the number of animals that could be used for some experiments. To 
avoid this issue, we could have tried to generate a second knock out mouse line with the 
tamoxifen-inducible AgRP-cre mouse models recently developed by Elmquist and colleagues 
(Berglund, Liu et al. 2013, Wang, Liu et al. 2014). 
 
In addition to the results obtained in this study, complementary experiments supporting 
the effect of PGC-1α in the arcuate nucleus could have been performed. For example, 
stereotaxic injections of resveratrol could have increased the AMPK/SIRT1-mediated activation 
of our transcriptional coactivator. This would have allowed us to measure the consequences of 
PGC-1α activation in AgRP neurons. In addition, the abrogation of the resveratrol effect upon 
PGC-1α deletion would have confirmed the role of the coactivator in mediating resveratrol 
action in the arcuate nucleus. However, while some works indeed presented an activation of the 
SIRT1/PGC1α pathway in muscle (Lagouge, Argmann et al. 2006), our laboratory recently 
showed that PGC-1α was dispensable for the systemic effect resveratrol and observed only 
marginal effects of this compound in muscle (Svensson, Schnyder et al. 2015). Moreover, our 
research group lacked the expertise in that kind of neuronal treatment. We therefore decided 
that those experiments were not valuable enough regarding the mild phenotype we observed in 
our mice and the possible failure of PGC-1α activation upon resveratrol treatment. 
 
Similarly, since the deletion of PGC-1α resulted in a mild or a complete absence of 
phenotype our mice, another interesting long term experiment would have been to establish 
mouse models with constant overexpression of PGC-1α in AgRP and POMC neurons. Indeed, in 
muscle, PGC-1α overexpression leads to much more drastic effects and remodeling than its 
ablation. For example, as we showed in this thesis, muscle loss of PGC-1α only impaired 
OXPHOS protein and mRNA levels while its overexpression led to a greater increase in 
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mitochondrial densities and function. It would therefore be interesting to evaluate whether 
increased PGC-1α content in POMC and AgRP neurons would result in larger alterations of 
whole body homeostasis than its deletion.  
3. PGC-1α and PGC-1β share a redundant function in the 
arcuate nucleus 
Alternatively, compensatory mechanisms may have blunted more severe dysfunctions 
caused by the absence of PGC-1α in AgRP and POMC neurons. PGC-1β shares many common 
functions and expression levels with its close homolog PGC-1α in several organs (Wu, 
Puigserver et al. 1999, Lin, Puigserver et al. 2002, Uldry, Yang et al. 2006, Lai, Leone et al. 
2008, Wareski, Vaarmann et al. 2009, Wenz, Rossi et al. 2009, Shao, Liu et al. 2010, Mitra, 
Nogee et al. 2012). For example, both PGC-1α and PGC-1β regulate mitochondrial mass in 
neurons (Wareski, Vaarmann et al. 2009). Moreover, PGC-1β is up and downregulated upon 
PGC-1α ablation and overexpression, respectively, in muscle (data not shown), strongly 
indicating a compensatory role for PGC-1β in the absence of PGC-1α. Finally, PGC-1β has been 
shown to control basal mitochondrial dynamics, whereas PGC-1α controls mitochondrial 
function upon enhanced energetic demand, such as exercise challenge (Baar, Wende et al. 
2002, Zorzano 2009). Thus, AgRP and POMC neuronal function might rely on basal 
mitochondrial metabolism and dynamics that can be sustained by PGC-1β in the absence of 
PGC-1α. For instance, PGC-1α does not influence AgRP expression in basal conditions but is 
important for AgRP induction upon fasting, thus supporting a role for PGC-1α in AgRP neurons’ 
adaptability to alterations in the energetic status. In this context, further studies including both 
single knock-outs of PGC-1β and double knock-outs of PGC-1α/PGC-1β in AgRP and POMC 
neurons are required to address the role of PGC-1β in the arcuate nucleus and its redundancy 
with PGC-1α. In light of those elements, we recently decided to generate mice with PGC-1β 
ablation in AgRP and POMC neurons with the same methods that were used for the generation 
of the AgRP-PGC1α KO and POMC-PGC1α KO mice. 
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Similarly to what we did to study the role of PGC-1α in the arcuate nucleus, we 
characterized the phenotype of AgRP-PGC1β KO and POMC-PGC1β KO animals by measuring 
body composition, whole body metabolism and energy expenditure. In line with what we 
observed in AgRP-PGC1α KO mice, deletion of PGC-1β in AgRP neurons tended to increase 
relative fat mass in the mice (Fig. 1a). Although RER was not changed, mice lacking PGC-1β in 
AgRP cells presented significantly reduced oxygen consumption during the light phase in basal 
conditions and a tendency towards lower O2 consumption during the dark period (Fig. 1b and 
c). Correlating to lower VO2 uptake, AgRP-PGC1β KO animals exhibited diminished energy 
expenditure during light time (Fig. 1d), reminiscent of the lower body temperature and 
locomotor activity we observed in AgRP-PGC1α KO mice. To evaluate how PGC-1β deletion 
would affect the mice's adaptability to energetic challenges, AgRP-PGC1β KO and controls 
animals were fasted for 24h. In agreement with data observed in basal conditions, AgRP-PGC1β 
KO mice presented a reduction in both oxygen consumption and a tendency towards lower 
energy expenditure during the re-feeding period compared to control animals (Fig. 1e and f). 
Similarly to AgRP-PGC1α KO animals, this preliminary data suggests that lower energy 
expenditure of AgRP-PGC1β KO mice could result in the tendency towards higher fat mass 
observed in those animals. Interestingly, the redundant results between the phenotypes 
triggered by PGC-1α and PGC-1β  deletion in AgRP neurons strongly suggest that both 
coactivators share similar functions in those cells and that they can each compensate for the 
deletion of the other. Regarding the consequences of the deletion of PGC-1β in POMC neurons, 
no differences were observed in body composition, oxygen consumption, fat utilization or 
energy expenditure in both basal and fasted conditions (Fig. 2a-f). This was again in agreement 
with what we observed when PGC-1α was ablated in those neurons. To complete the 
phenotypic characterization of POMC-PGC1β KO mice we implanted transmitters in their belly 
as we did with our AgRP-PGC1α KO mice in our previous study. In addition to the absence of 
changes in basal metabolism, no alteration of locomotor activity was detected in mice with PGC-
1β deletion in POMC neurons (Fig .2g). However, POMC-PGC1β KO presented an increase in 
their core body temperature, which neared significance in the light period and was significant in 
the dark period (Fig. 2h). Interestingly, in a very short pilot experiment, we evaluated the body 
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temperature of POMC-PGC1α KO animals and found that they also had a reduced body 
temperature compared to control animals, especially during fasting (data not shown), further 
attesting to the redundancy of the phenotypes triggered by the single deletion of each 
homolog. This strengthens the hypothesis of a compensatory mechanism upon single deletion 
of each coactivator in those neuronal cells. Taken together, the data seems to indicate distinct 
roles for the coactivators in AgRP and POMC neuronal cells. To follow up on those interesting 
results, a complete characterization of AgRP-PGC1β KO animals should be done, similarly to 
what has been done in AgRP-PGC1α KO mice, to define how similar the functions of the 
different PGC-1 factors are in AgRP cells. Also, according to our new preliminary data, PGC-1β 
and possibly PGC-1α regulates core body temperature in POMC neurons. Consequently, further 
experiments modulating core body temperature, such as leptin or noradrenaline injection and 
cold exposure, should be done with POMC-PGC1α/β KO animals to evaluate the role of the 
coactivators in adaptation to such energetic challenges. Additionally, it would be of interest to 
determine BAT activation, WAT browning and heat dissipation in those animals. Finally, since 
PGC-1β and PGC-1α might share a similar role in the arcuate nucleus, it would be particularly 
informative to compare single and double knock-out animals in order to establish how 
redundant the two coactivators are and possibly unravel a much stronger phenotype by 
preventing their compensatory functions. 
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Figure 1: Consequences of PGC-1β deletion in AgRP neurons on whole body metabolism (a) 
Relative body composition measured by echoMRI (n=12-16). (b-f) Oxygen consumption, 
respiratory exchange ratio and energy expenditure measured in the CLAMS system in fed and 
fasted conditions in AgRP-PGC1β KO and WT mice (n=8). Values and error bars represent the 
mean ± SEM. *p<0.05 ; **p<0.01 indicate statistically significant differences between 
genotypes. 
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Figure 2: Consequences of PGC-1β deletion in AgRP neurons on whole body metabolism (a) 
Relative body composition measured by echoMRI (n=8). (b-f) Oxygen consumption, respiratory 
exchange ratio and energy expenditure measured in the CLAMS system in fed and fasted 
conditions in AgRP-PGC1β KO and WT mice (n=7-8). (g and h) Locomotor activity and core body 
temperature measured by intraperitoneally implanted transmitters (n=7-8). Values and error 
bars represent the mean ± SEM. **p<0.01 indicate statistically significant differences between 
genotypes.  
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4. Summary and outlook of the general role of PGC-1α in the 
brain as a metabolic sensor  
Given the effect of PGC-1α modulation on mouse models of neurodegenerative diseases, 
its low expression in patients with neurological disorders and the neurodegeneration triggered 
by its ablation in the brain, studies determining the role of PGC-1α in the central nervous system 
have been highly focused on neuronal survival to date. Very few studies suggested a role for 
PGC-1α in the control of energy balance in the brain. One of them demonstrated that PGC-1α 
controls oxytocin expression, a hypothalamic neuropeptide responsible of appetite regulation, 
in zebrafish (Blechman, Amir-Zilberstein et al. 2011). Yet, no data showing actual dysregulation 
of food intake or energy balance was presented in this work. Another study reported increased 
food intake, locomotor activity and body temperature and reduced fasting induction of feeding 
peptides expression in PGC-1α brain knock-out mice, suggesting a possible role for the 
transcriptional coactivator in energy balance regulation. Nevertheless, the aforementioned 
alterations could also arise from indirect consequences of PGC-1α deletion in different brain 
areas or secondary peripheral tissue dysregulations. The dramatically opposite phenotype 
triggered by specific ablation of PGC-1α in AgRP neurons compared to the one observed upon 
PGC-1α whole brain or whole body deletion strongly support this hypothesis. Therefore, our 
study revealed for the first time the true function of PGC-1α in the arcuate nucleus and its role 
as a metabolic sensor in the brain. Notably, its increase upon fasting in the AgRP neuronal cell 
line and in the hypothalamus, as well as the abrogation of leptin response upon its deletion, 
demonstrates that PGC-1α is able to sense metabolic signals in the arcuate nucleus. Moreover, 
similarly to the exercise induced production of myokines in muscle, PGC-1α regulates AgRP 
expression in the arcuate nucleus, which in turn affects various tissues via the regulation of 
other brain areas. This reveals a central function for PGC-1α in the integration of metabolic 
signals by AgRP neurons. Finally, the dysregulation of food intake and energy expenditure in 
AgRP-PGC1α KO animals establishes the importance of neuronal PGC-1α expression for 
downstream regulation of whole body energy balance. PGC-1α is therefore necessary for both 
signal integration and the according appropriate control of whole body metabolism by AgRP 
neurons. 
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The role of PGC-1α in the regulation of whole body homeostasis is further supported by 
the fact that global deletion of PGC-1α impairs circadian rhythms in mice (Liu, Li et al. 2007) and 
that its expression follows a circadian pattern in the arcuate nucleus. However, the circadian 
oscillation of PGC-1α has only been established in POMC neurons (Agapito, Zhang et al. 2014) 
and it would be interesting to investigate whether it also follows a similar pattern of expression 
in AgRP neurons. Given the highlighted role of PGC-1α in arcuate nucleus nutrient sensing, the 
transcriptional coactivator now becomes a potential player in other brain processes requiring 
integration of metabolic signals. Nutrient sensing is not only important for food intake and 
energy expenditure regulation, but also for the control of multiple whole body homeostatic 
parameters that are regulated by the brain. For example, glucose sensing in the brain is very 
important because neurons requires a constant supply of glucose as fuel and for the regulation 
of their activity. Glucose transporter 2-dependent glucose sensing is an important mechanism 
for glucose level evaluation (Steinbusch, Labouebe et al. 2015). Interestingly, PGC-1α has been 
shown to regulate this glucose transporter (Yoon, Xu et al. 2003, Valtat, Riveline et al. 2013) 
and could therefore be important for glucose sensing in neurons. Furthermore, PGC-1α also 
influences expression of glucokinases (Yoon, Xu et al. 2003, Zhu, Liu et al. 2010), which play an 
important role in glucose sensing in the ventromedial nucleus of the hypothalamus (Kang, 
Dunn-Meynell et al. 2006). 
 
Fatty acids sensing in the brain is another mechanism for controlling energy balance and 
glucose homeostasis. Central administration of long-chain FA oleate reduces feeding and 
glucose production in rats (Obici, Feng et al. 2002, Morgan, Obici et al. 2004). Moreover, 
animals with specific ventromedial hypothalamus deletion CD36 present higher plasma leptin 
levels and exhibit subcutaneous fat depots with an abnormal glucose tolerance. Of note, PGC-
1α promotes lipogenesis in muscle (Summermatter, Baum et al. 2010), fatty acid metabolism in 
different tissue (Gerhart-Hines, Rodgers et al. 2007, Morris, Meers et al. 2012) and regulates 
CD36 levels in muscle (Summermatter, Baum et al. 2010). Thus, PGC-1α might also be 
implicated in fatty acids signaling in the brain. Furthermore, PPARγ activation induces AgRP 
expression increase in AgRP neurons and food intake (Garretson, Teubner et al. 2015). Given 
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PPARs function in fatty acids metabolism (Georgiadi and Kersten 2012) and the known 
interaction between PPARγ and PGC-1α, their collaboration could also help in fatty acids sensing 
and downstream regulation of energy homeostasis in AgRP neurons. Finally, high fat diet and 
fatty acids treatments downregulate hypothalamic PGC-1α expression, thereby dysregulating 
ERα levels and inducing hypothalamic inflammation (Morselli, Fuente-Martin et al. 2014). This 
data further attests for a critical function of PGC-1α in cellular responses to fatty acids signaling 
in the hypothalamus.  
 
To conclude, this work has now unraveled a new function for PGC-1 coactivators in the 
brain and identifies them as metabolic sensors in this tissue. It also shows that the recent 
emerging function of PGC-1α as a regulator of systemic homeostasis, discovered in the muscle 
through the regulation of myokines secretions, extend to the brain and therefore probably to 
other tissues. On the other side, this global coordinated response of PGC-1α in many metabolic 
tissues upon specific stimuli, followed by the coordinated output given by the coactivator 
further establishes him as a powerful controller of systemic homeostasis. 
 
B. The role of PGC-1α in skeletal muscle aging  
Skeletal muscle undergoes broad and varied changes while it ages, ultimately leading to 
muscle atrophy and dysfunction (see Introduction Fig. 6). During the past decades, an increasing 
number of studies reported that muscle aging was associated with mitochondrial dysfunctions, 
which occur at many different levels in the old mitochondria. Notably, muscle mitochondrial 
aging includes reduced mitochondrial mass (Barazzoni, Short et al. 2000, Conley, Jubrias et al. 
2000, Short, Bigelow et al. 2005), diminished respiratory capacities (Short, Vittone et al. 2004, 
Short, Bigelow et al. 2005), increased oxidative stress (Mansouri, Muller et al. 2006, Chabi, 
Ljubicic et al. 2008) leading to mtDNA mutations (Chabi, Mousson de Camaret et al. 2005), 
impaired mitochondrial dynamics and turnover (Crane, Devries et al. 2010, Ibebunjo, Chick et 
al. 2013), and compromised calcium homeostasis regulation (Fernandez-Sanz, Ruiz-Meana et 
al. 2014, Pietrangelo, D'Incecco et al. 2015).  
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This large panel of mitochondrial alterations prompted the scientific community to look 
for treatments, or signaling pathway modifications, to improve mitochondrial wellness as a 
potential therapy against skeletal muscle aging. For example, a study took advantage of a 
mouse model expressing the human catalase targeted to the mitochondria to study the effect of 
reduced oxidative stress on muscle aging. As expected, these animals exhibited lower oxidative 
stress, but also lower mtDNA deletion and an increased lifespan, thus demonstrating the 
importance of mitochondrial ROS in muscle and whole body aging (Schriner, Linford et al. 
2005). A more recent study revealed that this mouse model also presented with increased 
muscle specific force, with higher tetanic calcium transients, decreased intracellular calcium 
leakage and higher SR calcium load (Umanskaya, Santulli et al. 2014), further supporting the 
link between mitochondrial dysfunction and impaired calcium homeostasis during aging. 
Treatment with SRT1720, a known activator of SIRT1 and mitochondrial function, improved 
mice lifespan and health span and reduced age-related risk factors of metabolic diseases 
(Mitchell, Martin-Montalvo et al. 2014). In addition, caloric restriction and exercise, which both 
increase mitochondrial function (Lee, Aspnes et al. 1998, Konopka and Sreekumaran Nair 2013, 
Barbieri, Agostini et al. 2015), are considered as some of the best treatments against age-
associated muscle dysfunctions and substantially ameliorate mitochondrial disorders in skeletal 
muscle (Marzetti, Lawler et al. 2008, Anderson, Shanmuganayagam et al. 2009, Konopka and 
Sreekumaran Nair 2013, Cartee, Hepple et al. 2016). 
 
PGC-1α expression levels decrease with aging (Chabi, Ljubicic et al. 2008, Wenz, Rossi et 
al. 2009, Ghosh, Lertwattanarak et al. 2011, Kang, Chung et al. 2013). Since PGC-1α is a master 
mitochondrial regulator, several studies made use of its regulatory function to improve 
mitochondrial capacities in the context of muscle aging. PGC-1α overexpression alleviated age-
associated muscle disorders in models of pre-mature aging (Sahin, Colla et al. 2011, Dillon, 
Williams et al. 2012) as well as during natural aging in the mouse (Wenz, Rossi et al. 2009).  
 
In this thesis, we confirmed that muscle PGC-1α overexpression ameliorates the overall 
phenotype of aged mitochondria, notably by regulating mitochondrial respiration, but also by 
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modulating mitochondrial dynamics and calcium handling in aging muscle. This contributes to 
preserve cellular calcium content and homeostasis, thereby preventing tubular aggregate 
formation and protecting against ER stress, which ultimately alleviates age-associated muscle 
apoptosis. For example, PGC-1α prevented the downregulation of several proteins involved in 
mitochondrial OXPHOS, dynamics and calcium import in aged muscles and blunted the age-
dependent increase of important ER stress and cell death markers. During this thesis, we 
additionally reported that the above-mentioned PGC-1α-controlled mitochondrial regulations 
were ERRα dependent. Moreover, this thesis showed that muscle PGC-1α overexpression 
rescued the majority of the dysfunctions observed in old muscles, including endurance, balance 
and motor coordination, which ultimately led to preserved locomotor activity. Finally, this thesis 
also used a mouse model that is deficient in muscular PGC-1α expression to show that loss of 
PGC-1α accelerates the age-related loss of balance and muscle force and results in a premature 
sarcopenia.  
 
1. PGC-1α counters aging via regulation of mitochondrial 
function and dynamics 
In a previous study investigating the impact of PGC-1α overexpression in muscle aging, 
authors demonstrated that OXPHOS decline, increased oxidative stress and impairments of 
other non-mitochondrial muscle processes could be improved by PGC-1α elevation in the old 
muscle (Wenz, Rossi et al. 2009). While we confirmed that PGC-1α muscle overexpression 
preserved mitochondrial respiratory capacities, our results from the PGC-1α muscle deficient 
mice now further support the idea that PGC-1α downregulation in aging muscle might be one of 
the triggers for age-associated muscle disorders. For example, young PGC-1α deficient mice 
presented with reduced OXPHOS protein expression and premature sarcopenia, suggesting that 
mitochondrial defects contribute to premature muscle dysfunctions. However, our data from 
the young PGC-1α deficient mice did not reveal the expected changes in mitochondrial densities 
and mitochondrial respiration, implying that aggravated muscle disorders are not linked to an 
impaired mitochondrial oxidative capacity. Yet, other age-associated mitochondrial or cellular 
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dysregulations not studied in this work, such as increased oxidative stress (Bejma and Ji 1999, 
Capel, Rimbert et al. 2005) or excitation-contraction uncoupling (Renganathan, Messi et al. 
1997, Delbono 2000), may be mimicked by genetic deletion of PGC-1α and lead to the observed 
phenotype. Alternatively, our data on post exercise blood lactate amount and mRNA levels of β-
oxidation genes indicated a lower fatty acids oxidation rate in young and old muscle lacking 
PGC-1α. The impaired fatty acid oxidation could therefore lead to lower muscle ATP production 
and function in spite of normal mitochondrial oxidative function. Finally, in addition to 
preserving mitochondrial respiration in the old muscle, we now also showed that PGC-1α 
alleviated muscle and mitochondrial aging by improving other components of mitochondrial 
metabolism, namely mitochondrial dynamics and mitochondria-SR association via MAM protein 
regulation.  
 
Mitochondrial dynamics are an important element of mitochondrial homeostasis. Mouse 
models with specific muscle deletions of Mfn 1 or 2, genes regulating mitochondrial fusion, 
exhibit increased mtDNA deletion, higher depletion rates in mitochondrial DNA copy numbers 
and elevated muscle loss (Chen, Vermulst et al. 2010). On the other hand, fission proteins, such 
as Fis1 or Drp1, are also essential for mitochondrial quality control as they allow damaged 
mitochondria to be severed from the network and to enter mitophagy. Yet, they also represent 
an amplifying circle in muscle atrophy, where the muscle is already often subjected to 
mitochondrial depletion (Romanello, Guadagnin et al. 2010). Therefore, age-associated 
imbalance in mitochondrial dynamics through lower and higher expression of fusion and fission 
proteins, respectively, shown in this work and by others (Crane, Devries et al. 2010), certainly 
impacts mtDNA quality, oxidative capacities, ROS production and cell death. Recently reported 
in a model of disuse muscle atrophy, PGC-1α prevented reduction of mitochondrial fusion 
proteins and muscle mass loss (Cannavino, Brocca et al. 2015), further supporting the positive 
effect mediated by increased mitochondrial dynamics. The increase of Mfn2 and Drp1 gene 
expression in a mouse model of Duchenne muscular dystrophy was proposed to be a 
compensatory mechanism to meet the increased energetic demand of dystrophic muscles 
(Pant, Sopariwala et al. 2015). This constitutes another possible mechanism by which PGC-1α 
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overexpression alleviates the Duchenne muscular dystrophy phenotype in this mouse model 
(Handschin, Kobayashi et al. 2007). In the context of muscle aging, the increase of both fusion 
and fission protein expression in our PGC-1α muscle overexpressing animals likely restores the 
balance in mitochondrial dynamics during muscle aging and improves muscle function.  
 
Mitochondrial interaction with the SR is another important feature of mitochondrial 
metabolism that is impaired with age. Mitochondrial ATP production relies on calcium 
stimulations that mitochondria receive from calcium release subunits contained in the 
junctional SR and T tubules (Brookes, Yoon et al. 2004), which requires proper associations 
between mitochondria and SR (Franzini-Armstrong and Boncompagni 2011). Recent 
investigations in old mouse muscle showed age-associated mitochondria-SR disruption, 
misplaced mitochondria with regard to their normal position along calcium release subunits, 
and increased distances between mitochondria and SR (Fernandez-Sanz, Ruiz-Meana et al. 
2014, Pietrangelo, D'Incecco et al. 2015). In addition, disruption of mitochondria-SR association 
in young cardiomyocytes mimicked age-induced changes in calcium handling and impaired 
calcium transfer to the mitochondria (Fernandez-Sanz, Ruiz-Meana et al. 2014). Our work 
indicated that PGC-1α could control and improve mitochondrial association with SR through 
regulation of MAM protein expression, physically connecting mitochondria and SR. We found 
lower gene and protein expression levels of several MAM elements in the old muscle, including 
mitofusins, GRP75 and VDAC. We also reported increased levels of those MAM proteins in 
young and old animals with elevated PGC-1α expression, and conversely a premature decline in 
their levels in young muscle lacking PGC-1α. These results demonstrate that these genes are 
tightly regulated by the transcriptional coactivator and strongly suggest that PGC-1α could also 
control and restore functional mitochondrial-SR association in the old muscle. A key experiment 
firmly confirming this hypothesis would be the actual quantification of mitochondria-SR 
contacts and assessment of proper mitochondrial positioning. While preliminary measurements 
indicated an unchanged number of overall muscle mitochondrial-SR contacts with age and upon 
PGC-1α modulation (data not shown), it would be more informative to evaluate the proportion 
of SR that is in contact with mitochondria and not just the total number of contacts. In addition, 
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increased levels of MAM proteins by PGC-1α might not lead to increased number of contacts 
but might rather strengthen and improve each connection between mitochondria and SR, or 
increase the capacity of mitochondria to create new associations with SR when required. This is 
also in line with the fact that PGC-1α ameliorates mitochondrial responses to environmental 
changes and improves mitochondria dynamics. 
 
2. PGC-1α regulates calcium content and homeostasis during 
aging 
Our laboratory previously showed that PGC-1α could remodel cellular calcium 
homeostasis by altering SR protein expression and activity, thereby impacting muscle function 
(Summermatter, Thurnheer et al. 2012). The alterations of MAM protein expression mentioned 
above indicates that PGC-1α might also affect cellular calcium balance by improving the 
connection between SR and the mitochondria. Finally, in this thesis we demonstrated that PGC-
1α modulated cellular calcium handling through elevation of mitochondrial calcium uptake in 
muscle overexpressing PGC-1α. Increased calcium uptake was correlated with higher expression 
of genes and proteins crucial for mitochondrial calcium import such as MCU and VDAC. 
Importantly, increased calcium uptake volume for each mitochondrion combined with the larger 
number of mitochondria found in muscles with elevated PGC-1α levels confers those muscles 
with an extreme potential to modulate calcium import and excessive intracellular calcium levels. 
For example, upon high energetic demand—when mitochondria require more calcium to 
increase oxidative metabolism (McMillin and Madden 1989)—or upon  toxic myoplasmic 
calcium concentrations (Kass and Orrenius 1999), increased mitochondrial calcium import can 
be beneficial and allow mitochondria to better adapt to environmental changes. Interestingly, 
Pietrangelo and collaborators reported that mitochondrial calcium uptake is reduced in skeletal 
muscle of aged mice, in addition to the disruption of mitochondrial-SR communication 
(Kavanagh, Ainscow et al. 2000, Pietrangelo, D'Incecco et al. 2015), thereby possibly 
contributing to the reduction in activity-dependent ATP production in old muscles (Drew, 
Phaneuf et al. 2003, Nair 2005). Correlating with those data, mitochondrial calcium uptake 
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upon SR stimulated calcium release was found to be reduced in the hearts of old mice. This was 
concomitant with impaired VDAC-RYR communication, which reflects dysfunctional 
mitochondrial-SR interactions, and decreased NADPH regeneration (Fernandez-Sanz, Ruiz-
Meana et al. 2014). In addition, muscle specific deletion of the mitochondria uniporter MCU 
leads to reduced pyruvate dehydrogenase activity and O2 consumption upon calcium 
stimulation (Pan, Liu et al. 2013). Improved mitochondrial calcium uptake and mitochondrial-SR 
communication thus likely contribute to preserve ATP production and mitochondrial respiration 
in old muscle containing increased PGC-1α content. 
 
In addition to reduced oxidative functions, age-associated decrease in mitochondrial 
calcium uptake also correlates with increased resting cytosolic calcium content in both heart 
(Nitahara, Cheng et al. 1998) and muscle (Squier and Bigelow 2000, Fraysse, Desaphy et al. 
2006) of aged animals. Although age-related increase in SR calcium leak due to RYR oxidation 
(Andersson, Betzenhauser et al. 2011) and impaired calcium SR re-uptake (Hunter, Thompson 
et al. 1999) definitely account for the increased calcium levels in old muscle, mitochondria have 
also been shown to modulate intracellular calcium homeostasis and signaling, as well as cellular 
metabolism by buffering cytosolic calcium (Rizzuto, De Stefani et al. 2012). Notably, an 
amyotrophic lateral sclerosis mouse model (that displays impaired mitochondrial inner 
membrane potential and dysfunctional mitochondrial calcium uptake at the NMJ) allowed 
researchers to study the effect of mitochondrial calcium uptake defect (Yi, Ma et al. 2011). 
Using the mitochondria-targeted calcium biosensor, mt11-YC3.6, the authors found a 
diminished calcium uptake only in the fiber segment with depolarized mitochondria after 
voltage-stimulated SR calcium release, which mirrored an increased cytosolic calcium level in 
the same region. This clearly demonstrated the key role of mitochondrial calcium uptake in 
maintaining cytosolic calcium concentrations during excitation-contraction coupling and 
suggests that dysfunctional mitochondrial calcium import could participate to muscle 
degeneration and force reduction in amyotrophic lateral sclerosis and therefore possibly in the 
aged muscle. To follow up on this hypothesis, it would be interesting to investigate the 
consequences of impaired mitochondrial calcium uptake on cellular calcium homeostasis during 
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muscle aging. Of note, muscle specific deletion of MCU mimics age-associated reduction in 
mitochondrial calcium import in young animals, as well as loss of endurance and maximal and 
isometric strength (Pan, Liu et al. 2013). Other recent studies showed that MCU-dependent 
calcium uptake prevents muscle atrophy through the control of hypertrophic pathways in the 
muscle (Chemello, Mammucari et al. 2015, Mammucari, Gherardi et al. 2015). One could thus 
evaluate whether MCU deletion in muscle would promote age-induced intracellular calcium 
homeostasis disruption and the resulting consequences on excitation-contraction coupling, 
muscle mass and muscle dysfunction during aging. Intriguingly, one of the hypertrophy axis 
controlled by MCU implicates the PGC-1α4 isoform, indicating that while PGC-1α regulates MCU 
expression, the calcium uniporter feeds a positive regulatory feedback loop resulting in 
increased PGC-1α4 expression (Mammucari, Gherardi et al. 2015). This increases the interest in 
assessing the outcomes of combined modulation of PGC-1α and MCU levels in muscle to 
investigated how the alteration of one factor would abrogate or potentiate the effect of the 
other, in particular in the context of muscle aging.  
 
3. PGC-1α protects against tubular aggregate formation 
Since calcium controls many key cellular functions, disruption of calcium homeostasis in 
muscle can lead to cell damage (Kass and Orrenius 1999) and cellular stress responses, such as 
ER stress, which is designed to restore cellular homeostasis (Kania, Pajak et al. 2015, Krebs, 
Agellon et al. 2015). During muscle aging, we and others found increased levels of ER stress 
markers (Dirks and Leeuwenburgh 2004, Chung and Ng 2006, Ogata, Machida et al. 2009), 
correlating with impaired mitochondrial calcium uptake and mitochondria-SR interaction and 
with the rise in cytoplasmic calcium levels (Fraysse, Desaphy et al. 2006, Pietrangelo, D'Incecco 
et al. 2015). Age-induced tubular aggregates constitute another indicator of the strong 
remodeling through which SR goes during muscle aging (Agbulut, Destombes et al. 2000). 
Nevertheless, it is unknown whether those structures represent a consequence of unresolved 
ER stress or a compensatory mechanism of the SR to buffer excessive intracellular calcium upon 
diminished mitochondrial calcium import. In line with the latter hypothesis, we reported that 
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tubular aggregates cannot be found in aged muscles overexpressing PGC-1α, which present an 
enhanced capacity to buffer intracellular calcium. A recent publication showed that mice with 
muscle specific deletion of the MCU regulator, MICU1, exhibited both impaired mitochondrial 
calcium intake and tubular aggregate formation at a young age (Liu, Liu et al. 2016). This further 
strengthens the connection between tubular aggregate development, calcium homeostasis 
disruption and mitochondrial calcium import decline. Other experiments linking calcium 
dysregulation and SR masses showed that Csq1 and SERCA1, two SR regulators important for 
calcium homeostasis, are required to accumulate during SR clustering for the formation of 
tubular aggregate (Boncompagni, Protasi et al. 2012). Csq1 muscle-specific deletion led to 
incomplete development of tubular aggregate. Taken together, those results suggest that 
reduced accumulation of Csq1 in old muscle with elevated PGC-1α levels might contribute to 
prevent tubular aggregate formation. This is supported by our findings demonstrating that PGC-
1α controls Csq1 levels in a cell autonomous manner, which strongly indicates that Csq1 
downregulation in old transgenic muscle is not a secondary consequence of improved calcium 
homeostasis or absent tubular aggregates. Finally, we reported that old muscle lacking PGC-1α 
presented a large increase in number of fibers containing tubular aggregates. This is in 
agreement with another study showing that muscle specific PGC-1α deletion triggers the 
formation of SR aggregates in myofibers of a muscle disuse mouse model (Vainshtein, 
Desjardins et al. 2015). These data further support the key role of PGC-1α in the protection 
against tubular aggregate development in the context of muscle disorders and atrophy. 
 
To investigate the exact processes through which PGC-1α protects muscle from tubular 
aggregate formation, one should take advantage of mouse models exhibiting tubular aggregates 
and evaluate how PGC-1α modulation affects tubular aggregate development in the muscles of 
those mice and through which mechanisms. For example, in muscle with PGC-1α ablation, it 
would be of interest to define which elements or pathways modulated by PGC-1α trigger 
tubular aggregate formation upon denervation induced atrophy (Vainshtein, Desjardins et al. 
2015). Mice with muscle specific ablation of Caveolin protein expression develop tubular 
aggregates (Schubert, Sotgia et al. 2007) and represent another great model to evaluate how 
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PGC-1α protects muscle from such abnormalities. Notably, mice with caveolin 2 muscle specific 
deletion present abnormal SR organization, and therefore possible dysregulation of 
mitochondrial-SR communication, as well as impaired mitochondrial calcium regulation, possibly 
resulting in the observed tubular aggregates. These mice constitute an excellent model to 
determine whether PGC-1α prevents the development of tubular aggregates by improving 
mitochondrial control of calcium homeostasis. Alternatively, a combination of muscle-specific 
PGC-1α overexpression and MCU deletion would allow us to define the role of mitochondrial 
calcium uptake in the PGC-1α-mediated protection against tubular aggregates during muscle 
aging. Lastly, mutations in both STIM1 and ORA1 genes have recently been shown to trigger 
tubular aggregate myopathies in humans, accompanied by altered calcium homeostasis (Bohm, 
Chevessier et al. 2013, Endo, Noguchi et al. 2015, Okuma, Saito et al. 2016). Expression of the 
STIM1 mutant in cells similarly alters calcium homeostasis (Okuma, Saito et al. 2016). Based on 
these results and ours, one could overexpress PGC-1α concomitantly with the STIM1 mutant to 
see if PGC-1α can restore calcium homeostasis in those cells. Even more interesting would be to 
express those different mutated proteins in mouse muscles to determine whether alterations of 
calcium homeostasis indeed generate tubular aggregates and ultimately study the mechanism 
of their development and the impact of PGC-1α modulation on their formation. 
 
It is interesting to note that tubular aggregates are completely absent in aged oxidative 
soleus muscle and are only present in glycolytic fibers weakly stained for SDH in the TA of old 
WT mice in our study. Additionally, patients presenting tubular aggregates exhibit lower muscle 
fiber respiration rates and reduced OXPHOS complex activities than healthy patients (Vielhaber, 
Schroder et al. 2001). Intriguingly, muscle of patients that displayed tubular aggregates that did 
not stain for SR proteins – implying that the aggregates did not originate from the SR – showed 
a concomitant lack of mitochondrial defects. This strongly suggests a functional link between SR 
generated tubular aggregates and mitochondrial dysfunctions. On top of that, one study 
showed in a human patient that 96% of fibers presenting tubular aggregates were cytochrome C 
oxidase deficient and that tubular aggregates and cytochrome C oxidase labeling were mutually 
exclusive, further strengthening the association between mitochondrial dysfunction and tubular 
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aggregate formation. Taken together, these results strongly suggest that improved oxidative 
metabolism and enhanced mitochondrial mass and function play a central role in the protection 
against tubular aggregate formation in old muscles with elevated PGC-1α levels. Whether this 
protection is associated with improved mitochondrial calcium buffering capacities enabled by 
the enriched mitochondrial mass and function of those muscles is still unclear.  
 
4. PGC-1α reduces age-associated ER stress and apoptosis 
PGC-1α was previously shown to induce ER stress response after exercise, which is 
required for muscle adaptation to physical activity (Wu, Ruas et al. 2011). In the same study, 
authors showed that increased PGC-1α levels were sufficient to promote ER stress responses. 
While the ER stress response represents a mechanism to preserve cellular homeostasis upon an 
acute exercise stimulus, the increased level of ER stress markers in old muscle likely originated 
from prolonged and unresolved ER stress. Thus, it is tempting to think that PGC-1α promotion of 
ER stress response in the muscles of young animals helps the muscle to respond faster and 
better to any future stimulus causing ER stress, thereby preventing muscles from developing 
unresolved ER stress and preventing stable age-related increase of ER stress markers. 
 
Prolonged ER stress—as well as other cellular dysfunctions, such as mitochondrial 
defects and altered calcium homeostasis—are strong promoters of muscle apoptosis (Kass and 
Orrenius 1999, Singh 2004, Dirks, Hofer et al. 2006, Szegezdi, Logue et al. 2006, Braga, Sinha 
Hikim et al. 2008, Meng and Yu 2010, Sano and Reed 2013). Interestingly, reduction in age-
related apoptosis induction in old muscles with enhanced PGC-1α content strongly correlated 
with alleviations of SR-burden, mitochondrial decline and dysregulation of calcium metabolism. 
This suggests that the lower cell death observed in muscle of old transgenic PGC-1α mice is a 
secondary consequence of the substantial reduction in myofiber damages and improved cellular 
homeostasis. However, a direct anti-apoptotic role for PGC-1α has previously been postulated in 
various tissues (Valle, Alvarez-Barrientos et al. 2005, Luo, Zhu et al. 2009, Wenz, Rossi et al. 
2009, Egger, Samardzija et al. 2012). We therefore induced apoptosis in C2C12 cells using 
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ceramide and showed that PGC-1α was able to protect cells even after acute cellular damages 
were initiated. This is done through the positive and negative regulation of anti- and pro- 
apoptotic genes, respectively. Ceramide induces cell death by the dysregulation of multiple 
pathways and through damage of several cellular components, including mitochondria, ER 
stress response and calcium metabolism (Siskind 2005, Thon, Mohlig et al. 2005, Liu, Xia et al. 
2014). Ceramide thus represented a chemical of choice to mimic age-induced apoptosis in a cell 
culture model. However, this did not allow us to determine whether PGC-1α could actually 
protect myofibers from cell death induced specifically by calcium homeostasis dysregulation.  
 
Thapsigargin (TGP) is a non-competitive inhibitor of SERCA that blocks SR calcium uptake 
(Lytton, Westlin et al. 1991) and promotes cell apoptosis through a dramatic increase of 
cytosolic calcium and ER stress (Chen, Chiang et al. 2000, Rao, Hermel et al. 2001). To establish 
whether PGC-1α helps muscle cells to deal with altered calcium homeostasis and protects 
myocytes from cell death induced by cytosolic calcium increase, we treated control cells and 
myocytes overexpressing PGC-1α with TGP in a short pilot study. Similarly to what we observed 
after ceramide treatment, PGC-1α protected muscle cells from TGP-induced apoptosis as 
indicated by microscopic pictures of C2C12 cells and a cell death assay. (Fig.3a and b). In line 
with reduced cell death, PGC-1α overexpression blunted the activation of caspase 3 and pH2AX 
protein induction, as well as the decrease in ppRB protein levels (Fig. 3c) upon TGP treatment. 
PGC-1α upregulation diminished p21 protein expression after both DMSO and TGP exposure but 
did not prevent its induction by TGP. Moreover, PGC-1α abolished or alleviated the upregulation 
of several cell death related genes after TGP treatment, further supporting a protective function 
against TGP apoptosis induction in muscle cells (Fig. 3d). Surprisingly however, when PGC-1α 
overexpression led to the downregulation of Noxa, similarly to what we observed during the 
ceramide experiment, TGP exposure reduced Noxa expression too. Also, contrary to ceramide, 
TGP did not increase p53 protein levels, indicating that ceramide and TGP induces apoptosis 
through different pathways. Conversely to cell death markers, PGC-1α did not prevent the 
induction of BIP protein expression and the upregulation of many ER stress genes upon the 
acute stimulus of TGP, which is in agreement with previously reported data (Wu, Ruas et al. 
V. Discussion and outlook 
 
 
257 
 
2011). PGC-1α overexpression even promoted the expression of several unfolded protein 
response genes in the absence of TGP exposure, further supporting the hypothesis that PGC-1α 
prepares muscle cells to better respond to ER stress stimuli. However, PGC-1α prevented the 
induction of ATF4 expression and of one of its target genes, xbp1. This suggests that PGC-1α 
might coordinately promote and blunt the induction of different ER stress pathways to 
ultimately restore SR homeostasis and prevent apoptosis. Further investigations are required to 
dissect the exact mechanism by which PGC-1α regulates ER stress. Nevertheless, PGC-1α-
mediated protection against TGP-induced cell death confirms that the coactivator protects 
muscle from cellular damages induced by calcium homeostasis dysregulation and helps muscle 
to deal with increased cytosolic calcium. This further supports the protective role for PGC-1α 
against age-related calcium homeostasis disruption during muscle aging. Whether this 
protective effect is mediated by improved ER stress, enhanced mitochondrial calcium buffering, 
higher SR calcium handling or through general apoptotic pathway inhibition remains to be 
determined.  
 
The combined cell death experiments using ceramide and TGP also highlight and firmly 
confirm the powerful pro-survival action of PGC-1α upon different apoptotic stimulus. Based on 
those results, one could extend the study on the anti-apoptotic effect of PGC-1α in different 
contexts, whereby cell death is induced by denervation, muscular dystrophies or metabolic 
myopathies (Tews 2002). In addition, knock-down or forced expression of different elements 
involved in the different apoptotic pathways, such as mPTP opening, or caspase-dependent and 
independent pathways, in combination with PGC-1α overexpression and TGP or ceramide 
treatment would provide valuable information on the apoptotic or survival mechanism that 
PGC-1α alters to prevent cell death. 
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Fig. 3: PGC-1α protects from thapsigargin-induced cell death (a) Representative picture of 
C2C12 myoblasts expressing endogenous or increased PGC-1α levels after TGP or DMSO 
treatment (b) relative propidium ioide incorporation in C2C12 myoblasts after TGP or DMSO 
treatment (c-d) relative protein and mRNA levels of cell death and cell survival markers in C2C12 
myoblasts after TGP or DMSO treatment (e) relative mRNA levels of ER stress markers in C2C12 
myoblasts after TGP or DMSO treatment. Values represent 3-4 technical replicates in one 
experiment. Values are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 
indicate statistically significant differences between young and old animals of the same 
genotype or between cells treated with DMSO and TGP, # p<0.01; ## p<0.01; ### p<0.01; #### 
p<0.001 indicate statistically significant differences between cells with endogenous and 
overexpressed PGC-1α levels. 
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5. PGC-1α improves muscle motor skills and preserves 
locomotor activity during aging 
Results regarding balance performance, motor coordination and locomotor activity in 
old mice with abrogated and elevated PGC-1α expression not only demonstrated the ability of 
the coactivator to alleviate age-related muscle disorders but also reveals novel PGC-1α-
controlled motor skills. These ameliorations could arise from many different changes known to 
be triggered by PGC-1α in the muscle, such as enhanced muscle intrinsic function and 
metabolism (Lin, Handschin et al. 2005), improved neuromuscular junction communication 
(Handschin, Kobayashi et al. 2007, Arnold, Gill et al. 2014) and indirect central neuronal 
remodeling via muscle factor secretions (Kuipers and Bramham 2006, Wrann, White et al. 
2013, Agudelo, Femenia et al. 2014). In any case, the motor function data described above 
suggest that elevating muscle PGC-1α might be helpful to improve balance and motor 
coordination in the elderly, thereby improving life quality and preventing falls, which results in 
fractures and hospitalizations. In addition, PGC-1α modulation might be relevant for the 
treatment of other diseases that present with motor skills dysfunction, thus opening a whole 
new field of investigation. For example, amyotrophic lateral sclerosis is a motor neuron 
degenerative disorder that results in muscle weakness with loss of balance and motor 
coordination (Rowland and Shneider 2001, Lui and Byl 2009). Interestingly, it was reported that 
deletion of PGC-1α caused an earlier onset of the motor diseases in the amyotrophic lateral 
sclerosis SOD1(G93A) mouse model (Eschbach, Schwalenstocker et al. 2013). Another study 
demonstrated that overexpression of the transcriptional coactivator in muscle ameliorated 
endurance performance and locomotor activity in those mice (Da Cruz, Parone et al. 2012); 
however, potential ameliorations in balance and motor coordination  were not assessed in this 
study. Moreover, kynurenine metabolism has been identified as a pathomechanism of 
amyotrophic lateral sclerosis and multiple sclerosis, and kynurenic acid synthesis is considered 
to be a possible therapeutic candidate for the fight those diseases (Fuvesi, Rajda et al. 2012). 
The established role of muscle PGC-1α in the kynurenine pathway (Agudelo, Femenia et al. 
2014) further implicates the coactivator as a potential therapeutic target in the treatment of 
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those diseases and possibly represents a mechanism by which PGC-1α muscle transgenic 
expression improved the phenotype of SOD1(G93A) mice in the Da Cruz et al study. Likewise, 
PGC-1α overexpression improved endurance performance in a Duchenne muscular dystrophy 
mouse model, but its capacity to ameliorate other motor skill disabilities in those mice had not 
been tested yet (Handschin, Kobayashi et al. 2007). 
6. Limitations of the study 
While the work performed during this thesis allowed us to better understand the role of 
PGC-1α in muscle aging and to discover new functions of PGC-1α in muscle, different aspects of 
the study could have been optimized. Notably, we decided to use animals of 24 months of age 
as our aged groups, whereas older animals might have shown a broader and stronger 
phenotype and might have led to the discovery of a greater protective effect of PGC-1α. For 
example, while we did observe an age-associated loss of muscle strength and decline in isolated 
muscle masses when normalized to body weight in WT animals, we did not find a reduction in 
lean mass or muscle fiber cross-sectional area in those animals, suggesting that they were just 
at the onset of sarcopenia. This possibly masked a protective effect of PGC-1α in the old muscle 
against age-induced loss of muscle mass and precluded us from actually studying the 
mechanism of sarcopenia. Yet, the ideal age to study sarcopenia in mice is still a matter of 
debate. Notably, while sarcopenia occurs similarly in rats and humans, with a progressive loss of 
muscle mass and muscle function, mice tend to sustain their muscle mass for a longer time 
before a steep drop around 28 months of age. This severe drop might indeed represent a 
sarcopenia associated muscle mass reduction but could also arise from a drastic systemic failure 
and cancer-related cachexia, which would then make impossible to investigate the exclusive 
effect of sarcopenia. Further studies should be attempted to assess the best time point to study 
sarcopenia in mice, or in rats which would be an even better sarcopenic model according to the 
similar muscle aging pattern that they share with humans. Nevertheless, the decision to use 24 
month old animals was mainly based on the fact that the lifespan of PGC-1α muscle knock-out 
animals was unknown at this time. In addition, the previous work investigating the 
consequences of PGC-1α overexpression on muscle aging showed an increased lifespan of those 
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animals compared to WT mice (Wenz, Rossi et al. 2009). It was therefore very possible that 
mice lacking muscle PGC-1α would exhibit an opposite phenotype with a reduced lifespan. Since 
an aging study takes a considerable amount of time, we could not afford the risk of choosing an 
older time point and lose the majority of our knock-out animals. However, we found that mice 
with muscle deletion of PGC-1α had a similar lifespan compared to WT animals (data not 
shown). To our surprise, we also observed that mice with PGC-1α overexpression had a lifespan 
comparable to the one of WT animals (data not shown). The fact that 80% of WT animals were 
dead at the age of 24 months in the previous publication (Wenz, Rossi et al. 2009) whereas 
almost 90% of our WT mice were still alive at this age, similarly to what Jackson laboratories 
shows (https://www.jax.org/jax-mice-and-services/find-and-order-jax-mice/most-popular-jax-
mice-strains/aged-b6), strongly suggests that different housekeeping conditions between their 
study and our work drove the discrepancy in the observed lifespan and muscle mass loss. In 
addition, while we used 26 WT and 42 mTg animals for our survival curve, data presented in the 
previous study only included 12 WT and 17 PGC-1α overexpressing mice which might not be 
representative enough. Furthermore, the lifespan prolonging effect of PGC-1α could not be 
reproduced in later studies from the same group (interpersonal communication) making their 
assumptions about the effect of muscle PGC-1α on animal lifespan even less conclusive. 
 
In addition to the possibly suboptimal chosen animal age, the design of the study with 
the many different groups of mice forced us to test the animals in a staggered manner. 
Although the experiments with the different groups were all performed following the exact 
same protocol at the exact same period of the day, some parameters could not be controlled 
and might have led to increased variability between the groups. For example, construction 
works triggering vibrations were occurring sporadically for several days or weeks. Mice were 
always tested in the absence of such perturbations but the noise and the vibrations occurring 
outside of the test period might still have raised the general level of stress of some tested mice. 
Likewise, diverse animal caretakers handling the animals differently might also have generated 
various levels of anxiety in those animals.  
 
V. Discussion and outlook 
 
 
263 
 
Another problem that we encountered during the thesis was that although we tried to 
collect all possible organs in order to maximize the number of experiments that we could 
perform, we needed to decide the method for harvesting and treating all of the samples before 
having collected preliminary and informative molecular data. This limited us to perform only 
experiments that were compatible with the way we collected our samples. Especially, 
information about mitochondrial calcium uptake in aging muscles, as well as basal cytosolic 
calcium levels, would have provided valuable additional information about the protective role of 
PGC-1α against calcium dyshomeostasis in the aging myofiber. However, as we learned out 
about this particular function of PGC-1α only at the late stage of the thesis we did not have 
sufficient living animals at the appropriate age in all the groups of interest to perform those 
calcium assays that require freshly harvested muscle. Additionally, since PGC-1α has been linked 
to telomere protection in aged aortas (Xiong, Patrushev et al. 2015), it would have been 
interesting to correlate a protective role of PGC-1α in telomerase activity and telomere length in 
aged PGC-1α transgenic muscles, with concomitant reductions in cell death marker levels we 
observed. Unfortunately, those assays likewise necessitated fresh muscles. Furthermore, 
samples that were harvested at the beginning of the project were stored for a very long time. 
Following our results pointing towards a preventative role for PGC-1α against age-related 
apoptosis, we were eager to measure apoptosis with a Terminal deoxynucleotidyl transferase 
dUTP Nick-End Labeling immunostaining assay; however, it either failed to show a positive 
apoptotic signal in aging muscles or led to a false positive signal in young muscles, according to 
the protocol used. Immunolabeling of freshly isolated muscles from one young and one old 
animal showed the expected age-related increase in apoptotic signaling, demonstrating that 
long time storage made our samples unusable at least for some immunostainings. 
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7. Summary and outlook of the role of PGC-1α in skeletal 
muscle aging  
During this thesis we unraveled a novel aspect of metabolism in which PGC-1α 
contributes to slowing down skeletal muscle aging. While previously the main protective 
function of PGC-1α in the prevention of age-related muscle disorders was the preservation of 
mitochondrial oxidative functions (Wenz, Rossi et al. 2009), we now show that PGC-1α also 
controls and improves calcium homeostasis and ER stress through the regulation of 
mitochondrial calcium uptake and connection with SR during aging. At the same time, this thesis 
highlights a connection between mitochondrial dysfunction and calcium dyshomeostasis in 
aging muscle and shows that these are not necessarily distinct dysfunctional processes. 
Collectively, this improves our general understanding of transcriptional regulation of calcium 
metabolism in muscle and how PGC-1α can affect muscle metabolism. In addition, we 
demonstrated that positive effects of PGC-1α on age-associated muscle dysfunctions were not 
restricted to improving muscle endurance as previously described (Wenz, Rossi et al. 2009), but 
also impacted motor skills and muscle force. Taken together, these results suggest a therapeutic 
role for PGC-1α in muscle aging, but also in motor neuron disorders, such as amyotrophic lateral 
sclerosis and spinal muscle atrophy on one side and in calcium dysregulation associated 
diseases, such as central core disease or tubular aggregate myopathies on the other side. 
 
The newly highlighted functions of PGC-1α in calcium regulation and cell death 
prevention also open new domains of investigation regarding potential neuronal salvaging 
effects of the transcriptional co-activator in motor and neuromuscular diseases or other 
conditions involving calcium dysregulation in the central nervous system. Of note would be 
neuronal disorders, for many of which calcium dysregulations has been implicated in the 
pathogenesis. Upon ischemic injury, cellular calcium overload is thought to be a key player in 
neuronal death; addition of intracellular calcium chelators have been shown to protect neurons 
after stokes (Tymianski, Wallace et al. 1993). In addition, ER stress induced by calcium 
dyshomeostasis has been shown to contribute to neuronal cell death after a stroke (Paschen 
2003). Evaluations of brain tissue from patients with Parkinson, Huntington and Alzheimer 
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diseases all indicate a role for calcium overload in neuronal vulnerability to death. In Alzheimer 
disease patients, free and protein-bound calcium content, as well as activity of calcium-
dependent proteases, are increased in neurons containing neurofibrillary tangles as compared 
to tangle-free neurons (Murray, Landsberg et al. 1992, Nixon 2003). Αmyloid β-peptide causes 
an elevation of basal intracellular calcium levels through a mechanism involving the production 
of 4-hydroxy-2,3-nonenal, which sensitizes neurons to excitotoxicity and apoptosis (Mattson, 
Cheng et al. 1992, Mark, Hensley et al. 1995, Keller, Mark et al. 1997). Calcium metabolism is 
dysregulated in lymphoblast mitochondria and in the brain of Huntington disease patients, as 
well as in the central nervous system of Huntington disease mice (Bezprozvanny and Hayden 
2004). Lastly, spinal cord sections from amyotrophic lateral sclerosis patients showed a 
significant increase in the calcium content of motoneurons compared to control subjects 
(Kasarskis, Tandon et al. 1995). Of note, motor neurons exhibiting high levels of calcium-
binding proteins presented higher resistance to amyotrophic lateral sclerosis (Alexianu, Ho et 
al. 1994) and overexpression of the calcium-binding protein parvalbumin promotes motor 
neurons survival and delays disease onset in a mouse model of amyotrophic lateral sclerosis 
(Beers, Ho et al. 2001).  
 
Interestingly, PGC-1α is repressed in patients carrying these degenerative diseases 
(McGill and Beal 2006, Qin, Haroutunian et al. 2009, Zheng, Liao et al. 2010) and has been 
shown to exert a protective function against each of those neurological disorders (Cui, Jeong et 
al. 2006, Kim, Nguyen et al. 2007, Katsouri, Parr et al. 2011, Zhao, Varghese et al. 2011, Mudo, 
Makela et al. 2012). While until now the salvaging action mediated by PGC-1α and the 
dysfunction triggered by its repression were thought to be associated with mitochondrial 
function and oxidative stress alterations in neurodegenerative patients (Raymond 2016), our 
muscle data suggest that PGC-1α might also prevent neurological disorders by restoring 
disrupted calcium homeostasis and ameliorating ER stress response in neurons of those 
patients. In a similar manner, while mitochondrial defects and increased oxidative stress have 
been postulated to be at the origin of the neurodegenerative phenotype of PGC-1α brain and 
whole body knock out mice, because of the well-defined master role of PGC-1α in the regulation 
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of mitochondrial metabolism (Lin, Wu et al. 2004, Ma, Li et al. 2010), no evidence supporting 
this conclusion was actually provided and calcium homeostasis dysregulation might play a 
central role in the neurodegeneration of those animals. This leaves open a whole new field of 
study about the function and the benefits of PGC-1α in the preservation of calcium homeostasis 
in neurons, and further supports its therapeutic role in the treatment of neurodegenerative 
disorders. 
 
C. PGC-1α and exercise during muscle aging 
In the course of this thesis, the publication of a new paper about the investigations of 
PGC-1α muscle deletion on aging prompted us to push our investigations further and bring 
another dimension to the project to be able to differentiate ourselves from what had been done 
before. PGC-1α and exercise have many similar effects on muscle, such as increased 
mitochondrial function, NMJ remodeling and production of myokines (Gremeaux, Gayda et al. 
2012, Egan and Zierath 2013, Chan and Arany 2014, Schnyder and Handschin 2015). Moreover, 
exercise improves muscle aging disorders by ameliorating many of the above mentioned 
functions altered in aged muscles (Garatachea, Pareja-Galeano et al. 2015, Cartee, Hepple et 
al. 2016). Importantly, at least regarding some of those functions, PGC-1α is thought to mediate 
and to be required for the beneficial effect of exercise in young mice (Chan and Arany 2014) 
and in mouse models of premature aging (Leick, Lyngby et al. 2010, Safdar, Annis et al. 2016). 
However, the connection between exercise and PGC-1α during natural muscle aging is 
unknown. We therefore wanted to study the link between the positive effect of exercise and 
PGC-1α modulation during muscle aging. For that, we divided our groups of control, PGC-1α 
muscle deleted and PGC-1α muscle overexpressing mice into sub-groups that either received 
treadmill exercise for 3 months late in their lifespan or that stayed sedentary. This allowed us to 
evaluate the effects of exercise on muscle aging in a first time and to determine whether those 
effects were dependent on muscle PGC-1α expression and if they could be mimicked or even 
boosted by PGC-1α overexpression in muscle. 
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1. The effects of PGC-1α on exercise-controlled muscle 
enhancement during aging 
The results of this study revealed that PGC-1α expression at old age is required for some 
exercise-dependent muscle functions improvements but not for others. For example, increased 
maximal force and balance in old mice lacking muscle PGC-1α show that it is not required for 
theses specific beneficial effects of exercise. Conversely, absence of muscle PGC-1α completely 
abrogated exercise-mediated improvements in motor coordination and isometric strength. To 
our surprise, higher PGC-1α levels also abolished exercise-induced effects on isometric strength, 
indicating that there is an expression limit for PGC-1α's beneficial outcomes on muscle strength 
resistance when coupled with exercise. In addition to precluding exercise-dependent 
ameliorations on motor coordination and isometric strength, PGC-1α muscle deletion blunted 
exercise-mediated increase in muscle endurance. In accordance with this result, elevated 
muscle PGC-1α expression potentiated exercise effects on mice running capacities and lactate 
usage, further indicating that muscle PGC-1α does impacts specific exercise outcomes affecting 
muscle aging. In addition, PGC-1α muscle upregulation mimicked or even overridden exercise-
mediated improvements in almost all regards in the old muscle. This additionally suggests that 
exercise is acting through PGC-1α but that other cellular components might compensate for its 
absence and improve muscle function in PGC-1α deficient muscles upon exercise.  
 
Interestingly, with regard to muscle endurance and mitochondrial function and densities, 
the synergistic effect of exercise and PGC-1α muscle overexpression was superior to that of 
either exercise or PGC-1α upregulation alone. In humans, such an improved endurance would 
not only improve the quality of life of older adults but would also allow them to increase their 
exercise training intensity and duration, thereby potentiating any amelioration in age-related 
muscle disorders.  
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2. PGC-1α, exercise and caloric restriction 
While only a few treatments increase muscle PGC-1α levels, caloric restriction, which is 
one of the best prescription against muscle aging (Marzetti, Lees et al. 2009, Anderson and 
Weindruch 2010), has been shown to increase PGC-1α content in many tissues, including 
skeletal muscle (Ranhotra 2010, Handschin 2016). Thus, PGC-1α seems to be linked to both 
exercise and caloric restriction effects in muscle aging and might represent a common 
mechanism in those treatments. Similarly to exercise, caloric restriction-mediated induction and 
activation of PGC-1α is driven by the activation of SIRT1 and AMPK (Anderson, Barger et al. 
2008, Lettieri Barbato, Baldelli et al. 2012), which results in elevated mitochondrial biogenesis 
and function, possibly ultimately leading to improved muscle function and reduced muscle aging 
(Anderson, Shanmuganayagam et al. 2009). These pathways commonly induced by exercise 
and caloric restriction could be amplified by the combination or alternation of those treatments 
and therefore considerably increase muscle performances during aging. However, very strict 
patients monitoring should be observed during those treatments and appropriate and moderate 
caloric restriction should be given in order to avoid energy depletion. It would be additionally 
interesting to test if alterations in muscle PGC-1α expression would modulate those changes. 
Alternatively, one could conduct an aging study combining caloric restriction and PGC-1α muscle 
modulation, in a set up similar to our work on PGC-1α and exercise, to evaluate the potential of 
the coregulator to promote a caloric restriction effect on muscle aging. Although a recent study 
failed to show an elevation of metabolic improvements with the combination of caloric 
restriction and PGC-1α muscle upregulation upon high-fat diet (Wong, Mikus et al. 2015), the 
data mainly focused on systemic metabolism and did not investigate muscle function. In 
addition, another work showed that PGC-1α mediated mitochondrial adaptation and not 
metabolic changes upon caloric restriction, which indicates the importance of the 
transcriptional co-activator for caloric restriction effects in the context of muscle aging in which 
mitochondrial dysfunction plays a key role (Finley, Lee et al. 2012).  
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3. Distinct exercise regimes differentially affect muscle aging 
Exercise has long been recognized as one of the top prescription to reduce age-related 
muscle disorders. However, what still remains unclear is how to maximize the effect of exercise 
training on our muscles during aging. A relevant question is whether it is better to maintain a 
low intensity but regular physical activity regime throughout life or to start more intense 
endurance training later in life. In other words, are short and recent chronic exercise muscle 
adaptations more beneficial than permanent muscle changes acquired from consistent 
stimulation during life-long physical activity? To answer this question we gave life-long free and 
continuous running wheel access to a group of WT mice. We then compared the performance of 
those animals with the group of mice that received forced treadmill exercise only for the last 3 
months of their life and with the group of sedentary control mice. As we described in the study 
about the effect of PGC-1α and exercise, aging led to the reduction of all evaluated muscle 
functions (fig. 4a-g). Wheel and treadmill running both belong to the endurance type of exercise 
and therefore did not significantly affect maximal force. While resistance training is very 
challenging to set up with mice, this kind of exercise would have likely affected maximal muscle 
force in the aged mice (Fig. 4a). However, late-life treadmill exercise but not life-long physical 
activity significantly improved isometric force (Fig. 4b). Similarly, while both types of exercise 
improved balance performance at old age, only late-life treadmill exercise restored motor 
coordination (Fig.4c and d). Inversely, only life-long physical activity significantly ameliorated 
endurance and lactate utilization in old mice (Fig. 4e and g). Those results confirm that exercise 
increases general muscle function during aging but that different types of training impact 
distinct muscle dysfunctions.  
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Fig. 4: Life-long running wheel and late-life forced treadmill exercise effects on age-related 
muscle dysfunction (a) Maximal grip strength (b) isometric strength (c) balance (d) motor 
coordination (e) running endurance and (g) blood lactate levels pre- and post-exercise 
measured in 3 months old (WT Y), 24 months old sedentary (WT SO), 24 months old late-life 
treadmill trained (WT TO) and 24 months old life-long voluntary active (WRO) mice (n=8-12). 
Voluntary active mice were given free access to running wheel during their whole life. Values 
are mean ± SEM. *P < 0.05; **P < 0.01; ***; P < 0.001; ****p<0.0001 indicate statistically 
significant differences between young and old animals or between sedentary and 
exercised/voluntary active animals, # p<0.01; ## p<0.01; ### p<0.01; #### p<0.001 indicate 
statistically significant differences between late-life forced treadmill exercised and life-long 
voluntary active mice. 
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Several elements can explain the divergent impacts of life-long and late-life training. 
First, consistent life-long and shorter but recent muscle adaptations of late-life chronic exercise 
might lead to different muscle function ameliorations. Further molecular analyses are required 
to unravel the potentially divergent muscle adaptations triggered by life-long and shorter late-
life chronic exercise. However, some aspects of the exercise set-up could also be responsible for 
the observed changes. For example, the movements performed during treadmill exercise, 
where the mice need to adapt their steps to the belt rotation of the treadmill, and the 
movements on the rotarod are very similar. Therefore, forced treadmill exercise might actually 
provide a pre-training for the rotarod task and confer a serious advantage to this group of mice. 
Surprisingly, however, mice that received forced treadmill exercise training performed worse in 
the treadmill exhaustion test than mice that had free access to running wheels, while mice 
exercising with treadmill were actually already practicing this task when they were training. This 
could be due to higher endurance metabolism in mice that had access to running wheels, as 
suggested by their improved lactate utilization. Alternatively, these mice might be mentally 
better prepared for endurance test than mice that were forced to train. Indeed, it has been 
shown that mental preparation has a significant impact on athletic performance in professional 
sportsmen (Bar-Eli and Blumenstein 2004). In the case of mice, wheel running is addictive, and 
mice from which running wheels were removed have been reported to show signs of 
depression, demonstrating that running wheel activity increases the mouse's motivation to run 
(Novak, Burghardt et al. 2012, Nishijima, Llorens-Martin et al. 2013). On the other hand, It is 
very likely that forced treadmill training did not have the same positive mental impact on mice. 
Actually, the aversive and stressful stimulus used during treadmill training probably even 
increased anxiety levels in this group of mice along the endurance exhaustion test. The 
combination of improved endurance metabolism and mental resistance to fatigue therefore 
possibly both contributed to the increased endurance performance of the running wheel group 
compared to the treadmill exercise group. It would be interesting to dissect and evaluate brain 
rewarding signaling pathway alterations after forced and voluntary exercise, in addition to 
characterizing muscle metabolism and signaling pathways 
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The drawback of using running wheels as a model of life-long physical activity is that the 
duration and intensity of exercise cannot be controlled, and dramatically drops after 15 months 
of age (data not shown). Therefore, the absence of force and motor skills improvements in mice 
with life-long running wheel access might also arise from the fact that they had lower exercise 
intensities and amounts at the end of their life than the group of mice that received forced 
treadmill exercise.  
 
4. Limitations of the study 
While our results showed that exercise greatly improved age-related muscle and motor 
dysregulations in many regards, the mechanisms governing those ameliorations remain unclear. 
As described in the introduction of this thesis, exercise affects many muscle processes. 
However, we intriguingly did not find any histological or gene or protein expression alterations 
triggered by exercise (data not shown) in any signaling pathway we looked at in our aging 
studies, with the exception of increased OXPHOS protein expression and PGC-1α mRNA levels. 
Although we evaluated some possible changes at the protein levels, the majority of our data 
originates from gene expression analyses, for which changes are observable during acute 
exercise but disappear over chronic exercise (Egan, Hawley et al. 2016). It might therefore be 
more informative to examine protein post-translational modifications that can provide protein 
stabilization, prevent their degradation, or stimulate their activity, thereby triggering stable and 
lasting muscle adaptations. In addition, we did not evaluate changes in all processes altered by 
age and exercise. In an attempt to identify candidates mediating exercise effects and PGC-1α 
impacts on muscle aging, we sequenced the whole transcriptome of our different groups. The 
sequencing data are now ready to be analyzed and might reveal interesting candidates induced 
by PGC-1α modulation and exercise training. Even more informative would have been to 
perform deep sequencing of ribosome-protected mRNA fragments which reflects protein 
translation and predict protein abundance of the whole proteome. Unfortunately, lack of 
material precluded such an experiment. 
V. Discussion and outlook 
 
 
274 
 
 
5. Summary and outlook of the role and complementarity of 
PGC-1α and exercise in skeletal muscle aging  
In conclusion, this study showed that both exercise and PGC-1α improve age-related 
muscle disorders and that they work synergistically in many regards to achieve this aim. Our 
work now reveals that PGC-1α can be used to potentiate the beneficial effects of exercise on 
muscle dysfunctions and mitochondria protein expression during aging. This highlights a 
therapeutic role for PGC-1α, not only in the prevention of muscle aging, but also in supporting 
exercise in ameliorating age-related muscle disorders and possibly other muscle conditions for 
which exercise is advised. Further studies should however investigate the mechanisms and 
muscle adaptations driven by PGC-1α during exercise in the context of muscle aging. To take full 
advantage of the benefits of PGC-1α and exercise on muscle aging, it is important to identify 
which types of training are the most effective in slowing down sarcopenia and what methods 
could be used to increase PGC-1α levels in humans. The results of this thesis revealed the 
importance of PGC-1α in maximizing exercise-mediated prevention of muscle aging, settling up 
the foundations for forthcoming studies aimed at designing better treatments against age-
related muscle disorders. 
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